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CHAPTER 1 
1.0 INTRODUCTION 
 Cancer is an ailment in which cells escape from the normal regulatory mechanisms 
and behave ectopically, characterized by uncontrollable proliferation, unregulated 
differentiation, and invasion to surrounding tissues and organs (Laundry de Mesquita et al., 
2009). Cancer can be treated successfully by surgical removal of the tumours if the 
malignant cells are localized. However, most malignant tumours are capable of detaching 
from the primary tumour mass, entering the blood stream or lymphatic channels, followed 
by localization and growth of secondary tumours at new sites (Hayot et al., 2006). The 
dispersion of tumour within the body is known as metastasis which significantly results in 
mortality making cancer a devastating disease. 
 Conventional approaches for combating cancers, namely surgery, chemotherapy and 
radiation therapy are not effective in curing a patient with metastatic cancer. These 
therapies kill a large number of normal cells along with the cancer cells due to their low 
specificity. It is also a painfully evident that chemotherapy and radiation cause severe 
adverse effects, such as bone marrow suppression resulting in cytopoenia, and subsequent 
devastation of the immune responses (Devasagayam & Sainis, 2002), in addition to 
exhibiting limited curative value for most advance cancers.  Based on these scenarios, 
agents that can inhibit the metastatic activity of the cancer cells are considered as a 
promising cancer treatment. 
One approach to control metastasis cancer is through growth inhibition by which 
the disease can be prevented, slowed-down, or reversed substantially. As with any drug 
development, an empirical screening for examining the biochemical influences of the 
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agents are essential in order to understand the cytotoxic effects (Vani, Vanisree, & 
Shyamaladevi, 2006). 
 Many experimental studies and clinical trials indicated that natural immunity 
possesses the ability to control the growth of primary tumours and block metastasis 
(Schantz, Brown, Lira, Taylor, & Beddingfield, 1987). Macrophages and natural killer (NK) 
cells are the most relevant effectors among the immune-related cells that act against tumour 
cells (Andreesen et al., 1990; Barlozzari, Leonhardt, Wiltrout, Heberman, & Reynolds, 
1985). In addition, the activation of macrophages and NK cells are able to elicit functions 
which suppress tumour growth and inhibit metastasis activity (Yoon et al., 2004). Based on 
this scenario, the enhancement of host immune responses have been recognized as a 
potential avenue of inhibiting tumour growth without harming the host (Tu, Sun, & Ye, 
2008). Therefore, the search of novel therapeutic substances with immunomodulatory 
property is an important approach in the field of cancer treatment and prevention.  
 Numerous epidemiological, biological and clinical studies have indicated a strong 
correlation between dietary factors and cancer prevention (Rogers, Zeisel, & Groopman, 
1993; Surh, 2003). Herbs possess various pharmacological activities including antioxidant 
and anti-inflammatory effects which are associated with anti-mutagenic and anti-
carcinogenic properties (Bode, Ma, Surh, & Dong, 2001). Oxidative and inflammatory 
tissue damages occur mostly during the promotion stage. A compound with strong 
antioxidant and anti-inflammatory properties are believed to function as an anti-tumour 
promoter (Ippoushi, Takeuchi, Ito, Horie, & Azuma, 2007). In this study, the Zingiberaceae 
plants, which have proved to exhibit various biological properties, were opted for 
investigation. Investigations of nutraceuticals and phytochemicals as an alternative for 
cancer chemoprevention have become a flourishing field of research over the past decades 
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(Manson, 2003; Surh & Ferguson, 2003; Gosslau & Chen, 2004; Wei, Ma, Cai, Yang, & 
Liu, 2005).  
This main objective of this study is to evaluate the immunomodulatory and anti-
metastatic activities of ten selected local Zingiberaceae species, namely Alpinia galanga, 
Boesenbergia rotunda, Curcuma aeruginosa, C. domestica, C. mangga, C. xanthorrhiza, 
Kaempferia galanga, Zingiber officinale, Z. montanum, and Z. zerumbet. Each species were 
extracted with petroleum ether, chloroform and methanol using Soxhlet extractor system. A 
total of 30 crude Zingiberaceae extracts were obtained for the screening tests. Literally, the 
objectives include: 
(i) evaluation of the extracts for their immunomodulatory activities by screening on 
their nitric oxide (NO) inhibitory potentials in murine macrophages cells (RAW 
264.7) using NO assay, 
(ii) evaluation of the extracts for their anti-metastatic activities by screening their 
anti-proliferative potentials against human breast cancer cells (MDA-MB-231) 
using MTT assay, cell migration inhibition potentials on MDA-MB-231 cells 
using the scratch wound assay,  
(iii) examination of the most active extracts based on (ii) for their toxicity against 
human lung fibroblast cells (MRC-5) using MTT assay, and 
(iv) examination of the chemical groups for the most active extract screened using 
thin-layer Chromatography (TLC).  
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CHAPTER 2 
2.0 LITERATURE REVIEW 
2.1 Cancer 
Cancer is a genetic disease as it occurs when specific genes in an organism have 
undergone alterations. In most of the cases, it is not an inherited disease. The genetic 
alterations that lead to cancer ailments usually originate in the DNA of a somatic cell 
during the lifetime of the cancer patients, rather than inherited from the chromosomes of 
their parents. In contrast to other diseases that require modifications of a large number of 
cells, cancer is said to be monoclonal as it results from uncontrolled proliferation of a single 
wayward cells (Karp, 2008). 
Development of a malignant tumour or carcinogenesis is characterized by 
progression of permanent alterations in a single line of cells, which are able to attain many 
successive cell divisions and take years to complete. Each genetic change is responsible for 
a particular character of the malignant state, such as protection from apoptosis in order 
escape the host defence mechanism (Karp, 2008). These genetic changes result in lack of 
control of the cancer cells proliferation and consequently, forming malignant tumours 
which become increasingly less responsive to the body‟s normal regulatory machinery and 
better able to invade the surrounding healthy tissues and organs (Laundry de Mesquita et al., 
2009).  
Based on this concept, cells responsible for initiating cancer must be capable of 
acquiring large number of cell divisions in tumorigenesis. The most common solid tumours, 
such as those derived from breast, colon, prostate, and lung are arise in the epithelial tissues 
that are involved in a relatively high level of cell divisions. Since extensive cell divisions 
are critically important for tumour formation, two general scenarios have been considered 
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for the origin of tumours. The first scenario indicated that cancer arises from within a small 
population of stem cells in a tissue. Stem cells, which possess unlimited proliferation 
potential, undergo massive cell divisions to accumulate mutations required for malignant 
formation. In a different scenario, progenitor cells can form malignant tumours by 
acquiring certain properties, such as capacity of uncontrollably proliferation or tumour 
progression (Karp, 2008). However, these two scenarios are not mutually exclusive as 
whether the tumours arise from stem cells or progenitor cells depend on the types of cancer. 
In vitro system is a fundamental avenue to study the behavior of cancer cells. 
Different cell lines have their unique characteristics, while at the same time possessing 
similar basic properties of cancer cells. Normal cells and cancer cells have similar capacity 
to grow and divide when being cultured under the same condition with substantial growing 
media. However, the growth ceases when the proliferated normal cells cover the bottom 
layer of the culture dish, remaining as a monolayer. Grow rates decreases as normal cells 
respond to the inhibitory factors from the environment, such as depletion of growth factors 
in the culture medium or due to the contact between cells in the culture dish. In contrast, 
cancer cells grow indefinitely regardless of the growth signals. As a result, cancer cells 
grow continuously, pilling on top of one another and form clumps in the culture dish (Karp, 
2008).  
Cancer cells can grow in the absence of growth signals which are mandatory for 
growing normal cells. Therefore, cancer cells have the potential to grow without serum 
which provide the nutrition for cells, because the cell cycle for cancer cells are independent 
of the interaction between the growth factors and their receptors located on the cell surfaces. 
The ability of uncontrollable proliferation of cancer cells is due to the presence of 
telomerase in the chromosomes of the cancer cells. Telomerase is an enzyme that remains 
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telomeres at the tips of chromosomes, which keep promoting the cells for divisions. It is 
said that normal cells are protected against tumour growth by the absence of telomerase 
(Karp, 2008).  
Massive research effort on cancer treatments has been carried out for decades. 
Although the understanding of the cellular and molecular basis of cancer has increased 
through the years, there is still not much impact on reducing the incidence of cancer deaths. 
In addition, current cancer treatments, such as chemotherapy and radiation therapy not only 
lack the specificity in killing cancer cells, but also results in serious side effects to the 
patients (Karp, 2008).  
 
2.1.1 Carcinogenesis 
Carcinogenesis is a multi-step process which consists of three main stages such as 
initiation, promotion and progression. In the initiation stage, the genetic changes that occur 
during tumorigenesis are accompanied by histological changes. Cells with initial changes 
are identified as “precancerous”, indicating that the cells exhibit some cancerous properties, 
such as lack of growth control, but lack the capability to invade normal tissues or 
metastasize to distant sites. Alterations of the types and numbers of cell-adhesion molecules 
or interference of the cell-adhesion ability to other cells or to extracellular matrices are 
implicated in the promotion stage towards metastasis. The cancer progression involves the 
detachment of tumour cells from the primary tumour mass and dispersion to a new location 
far from the original points, which leads to the process of metastasis (Hayot et al., 2006).  
 The genes that are implicated in carcinogenesis can be grouped under two broad 
categories: tumour-suppressor genes and oncogenes. Tumour-suppressor genes encode 
proteins that restrain proliferation of the mutated cells and prevent the cells from becoming 
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malignant. Loss of functions of one or more tumour-suppressor genes lead to the 
transformation of a normal cell to a cancer cell. This is to say that, tumour-suppressor genes 
encode proteins that help maintain genetic stability. Most of the products encoded by 
tumour-suppressor genes act as negative regulators of cell proliferation. Thus, 
dysfunctional or elimination of the genes commonly results in lack of growth control (Karp, 
2008). 
Oncogenes, on the other hand, encode proteins that promote uncontrolled cell 
growth and the conversion of a cell to malignant state. Most oncogenes facilitate cell 
proliferations, but they are also implicated in other roles. Oncogenes interfere with the 
cell‟s normal activities, which lead to genetic instability, and may even promote metastatic 
activity. Genetic alterations such as gene mutation, gene duplication, or chromosome 
rearrangement can cause a cell to function abnormally to normal growth controls, leading it 
to behave as a malignant cell. Oncogenes are the dominant genes, which mean that a single 
copy of an oncogene can alter the phenotype of the cell, regardless of whether or not there 
is a normal gene on the homologous chromosome (Karp, 2008).  
Oncogenes were discovered through the investigation of RNA tumour viruses. The 
existence of oncogene in RNA viruses encode protein that interfere with the cell‟s normal 
regulatory system and thus transform the normal cell to malignant state. Mutation in one of 
the two copies (alleles) of an oncogene may be sufficient to cause a cell to lose growth 
control. In contrast, both copies of a tumour-suppressor gene must be knocked out in order 
to induce the same effects. Oncogenes arise from proto-oncogenes due to the result of gain-
of-function mutations, i.e., mutations that cause gene product to exhibit new functions that 
lead to malignancy. On the other hand, tumour-suppressor genes suffer loss-of-function 
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mutations and/or epigenic inactivation that render them unable to restrain cell growth 
(Figure 2.1) (Karp, 2008). 
 
 
Figure 2.1: Contrasting effects of mutations in (a) tumour suppressor genes and (b) 
oncogenes (Karp, 2008). 
 
2.1.2 Cancer Metastasis 
Malignant tumours are ranked as the second largest deadly disease after heart 
disease (Tu, Sun, & Ye, 2008). Neoplastic disease detected early can be cured successfully 
through the removal of the primary tumours as solid cancer in the early stage is often 
localized. However, more than 90% of the mortality for cancer patients is not due to 
primary tumour but the dissemination of the primary tumours to secondary sites by a series 
of events known as the metastatic cascade (Entschladen, Drell IV, Lang, Joseph, & Zaenker, 
2004; Fidler, 1991; Liotta, Steeg, & Stetler-Stevenson, 1991; Sporn, 1996).  
Cancer metastasis consists of a complex cascade of events that ultimately allow 
tumour cells to escape and grow (Yoon, Kim, & Chung, 2001). Metastasis is characterized 
by a series of sequential events involving loss of intercellular cohesion, cell migration, 
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angiogenesis, accession to the systemic blood circulation (intra-vasation), survival in 
circulation, arrest and subsequent extra-vasation, evasion of local immune responses, as 
well as growth at distant organs (Chambers et al., 2001; Fidler, 1999). An estimation of 3 – 
4 × 10 cells/g of tumour can reach the blood stream per day in animal models. However, 
only a minority of those cancer cells will survive and grow at distant sites (Fidler, 1970; 
Weiss, 1990). 
Metastatic cells are cancer cells that are able to initiate the formation of secondary 
tumours. They are thought to exhibit unique properties that are distinct from other cells in 
the tumours. Metastatic cells must be less adhesive than other cells in order to detach from 
the tumour mass. Besides that, metastatic cells must be capable of penetrating numerous 
barriers, such as the extracellular matrices of surrounding connective tissue as well as the 
basement membranes that line the blood vessels that carry them to distant sites. In addition, 
the cells must able to invade normal tissues to form secondary colonies (Karp, 2008).  
Bone is one of the most frequent sites of metastasis. Breast cancer is one of the 
leading causes for the majority of the skeletal metastases (Cecchini, Watterwald, van der 
Pluijm, & Thalmann, 2005). Many researches on the molecular mechanism of breast cancer 
development have been carried out, however, pathway for initiating the development of 
breast malignancy still remain elusive (Choi et al., 2009). 
Based on Figure 2.2, invasive phenotypes, such as loss of cell-cell adhesion, 
increased motility, and matrix degradation are conferred by epithelial mesenchymal 
transition (EMT). At the same time, primary tumour promotes angiogenesis, which aid in 
access of the cancer cells to the systemic circulation, through a process known as 
intravasation. This event is followed by aggregation between cancer cells, platelets and 
leukocytes to form cell emboli. The aggregation protects the tumour cells from immune 
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responses and facilitates arrest in the bone capillaries by a mechanical mechanism and by 
adhesion to bone marrow endothelium-specific cell adhesion molecules. Chemokines and 
bone matrix molecules mediate their bone marrow or bone microenvireonment. Cancer 
cells are exposed to the survival and growth support normally exerted on haemopoietic 
cells by marrow stromal cells, known as stromal fibroblasts and tissue macrophages, as 
well as endothelial cells. Furthermore, osteoblasts and osteoclasts, or matrix-integrated 
secrete bone cytokines, which are released and activated during bone reabsorption, and 
contribute critically to survival and proliferation of the metastatic cancer cells (Cecchini et 
al., 2005).  
 
 
Figure 2.2: Series of events involve in cancer cell metastasis from primary tumour sites to 
the skeleton (Cecchini et al., 2005). 
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 Breast carcinoma cells lack tight junctions (TJs) (Hoover, Liao, & Bryant, 1998), 
resulting in loss of cell-cell adhesion essential for tumour invasion (Glukhova, Koteliansky, 
Sastre, & Thiery, 1995). TJs are the association areas of two cells whose membranes adhere 
together to form a primary barrier for paracellular transportation of solutes across the cells 
(Figure 2.3). TJs play crucial roles in holding adjacent cells together. Besides that, it helps 
to maintain epithelial cell polarity by acting as diffusion barrier for protein and lipid 
transportation within the plasma membrane (Choi et al., 2009). TJs also prevent the passage 
of molecules or ions through the spaces between cells, which is to control over substances 
that are allowed to pass through. In precancerous lesions of the epithelial and cancerous 
epithelial, TJs‟ functions are interfered and destructed as TJs strands become disorganized 
or lost altogether (Soler et al., 1999). 
 Tight junctions consist of a variety of claudins, which form homodimers or 
heterodimers to produce paired strands between adjacent cells, are the major integral 
membrane proteins that structure the backbone of TJs. Several studies have reported that 
aberrant claudins are found in various cancers that function distinctly as in the TJs 
complexes. For example, claudin-3 and claudin-4 are overexpressed in breast carcinoma 
cells and in metastatic cells in particular, that the cells possess great tendency to spread to 
other sites (Kominsky, 2006). However, the roles of claudin overexpression in metastasis 
cancer development are still remained unclear (Choi et al., 2009). 
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Figure 2.3: Schematic diagram showing an intercellular junctional complex. The complex 
consists of a tight junction (zonula occludems), adherens junction (zonula), and desmosome 
(macula adherens). Adherens junction and tight junction encircle the cells. Desmosomes 
and gap junctions are restricted to particular site between adjacent cells. Other gap 
junctions and desmosomes are located deeper along the lateral surfaces of the cells (Karp, 
2008).  
 
 A family of Zn-dependent endopeptides, known as matrix metalloproteinase 
(MMPs) is also implicated as possible mediators for invasion and penetration of 
extracellular matrices (ECM) components including collagen, fibronectin, and lamina in 
metastasis of breast cancers. MMPs are ECM-digesting enzymes which play important 
roles in several biological processes, but are also collectively capable of cleaving virtually 
all extracellular matrix substrates that implicated in various physiological and pathological 
processes in metastasis (Zucker, Cao, & Chen, 2000; Mook, Frederiks, & Van Noorden, 
2004). In cancer metastasis, these enzymes degrade the proteins and proteoglycans 
resulting in cancer cell migration. In addition, MMPs that cleave certain proteins of ECM 
produces active protein fragments that act back on the cancer cells to stimulate their growth 
and invasive characters.  
Studies have found that mRNA transcripts of MMP-2 and MMP-9 are 
overexpressed in breast cancer cells (Canning, Postovit, Clarke, & Graham, 2001; Bartsch, 
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Staren, & Appert, 2003). Both MMP-2 and MMP-9 are implicated with the invasive 
metastatic potential of tumour cells (Choi et al., 2009; Rose, Huang, Ong, & Whiteman, 
2005). MMPs have become a prominent target of the pharmaceutical industry due to their 
apparent roles in the development of malignant tumours. Since synthetic MMP inhibitors 
were demonstrated to be able to reduce metastasis in vivo, several clinical trials were 
conducted. Unfortunately, the inhibitors only hold a little promise in treating late-stage 
tumour progression. In some cases, the inhibitors show adverse effect such as joint damage. 
To date, Periostat is the only MMP inhibitor approved by Food and Drug Administration 
(FDA) for treating periodontal disease. 
 
2.1.3 Angiogenesis 
Angiogenesis is the process of new blood vessel development from the pre-existing 
vascular network, which is regulated by the balance of various stimulators and inhibitors 
(Folkman, 2006). Development of new blood vessels occurs mostly during embryogenesis 
and pathogenic periods. New blood vessels are developed via two distinct processes, 
namely vasculogenesis and angiogenesis. Vasculogenesis involves the formation of 
vascular cells that originate from undifferentiated precursors. On the other hand, 
angiogenesis is responsible for the vascularization in embryos, growing and repairing 
tissues, as well as in the uterine and ovarian cycles (Goodwin, 2007; Ribatti, Vacca, Nico, 
Roncali, & Dammacco, 2001). 
Physiological angiogenesis is under strict regulation, which activated only when 
development or tissue repair are required. However, disruption of the balance between 
stimulating and inhibiting factors, leads to excessive blood vessels formation and 
consequently, results in pathological angiogenesis (Kim, Lee, Kim, Yu, & Kim, 2009). 
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Either insufficient or excessive blood vessel formations results in diseases pathogenesis 
which are critically fatal. Excessive blood vessel formations through angiogenesis have 
been found in disorders, such as cancer, rheumatoid arthritis, and retinopathies (Goodwin, 
2007). As tumour grows in size, it stimulates the formation of new blood vessels. Blood 
vessels function to deliver nutrients and oxygen to the tumour and remove waste products 
from the tumour. Besides that, new blood vessels formed provide the conduits for cancer 
cells and facilitate them to disperse and spread to other sites in the body (Karp, 2008).  
 
Sequence of Events during Angiogenesis 
Angiogenesis involves a sequences of events, such as degradation of the 
extracellular matrix surrounding the parent vessel, migration and proliferation of the 
endothelial cells and mural cells to adduct the new vessel, as well as morphogenesis by 
forming lumen and smooth muscle cells associated with the mural cells (Goodwin, 2007; 
Carmeliet, 2000) (Figure 2.4). Endothelial cells are the major constituent for developing 
new blood vessels. 
 
 
Figure 2.4: Stages of endothelial cell functions involve in angiogenesis (Goodwin, 2007) 
 
Matrix degradation is the primary event for vessel sprouting, which involves 
degradation of the laminin-rich basement membrane surrounding the endothelial cells, and 
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proteolysis of the collagen-rich extracellular matrix of the surrounding connective tissues. 
This process is followed by activation of angiogenic proteins or secreting matrix- or 
membrane-bound growth factors that facilitate angiogenesis by the tumour cells (Davis & 
Senger, 2005; Pepper, 2001, Rundhaug, 2005; van Hinsbergh, Engelse, & Quax, 2006).  
Matrix degradation is carried out proteases, typically MMPs, as well as other 
metalloproteinases, cysteine cathepsins, serine proteases, and aminopeptidases. Activated 
MMPs digest matrix components, such as collagen, fibrin, laminin and fibronectin in order 
to separate the endothelial cells for sprouting (Rundhaug, 2005; van Hinsbergh et al., 2006). 
Based on the functions of MMPs and other proteases that facilitate tumour invasion and 
angiogenesis, agents that inhibit their activities have been tested as anti-cancer agents 
(Egeblad & Werb, 2002; Liekens, De Clercq, & Neyts, 2001; Mannello, Tonti, & Papa, 
2005; Overall & Lopez-Otin, 2002).  
Matrix degradation of endothelial cells is followed by the migration process. 
Endothelial cells migrate to surrounding tissues in response to angiogenic chemokines. 
Growth factors facilitate endothelial cell motility by causing random cell movement 
(chemokinesis) or directed migration toward a stimulatory factor (chemotaxis) (Goodwin, 
2007). Since cell migration is significant in tumour invasion and tumour angiogenesis, anti-
cancer agents that can prevent or halt the migration activity can be an effective cancer 
therapeutic avenue. 
Once the endothelial cells are migrated, tumour cells secrete growth factors, such as 
VEGF, that act on the endothelial cells of the surrounding blood vessels, and stimulate 
them to proliferate and develop into new blood vessels (Karp, 2008) (Figure 2.5). Finally, 
endothelial cells must assemble in an appropriate order to acquire the morphology of vessel 
tubes (Goodwin, 2007). 
16 
 
 
Figure 2.5: Angiogenesis and growth of primary tumour. In step 1, primary tumour 
proliferates to form a small mass of cells. The tumour remains very small (1–2 mm) as long 
as it is avascular (without blood vessel). In step 2, the tumour mass has produced 
angiogenic factors that stimulate the endothelial cells to grow toward the tumour cells. In 
step 3, the tumour has vascularized and capable of unlimited grow (Karp, 2008). 
 
Naturally occurring inhibitors of angiogenesis are endostatin and thrombospondin. 
Biotechnology companies have developed various angiogenic inhibitors for cancer 
treatment studies. Development of angiogenic inhibitors are a promising cancer therapy 
because they do not interfere with normal physiological activities as angiogenesis is not a 
required activity in a mature adult. Besides that, angiogenic inhibitors act on cell lining of 
the bloodstream, which can directly accessible to blood-borne drugs, and should be 
effective against various types of tumours. Although angiogenic inhibitors were effectively 
inhibit tumour growths in preclinical studies on mice and rats, inhibiting angiogenesis in 
human tumours are far more complicated and difficult to achive (Karp, 2008). To date, the 
best anticancer strategy is still prevention and early detection. 
 
2.2 Innate Immune Responses  
Innate immune responses are non-specific, quickly recognizing and responding to a 
broad range of microbes regardless of their actual identity. The most prominent defense 
mechanism is phagocytosis, the ingestion of invading microorganisms by phagocytes 
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(Campbell & Reece, 2005). Phagocytes, such as macrophages and dendritic cells mount the 
initial contact with any invading pathogens. These phagocytes possess a great variety of 
receptor proteins on their surface that can identify certain highly conserved 
macromolecules belonging to foreign viruses and bacteria. Several pathogen receptors have 
been identified, the most prominent of which are the Toll-like receptors (TLRs) (Karp, 
2008). 
Humans can express at least ten functional TLRs which are made up of 
transmembrane protein, and located on the surfaces or within certain cytoplasmic 
membranes of many distinct cell types. These receptors possess the ability to recognize the 
lipopolysaccharide or peptidoglycan components on the bacterial cell wall, the protein 
flagellin on the bacterial flagella, double-stranded RNA in replicating viruses, and 
unmethylated CpG dinucleotides on bacterial DNA. Activation of TLRs by pathogen-
derived molecules leads to a series of signal transduction within the cell and eventually 
resulting in the activation of a variety immune defence response including the adaptive 
immunity. Therefore, agents or drugs that can stimulate the activity of TLRs are believed to 
be able to enhance the body‟s immune responses (Karp, 2008).  
Innate immune responses to invading pathogens are always accompanied by the 
process of inflammation at the infected area, where fluid, cells, and dissolved substances 
leak out of the blood into the affected tissues. During inflammation, the body defense 
agents concentrate at the affected site, causing local redness, swelling, and fever (Campbell 
& Reece, 2005; Karp, 2008). Phagocytic cells will move to the affected area in response to 
the chemoattractants released at the site, recognize, engulf, and then destroy the pathogen. 
However, the process of inflammation must terminate in a timely manner as prolonged 
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inflammation results in damages to the body normal tissues and eventually lead to chronic 
diseases (Campbell & Reece, 2005). 
Phagocytosis is not the sole mechanism in the innate immune response against 
extracellular pathogens. Epithelial cells and lymphocytes secrete a variety of antimicrobial 
peptides or defensins, which are able to bind to viruses, bacteria or fungi and destroy them. 
Besides that, blood contains soluble protein, called the complement which is able to bind 
and trigger destruction to the pathogen (Campbell & Reece, 2005). 
On the other hand, innate immune response to intracellular pathogen is basically 
protected by a non-specific lymphocyte, called natural killer (NK) cell. NK cells are not 
phagocytic, but they attach to the infected cells, and induce apoptosis to the cells (Campbell 
& Reece, 2005). Normal cells possess surface molecules that protect them from being 
attacked by the NK cells. There is another type of innate antiviral response, which is 
initiated by the infected cell itself. The virus-infected cells secrete a substance, called type-
1 interferons (interferon α and interferon β) into the extracellular space, where they bind to 
the surface of non-infected cells, rendering them resistant to infection (Karp, 2008).  
Innate immune responses work closely with the adaptive immune response to 
accomplish the whole immune defence with the adaptive immunity, organisms are able to 
effectively destroy specific microorganisms, cancer cells and viruses (Campbell & Reece, 
2005). Phagocytic cells and NK cells are two important elements for stimulating the much 
slower, more specific adaptive immune responses.  
 
2.2.1 Macrophage 
Phagocytes (macrophages, monocytes, dendritic cells, and neutrophils) are the key 
participants in the innate immune responses as they form the first line defense against 
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invading pathogens after the physical barriers provided by epithelial layers. Macrophages 
are ancient and phylogenetically-conserved, long-lived cells, which constitute about 5% of 
the circulating white blood cells. Macrophages originated from the blood monocyte in all 
multicellular organisms (Schepetkin & Quinn, 2006).  
Based on Figure 2.6, a hematopoietic stem cell can give rise to myeloid progenitor 
cell and lymphoid progenitor cell. A myeloid progenitor cells can differentiate into various 
blood cells (e.g., erythrocytes, basophils, and neutrophils), macrophages, or dendritic cells. 
A lymphoid progenitor cells can differentiate into various types of lymphocytes, such as 
NK cells, T cells, or B cells. T-cell precursors migrate to the thymus where they 
differentiated into T cells; whereas B cells undergo differentiation in the bone marrow 
(Karp, 2008). 
 
Figure 2.6: Differentiation pathway of a bone marrow hematopoietic stem cell (Karp, 2008) 
 
Macrophages play an important role in the innate immune responses against foreign 
agents. Some macrophages patrol throughout the body, while others reside permanently in 
certain organs or tissues. (Campbell & Reece, 2005). The functions of macrophages include 
surveillance, chemotaxis, phagocytosis resulting in destruction to the targeted organisms, 
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such as fungi, bacteria, and virus-infected cells (Beutler, 2004). Besides that, macrophages 
are also involved in tissue remodeling during embryogenesis, wound repair, removal of cell 
debris or apoptotic cells and hematopoiesis (Klimp, de Vries, Scherphof, & Daemen, 2002; 
Lingen, 2001). In addition, macrophages act as antigen-presenting cells to T lymphocytes 
in order to activate the adaptive immune responses (Kinne, Brauer, Stuhlmuller, Palombo-
Kinne, & Burmester, 2000). Therefore, macrophage is the key event for initiating adaptive 
immunity. 
Activation of macrophages occurs when the host is stimulated by foreign pathogens 
or injury. Macrophages possess TLRs on the surface, which can recognize 
lipopolysaccharides and peptidoglycan present on the surface of foreign pathogens, such as 
bacterial cell wall. The overall activation is a complex system that requires a series of 
intracellular signaling events controlled by a variety of signaling enzymes, such as protein 
tyrosine kinases, phosphatidylinositol 3-kinase/Akt, mitogen-activated protein kinases 
(MAPKs), as well as various transcriptional factors, such as nuclear factor [NF]-κB (Sekine 
et al., 2006).  
Activated macrophages function prominently in the host defense against neoplastic 
growth in experimental tumour systems (Kimoto et al., 1998; Oršolić & Bašić, 2003). Upon 
activation, macrophages release numerous pro-inflammatory cytokines (e.g., tumour 
necrosis factor [TNF]-α and interleukin [IL]-1), chemokines and chemoattractants (e.g. IL-
8 and monocyte chemoattractant protein [MCP]-1), as well as cytotoxic and inflammatory 
molecules (e.g., nitric oxide [NO], reactive oxygen species [ROS], and prostaglandin [PG] 
E2). These secretory products are involved in the destruction of susceptible tumour cells 
and inhibition of DNA synthesis in target cells (Stuehr & Nathan, 1989). The production of 
cytokines, nitric oxide, and prostaglandin are mediated by the activation of the transcription 
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factor, NF-κB. In addition, up-regulation of the surface levels of glycoprotein (e.g., 
costimulatory molecules [CD80 and CD86]) and adhesion molecules (e.g., selectins and 
integrins) of macrophages occurs simultaneously (Bresnihan, 1999; Burmester, Stuhlmuller, 
Keyszer, & Kinne, 1997; Gracie et al., 1999). 
Activation of macrophages are important in the field of imunomodulation as its 
secretory products involve in regulating activities of B- and T-cells (Oršolić, Knežević, 
Šver, Terzić, & Bašić, 2004). However, the overall event must be controlled and regulated 
delicately as excessive secretions of macrophages-derived inflammatory molecules are 
toxic to normal tissues and causes chronic inflammatory diseases, such as septic shocks, 
rheumatic arthritis, and arteriosclerosis (Gracie et al., 1999; Michaelsson et al., 1995; 
Stuhmuller et al., 2000). Therefore, effective regulations of macrophages are the key 
element for enhancing the body defense mechanisms. 
 
2.2.2 Inflammatory responses 
Inflammation is one of the primary responses to infection. Tissue injury or invading 
pathogen leads to the production of various chemical signals (e.g., histamine) that results in 
the initiation of localized inflammatory response. Histamine released by mast cell triggers 
dilation and increases permeability of nearby capillaries. Activated macrophages discharge 
additional chemical signals (e.g., prostaglandins) and pro-inflammatory molecules (e.g., 
NO and ROS) that promote blood flow to the injured site. Increased blood supply to the 
injured area results in local redness, heat, and swelling (Campbell & Reece, 2005).  
Vascular changes during inflammation facilitate transportation of antimicrobial 
protein and clotting materials to the injured area. Chemokines secreted by blood vessel 
endothelial cells near the injured site attract the migration of macrophages to the injured 
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area and trigger phagocytosis. Blood clotting components aid in repairing the wound and 
blocking the spread of microbe to other parts of the body. Toxins from pathogens and 
chemical substances released by macrophages set the body‟s thermostat at a higher 
temperature, causing fever to the patient. Moderate fever can promote phagocytosis but 
sustainable high fever can be fatal (Campbell & Reece, 2005).   
Local inflammation occurs with minor injury or infection. When severe tissue 
damages and infectious occur, the body mounts a systemic (widespread) inflammatory 
response. In this case, injured cells secrete various chemicals that induce the bone marrow 
to produce more neutrophils (Campbell & Reece, 2005). Neutrophils, a phagocytic 
leucocyte capable of carrying out a rapid, nonspecific attack on invading pathogens, 
normally present in the blood stream are stimulated to transverse the endothelial layer that 
lines the smallest veins (venules) in the region and enter the tissue. Members of leucocytes 
increase by several folds within several hours of the initial inflammation event (Campbell 
& Reece, 2005). 
More serious bacterial infections can trigger an overwhelming systemic 
inflammatory response, known as septic shock. This condition is characterized by very high 
fever and low blood pressure which can lead to death (Campbell & Reece, 2005). Besides 
that, an overzealous inflammatory response can also leads to asthma, toxic shock syndrome, 
and respiratory distress syndrome (Karp, 2008). Literally, local inflammation is essential 
for healing but systemic inflammation is devastating. 
 
2.2.3 Cytokines 
Cytokines are regulatory polypeptides and low-molecular proteins produced by 
virtually all cells in response to the presence of appropriate stimuli (Thompson, 1998; Tu et 
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al., 2008). One of the most common stimuli is lipopolysaccharide (LPS) from gram 
negative bacteria, which stimulate, increased gene expression for various cytokines 
including TNF-α and IL-1β (Evans, Kamdar, & Duffy, 1991) and inducible nitric oxide 
synthase (iNOS) which catalyzes the conversion of arginine to citrulline and secretes NO 
(Bogdan, 2001). TNF-α and IL-1 are two main cytokines involved in the initiation of 
inflammatory responses.  
LPS binds to its specific receptor CD14 on the surface of macrophages, through 
LPS-binding plasma protein (Barbour, Wong, Rabah, Kapur, & Carter, 1998; Kim et al., 
2006) in order to elicit the pro-inflammatory signals. Exposure of LPS increases the 
expression of CD14 (Barbour et al., 1998; Kim et al., 2006) as well as its co-stimulatory 
molecules including CD40 (Grewal & Flavell, 1996), CD80, and CD86 also present on the 
surface of macrophage (Hathcock, Laszlo, Pucillo, Linsley, & Hodes, 1994). The gene 
expression for cytokines production is partly regulated by activated transcription factors, 
such as NF-κB and AP-1 (Lantz, Chen, Solyom, Jolad, & Timmermann, 2005). 
Cytokines plays a pivotal role in the immune system as many immune-related 
disease conditions are associated with the alterations in cytokine network, which may 
interfere with TH1/Th2-type immunity (Xing & Wang, 2000). The subclasses of T helper 
(CD4
+
) lymphocytes exhibit Th1 and Th2 cells which are responsible in secreting various 
cytokines. Mature Th1 cells synthesize IL-2, IFN-γ, and TNF-α, whereas Th2 cells generate 
IL-4, IL-5, IL-6, IL-9, IL-10. However, Th1 and Th2 cells do secrete the same cytokines 
such as IL-3, and GM-CSF (Mossman & Coffman, 1989; Rosmagnani, 1994).  
Th1 and Th2-type cytokines play two distinct roles in the immune system. Th1-type 
cytokines are effective in eliminating cancer cells, whereas Th2-type cytokines inhibit the 
Th1-mediated anti-cancer activity (Gorelik, Prokhorova, & Mokyr, 1994; Takeuchi et al., 
24 
 
1997). An imbalance between Th1 and Th2 cytokine productions can result in various 
infections and autoimmune diseases (Kmoníčková, Melkusová, Farghali, Holý, & Zídĕk, 
2007). For example, a shift from Th1 to Th2 predominance can promote progression of 
AIDS and deteriorate the conditions of HIV-infected patients (Clerici & Shearer, 1992; 
Klein et al., 1997).  
Since Th1/Th2 balance is significant in maintaining the homogeneity of the immune 
system, the manipulation of cytokine network has been the central paradigm for successful 
immunotherapy (Kmoníčková et al., 2007). Although IL-2, IL-4, and IL-7 possess 
immunomodulatory properties to cure cancer patients, the research for new drugs that can 
modulate the cytokine productions has garnered attention in the immunopharmacological 
area. Table 2.1 shows the action of certain cytokine produced by macrophages. 
 
Table 2.1: Action of certain cytokines produced by macrophages (Campbell & Reece, 2005) 
Cytokine Local Effects
1
 Systemic 
Effects 
Interleukin-1 (IL-1) Tissue destruction;  
increase access off other leukocytes 
Fever 
Interleukin-6 (IL-6) Stimulates adaptive immune  
response (antibody production) 
Fever 
Interleukin-8 (IL-8) Chemotactic factors;  
attracts leukocytes including neutrophils  
to infected area 
 
Interleukin-12 (IL-12) Activates NK cells; also induces CD4  
T cells to differentiate 
 
Tumour-necrosis factor-
alpha (TNF-α) 
Increases permeability of blood capillaries  
in infected area 
Fever; shock 
1
 Most cytokines exert multiple effects; the cytokines listed here are the most relevant. 
 
2.2.4 Nitric Oxide 
Nitric Oxide (NO) has been implicated in various diseases such as cancer, 
rheumatoid arthritis, diabetes, liver cirrhosis, septic shock and cardiovascular diseases 
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(Lechner, Lirk, & Rieder, 2005). NO is an inorganic gaseous free radical synthesized by 
amino acid L-arginine in a reaction that requires oxygen and nicotinamide adenine 
dinucleotide phosphate-oxidase (NADPH) and catalyzed by the enzyme nitric oxide 
synthase (NOS) (Konkimalla, Blunder, Bauer, & Efferth, 2010). Two main types of 
distinguishable NOS are known. They are constitutive isoform (cNOS) and inducible nitric 
oxide synthase (iNOS).  
Constitutive isoform, cNOS is subdivided into neuronal (nNOS) and endothelial 
(eNOS) NOS which is calcium-dependent and produce only low concentrations of NO for 
mediating tissue homeostatsis (Min et al., 2009). Sustainable NO release by cNOS is to 
actively vasodilate the vasculature in order to maintain normal blood pressure (Kim, 
Murakami, Nakamura, & Ohigashi, 1998). On the other hand, iNOS generates a large 
quantity of NO, plays an important role in various physiological and pathophysiological 
conditions such as tumoricidal, bactericidal, inflammatory and immunoregulatory activities 
(Ippoushi, Azuma, Ito, Horie, & Higashio, 2003; Konkimalla et al., 2010).  
Nitric oxide generated by iNOS defends against pathogens and regulates immune 
system, but overproduced NO by up-regulation of iNOS is known to be carcinogenic as 
high level of NO can result in mutagenesis through NO-mediated DNA damage, 
deamination of DNA bases or hindrance to DNA repair (Felley-Bosco, 1998). Absence of 
NO can even stimulate tumour growth and cancer metastasis through the promotion of 
migratory, invasive, and angiogenic activities of tumour cells (Murakami & Ohigashi, 2007; 
Perwez Hussain & Harris, 2007; Sawa & Oshima, 2006). Thus, excessive NO generations 
during chronic infection or inflammation can lead to carcinogenesis (Ippoushi et al., 2003).  
Overproduced intracellular NO usually reacts with superoxide anions resulting in 
the formation potent oxidizing and nitrating molecules such as peroxynitrite (ONOO
-
). 
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Peroxynitrite is reactive nitrogen species (RNS) which is toxic to mitochondrion as well as 
macromolecules such as DNA, proteins and lipids (Ippoushi et al., 2003) and eventually, 
causing cell death to the surrounding tissues, destructing the tissue homeostasis (Coleman, 
2001). Moreover, macrophages will further increase the NO and superoxide anion (O2
-
) 
production during inflammation, reacts spontaneously with each other to generate 
peroxynitrite (Ischiropoulos, Zhu, & Beckman, 1992; Xia & Zweier, 1997). Peroxynitrite 
formed activates two types of rate-determining enzymes for prostaglandin biosynthesis, 
known as the constitutive and inducible forms of cycloxygenase (COX-1 and COX-2) 
during the inflammation conditions (Landino, Crews, Timmons, Morrow, & Marnett, 1996; 
Salvemini et al., 1993). This reaction will lead to the incidence of chronic inflammation 
and eventually carcinogenesis. 
Inducible nitric oxide synthase-stimulated NO production is known to be associated 
with the conversion of L-arginine to L-citruline (Kerwin & Heller, 1994; Szabo, Mitchell, 
Thiemermann, & Vane, 1993). However, some L-arginine analogs have been reported as 
iNOS inhibitors which inhibit NO production in activated murine macrophages, such as 
aminoguanidine, N
G
-nitro-L-arginine methyl ester (L-NAME), N-iminoethyl-L-ornithine (L-
NIO) and N
G
-nitro-L-arginine (L-NNA) (Kmoníčková, 2007; Liew et al., 1991; Migliorini, 
G. Corradin, & S. Corradin, 1991).  
Besides that, high-output of NO production due to iNOS activation is also 
correlated with the action of cytokines. Endotoxin and some cytokines such as interleukin 
and interferon are responsible for the expression of iNOS in macrophages (Kim et al., 
1998). The inhibitory effect of phytochemicals on NO generation and the underlying iNOS 
activity are associated with the suppression of specific cytokines such as TNF-α, IL-1, IL-6 
or IL-10 (Jiang et al., 2003; Radtke, Kiderlen, Kayser, & Kolodziej, 2004).  
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Nitric oxide is an important signaling molecule that can activate both pro- and anti-
proliferative signal transduction pathway which is dependent to its concentration levels. 
The concentration of NO is critical as low levels of NO stimulate the growth of tumour 
cells, whereas high levels of NO are toxic to cells (Verma & Goldin, 2003). 
Phytochemicals NO inhibitors exhibit valuable therapeutic properties for 
immunomodulatory and anti-inflammatory responses (Konkimalla et al., 2010). Several 
studies based on phytochemicals NO inhibitors have been shown to suppress the activation 
and translocation of the transcription factor NFκB from the cytoplasm to the nucleus. This 
indicates that NFκB is an important mediator for the NO inhibition pathway (Ko, Kuo, Wei, 
& Chiou, 2005).  
Previous studies have indicated that tumours contain higher amounts of NO and 
iNOS as compared to normal tissues (Jang & Kim, 2002). Therefore, NO and iNOS is not 
only important for diagnosis and prognosis, but also potent as a target for novel therapeutic 
options (Hirst & Robson, 2007).  
 
2.3 Adaptive Immune Responses 
Adaptive or acquired immune response is highly specific and can differentiate 
between two very similar molecules. Unlike the innate immune system, adaptive immune 
system has a “memory” for previous infections. Besides that, adaptive immune responses 
do not act immediately as the innate immune responses. It requires a lag period to be 
activated in order to attack the foreign agents (Campbell & Reece, 2005).  
Adaptive immunity can be divided into two categories, known as the humoral 
immunity and cell-mediated immunity. Both types of the immunity are mediated by 
lymphocytes, that circulate between the blood and lymphoid or organs. Humoral and cell-
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mediated immunity are mediated by B and T lymphocytes, respectively (Karp, 2008). B 
and T cells are derived from the same precursor cells, called hematopoietic stem cell, but 
they differentiate in distinct pathways and lymphoid organs. B lymphocytes differentiate in 
fetal liver or adult bone marrow, whereas T lymphocytes differentiate in the thymus gland 
(Campbell & Reece, 2005; Karp, 2008).  
In humoral immunity, B lymphocytes (B cells) differentiate into cells that produce 
antibodies when activated. Antibodies can effectively protect the body against foreign 
materials outside the body‟s cells (Karp, 2008). Antibodies act by binding to protein and 
polysaccharide components on the bacterial cell walls, bacterial toxins, and viral coat 
proteins. Antibodies function as “tags” that bind to the invading pathogens and mark them 
for destructions. Destructions are carried out by phagocytes or by complement molecules 
present in the blood. Some of the bacterial toxin and viral particle with attached antibodies 
are prevented from entering the host cell directly. However, antibodies are not effective 
against intracellular pathogens. Cell-mediated immunity is carried out by T lymphocytes (T 
cells), can specifically identify and kill an infected cells when activated (Campbell & Reece, 
2005; Karp, 2008). 
 
2.4 Cancer and Immunity 
Defects and derangements in the innate and adaptive immune response lead to 
immunodeficiency, allergy, autoimmunity and immune-malignancies (Agarwal & Singh, 
1999). Therefore, enhancement of the immunity is an effective preventive measure to resist 
diseases (Hackett, 2003; Lolis & Bucala, 2003).  
Researches on innate immunity as of novel therapeutic strategies hold a great 
promise for combating various diseases. Since plant-derived immunomodulatory 
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compounds have been used extensively in traditional medicine, research on them are on the 
rise. These researches show that some of the plant-derived immunomodulators have been 
proved to possess the ability to modulate the macrophages activities, leading to various 
beneficial pharmacological effects (Schepetkin & Quinn, 2006).  
An immunomodulator can be defined as biological or synthetic substance which can 
stimulate, suppress or modulate any component of the immune system, including both 
innate and adaptive arms of the immune response (Agarwal & Singh, 1999). This means 
that, immunomodulators exert biphasic effects. Some tend to boost the immune responses, 
while others tend to control or inhibit the activated immune responses to certain magnitude 
(Deharo, Baelmans, Gimenez, Quenevo, & Bourdy, 2004).  
The search for new cancer treatment strategy has been one of the starting points in 
the field of immunomodulation. Plant-derived immunomodulatory polysaccharides, 
proteins, peptides, and lectins have been shown to possess imunomodulatory activities 
(Schepetkin & Quinn, 2006). Some of the plants with proven immunomodulatory activities 
are Astragalus membranaceus (Cho & Leung, 2007), Brassica oleraceae (Thejass& Kuttan, 
2007), Hibiscus cannabinus (Lee et al., 2007), Piper longum (Sunila & Kuttan, 2004), 
Tinospora cordifolia (Sonel & Kuttan, 1999), Withania somnifera (Davis & Kuttan, 2000), 
etc. 
 
2.4.1 Immunomodulators 
Immunomodulators can be categorized into three main classes according to the 
clinical perspective, known as immunoadjuvants, immunostimulants, and 
immunosuppressant. Immunoadjuvants, also known as specific immune stimulants are 
prominently used to enhance the efficacy of vaccines. These agents are important in aiding 
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the development of new vaccines, however, the lack of availability of appropriate 
immunoadjuvant has been the major stumbling stone for producing effective vaccines 
(Agarwal & Singh, 1999). One of the popular immunoadjuvant is Freund‟s adjuvant, but it 
is not suitable for human use due to the presence of Bacillus Calmette Guiren (BCG) 
(Claassen, de Leeuw, de Greeve, Hendriksen, & Boersma, 1992). 
Immunostimulants are envisages for augmenting the host immune responses against 
foreign pathogens. The agents are also known as non-specific immunostimulants, which 
can enhance both arms of the innate and adaptive immune responses. Immunostimulants 
are expected to serve as preventive agents that augment the immune responses against 
infectious agents in a healthy individual. These agents hold a promise as 
immunotherapeutic agents for immune deficiencies patients (Agarwal & Singh, 1999).  
 Immunosuppressants are implied for controlling pathological immune response in 
autoimmune diseases, graft rejection, graft versus host diseases, immediate or 
hypersensitivity immune reaction, as well as immune pathology associated with infections. 
It is used extensively in the prevention of graft rejection as well as treatment of 
autoimmune diseases (Agarwal & Singh, 1999). 
 The search for a safe and effective compound with immunomodulatory properties 
for clinical use has become a major goal of many research laboratories since the immune 
system plays the fundamental roles in host defense against pathogens as well as 
surveillance against tumours. Different immunomodulators can affect the immune 
responses at various levels, either to promote or to depress the ability to mount an immune 
system, or to defend against pathogens or tumours (Cho & Leung, 2007).  
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2.5 Natural Products and Phytochemicals 
Plants contains of a wide variety of biologically active phytochemicals which have 
been consumed as dietary agents and many have been applied in traditional medicines for 
thousands of years (Aggarwal & Shishodia, 2006). Several population-based studies 
indicate that populations with colon, gastrointestinal, prostate and breast cancers in South 
East Asia countries are lower than the Western counterparts (Dorai & Aggarwal, 2004). 
Epidemiological studies show that the appearance in cancer incidences between South East 
Asia and Western countries are strongly believed to cause by environmental factors, 
particularly the differences of diet intake between both populations (Karp, 2008).  
There is a general consensus among epidemiologists, indicating that diet which 
possesses high amount of animal fats and alcohol increases the risks of cancer development, 
whereas fruits, vegetables or tea reduce the risks (Karp, 2008). Indeed, many fruits, 
vegetables and herbs rich in phytochemicals have been proven to possess cancer 
chemopreventive activities, both in vitro and in vivo (Kim, Chun, Kundu, & Surh, 2004; 
Mahmoud et al., 2000; Murakami et al., 2004; Surh, 1999). According to Cragg and 
Newman (2000), more than 50% of the anti-cancer drugs applied in clinical trials were 
isolated from natural products. Hence, the search for anti-cancer drugs from natural 
products is one of the most prominent researches for cancer treatment. 
 
2.6 Zingiberaceae 
 Zingiberaceae, or the ginger family is a family of flowering plants with perennial 
herbs, rarely epiphytic, and mostly with creeping horizontal or tuberous rhizomes. The 
stems of the plants are usually short, replaced by pseudostems derived from leaf sheaths. 
The leaves are alternate and distichous, those that grow towards the base are bladeless and 
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reduced to sheath, and the blades are mostly linear to elliptic with penni-parallel, strongly 
ascending veins. Zingiberaceae species grow naturally in damp, shaded parts of low-land or 
hill slopes, as scattered plants or thickets (Yap et al., 2007).  
 Zingiberaceae species are among the most prolific plants in the tropical rain forest 
(Ruslay et al., 2007). The Zingiberaceae family comprises of about 50 genera and 1300 
species that are distributed throughout the tropics, especially in the Southeast Asia. Some 
species can be found in America and the tropics of Africa (Wu & Kai, 2000). The 
Peninsular Malaysia, is estimated to consist of approximately 150 species of the ginger 
with 23 genera (Holtom, 1950).  
 The rhizomes of Zingiberaceae are usually spicy, and are widely used around the 
world as an important spice or flavouring agents in culinary. Members of the family which 
are commonly cultivated for these purposes are Zingiber officinale, Curcuma longa, and 
Zingiber zerumbet, etc. Some species are widely cultivated as ornamental plants, namely 
Alpinia speciosa, Alpinia purpurata, Hedychium coronarium Koening, the ginger lily, etc 
(Lock, 1985). Zingiberaceae plants are also well-known as the medicinal plants in Asia, the 
Ayuverda, and Chinese medical systems since thousands of years ago (Kala, 2006). The 
rhizomes of various ginger exhibit health-promoting effects that have been utilized for 
ailments, such as stomache, diarrhea, disgestive disorder, rheumatism, swelling, common 
cold and cough (Yap et al., 2007). 
 Zingiberaceae species consist of a great variety of chemical constituents which vary 
based on the place of origin, weather as well as whether the rhizomes are fresh or dried (Ali, 
Blunden, Tanira, & Nemmar, 2008). Some phenolic compounds present in most of the 
Zingiberaceae plants, possess strong anti-inflammatory and anti-oxidative properties and 
are potent in inducing anti-oxidative and anti-mutagenic activities (Surh, 2002; Surh, E. 
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Lee, & J. Lee, 1998; Surh et al., 1999). These phytochemicals are believe to work 
potentially in the suppression of transformation, hyperproliferation, and inflammatory 
activities, all of which are crucial in initiating carcinogenesis, angiogenesis and metastasis 
(Shukla & Singh, 2007).  
 
2.6.1 Alpinia galanga 
 
Figure 2.7: Rhizome of Alpinia galanga 
 
 The herb A. galanga is distributed in South and Southeast Asian countries. It is 
commonly known as greater galangal, blue ginger or Thai ginger, and lengkuas in Malaysia. 
The rhizome of this plant (Figure 2.7) is globally used as a spice or ginger substitute for 
flavouring foods, especially soup and curry. In addition to the culinary uses, the rhizome 
has been used as in traditional medicine as stomachic, carminative, antiflatulent, antifungal 
and anti-itching agents (Kaur et al., 2010).  
 Scientists have studied on the rhizome of A. galanga and found that it exhibits 
various biological activities, such as antifungal, antibacterial, antimycobacterial, antiviral, 
anticancer, antitrypanosomal etc. The main compounds found in the rhizome are 
phenylpropanoids, and most abundantly of which are 1‟S-1‟-acetoxychavicol acetate 
(Chappuis et al., 2007), 1‟S-1‟-acetoxyeugenol acetate (Laguna, 2003), and p-coumaryl 
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diacetate (Desjeux, 2001) etc. Most of the biological activities are due to the presence of 
phenylpropanoids (Kaur et al., 2010). 
 
2.6.2 Boesenbergia rotunda 
 
                                    Figure 2.8: Rhizomes of Boesenbergia rotunda 
 
 The perennial herb B. rotunda is the most abundant Boesenbergia species found in 
Malaysia and is locally known as Temu kunci. It is a herbaceous plant with short and 
slender rhizomes. The rhizomes (Figure 2.8) which have a characteristic aroma and slightly 
pungent in taste, are usually used as food ingredients in Southeast Asia.  
 In the olden days, it is a medicinal plant for several disease treatments, such as 
aphtlous ulcer, dry mouth, stomach discomfort, leucorrhea and dysentery. Besides that, the 
rhizomes are given as tonics to women after childbirths, or applied in lotions for 
rheumatism and muscular pains, and into pastes for application to the body after 
confinement (Burkill, 1935). The biological properties of B. rotunda includes 
antimutagenic, antitumor, antibacterial, antifungal, analgesic, antipyretic, antispasmodic, 
anti-inflammatory and insecticidal activities (Cheenpracha, Karalai, Ponglimanont, 
Subhadhirasakul, & Tewtrakul, 2005). 
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2.6.3 Curcuma aeruginosa 
 
                                    Figure 2.9: Rhizomes of Curcuma aeruginosa 
 
Curcuma aeruginosa is a native tropical plant of the Southeast Asia, especially 
Myanmar, Cambodia, Vietnam, Malaysia, Indonesia and Thailand (Sirirugsa, 1992). It is 
commonly known as blue or pink ginger in English, temu hitam in Malaysia, and waan-
maa-haa-mek or kajeawdang in Thailand (Thaina, Tungcharoen, Wongnawa, Reanmongkol, 
& Subhadhirasakul, 2009). Fresh rhizome of the plant (Figure 2.9) emits a mild ginger-like 
aroma (Srivastava et al., 2006).  
 In traditional medicines, the rhizome of C. aeruginosa has been used for 
gastrointestinal remedies in the treatment of asthma, cough, scurvy, mental derangement, 
diarrhea and colic, used in women for postpartum care, uterine involution, treatment of 
uterine pain and uterine inflammation (Perry, 1980). It is regarded as an active ingredient in 
many Thai herbal preparations as a tonic to alleviate irregular, painful or excessive 
menstruation in female and for uterine pain or dysfunction (Pongbunrod, 1979). It is also 
considered as a depurative which can be used both internally and externally for treating 
exanthema and act as a poultice for itching (Perry, 1980). 
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2.6.4 Curcuma domestica 
 
                                    Figure 2.10: Rhizomes of Curcuma domestica 
 
 The dried ground rhizome of C. domestica (Figure 2.10) is commonly known as 
turmeric in English, haldi in Hindi, ukon in Japanese, and kunyit in Malaysia and Indonesia 
(Sharma, Gescher, & Steward, 2005). Turmeric is used extensively in foods for its aromatic, 
flavouring and yellow colouring properties. 
 Turmeric has been used in Asian medicine since the second millennium BC (Brouk, 
1975). It has a long history of traditional uses in Chinese and Ayurvedic medical systems 
for the treatments of flatulence, jaundice, menstrual difficulties, hematuria, hemorrhage, 
and colic. Dietary consumption of turmeric in certain Southeast Asia communities is as 
high as 1.5g per person, however, smaller quantities of turmeric tend to be used for 
medicinal purposes (Eigner & Sholz, 1999).  
 The active principle identified in turmeric is curcurmin which has been shown to 
exhibit antioxidant, anti-inflammatory, antimicrobial, and anti-carcinogenic activities. 
Besides that, it also possesses hepatoprotective and nephroprotective activities, thrombosis 
suppression, protects against myocardial infarction, as well as hypoglycemic and anti-
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rheumatic properties (Anand et al., 2008). Chemical structure of curcumin is shown in 
Figure 2.11. 
 
Figure 2.11: Chemical structure of curcumin (Anand et al., 2008) 
 
2.6.5 Curcuma mangga 
 
                                       Figure 2.12: Rhizomes of Curcuma mangga 
 
 Curcuma mangga is widely distributed throughout South India. It has been first 
reported by Balakrishnan and Bhargaya (1984) from the Andaman Islands. It is a bush 
perennial and has stalk rhizomes (Figure 2.12). The flesh of the rhizome is yellowish in the 
outer layer, and light yellow in the center layer.  
 The rhizome has a unique characteristic of raw mango taste, and because of that the 
plant is also known as mango ginger. It is also called white turmeric in English and temu 
pauh in Malaysia. The rhizomes of C. mangga are usually used as a spice to pickle foods in 
South India. In addition to its culinary uses, the rhizomes are utilized in traditional 
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medicines as a stomachic for the treatments of chest pains, fever, general debility, as well 
as aid in womb healing (Suhaila, Suzana, Saleh, Ali, & Sepiah, 1996).  
 
2.6.6 Curcuma xanthorrhiza 
 
                                   Figure 2.13: Rhizomes of Curcuma xanthorrhiza 
 
 Curcuma xanthorrhiza is commonly known as false turmeric in English, temu 
lawak in Malaysia and Javanese turmeric in Indonesia. When the rhizome is cut, the flesh is 
orange in colour with a characteristic aroma. The rhizome of C. xanthorrhiza (Figure 2.13) 
is popularly used as an ingredient for preparing traditional health supplements, known as 
„jamu‟ and „maajun‟, or used individually as a remedy for certain health problems. The 
juice made from the rhizome of the plant is used as a remedy for indigestion, constipation, 
bloody diarrhea, dysentery, rheumatism, or applied to the body after childbirth (Hwang, 
Shim, & Pyun, 2000; Ruslay et al., 2007), asthma and respiratory disorders in traditional 
medicines (Ikawati, Wahyuono, & Maeyama, 2001). Moreover, the syrup made from the 
rhizome is used as appetizer for the children. 
 
 
39 
 
2.6.7 Kaempferia galanga 
 
                                     Figure 2.14: Rhizomes of Kaempferia galanga 
 
 Kaempferia galanga is commonly known as sand ginger in English, proh hom in 
Thai (Kanjanapothi et al., 2004), Shan-nai in Chinese (Perry& Metzger, 1980), kencur in 
Indonesia, and cekur in Malaysia. It is an acaulescent perennial aromatic rhizomous herb 
(Figure 2.14) that grows in Southern China, Indochina, Malaysia, and India (Kanjanapothi 
et al., 2004). It is globally used as a spice, food favouring agent, and an ingredient for 
„jamu‟ preparation, which is a local tonic consumed by the Malays (Othman, Ibrahim, 
Mohd, Mustafa, & Awang, 2006).  
 The rhizome of K. galanga is well recognized as carminative, diuretic, aromatic 
stomachic, insecticidal, and incense (Huang, Yagura, & Chen, 2008). The aromatic 
essential oil from the rhizomes is valuable for perfumery industry (Chithra, Martin, 
Sunandakumari, & Madhusoodanan, 2005). It possesses a strong characteristic balsamic 
aroma, has a long history in fragrance use for the alleviation of stressfulness, restlessness, 
anxiety and depression. In Japan, it has been utilized as one of the main ingredients in scent 
bag, which is useful in improving sleep, relaxation and minimizing stress (Huang, Yagura, 
& Chen, 2008).  
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 Besides that, the rhizomes contain essential oils and have been used traditionally in 
a decoction or powder for indigestion, cold, pectoral and abdominal pains, headache and 
toothache (Kanjanapothi et al., 2004), hypertension, asthma and inflammatory tumours 
(Huang et al., 2008). The alcoholic maceration of the rhizome has been applied as liniment 
for rheumatism. In addition, the rhizome extract is also useful for the treatments of skin 
diseases, wounds, spleen disorders, cough, and pectoral afflictions (Chithra et al., 2005).  
 The herbs exhibit a broad spectrum of pharmacological and biological activities, 
such as larvicidal (Kiuchi, Nakamura, Tsuda, Kondo, & Yoshimura, 1988), amebicidal 
(Chu, Miles, Toney, Ngyuen, & Marciano-Cabral, 1998), antibacterial (George & Pandalai, 
1949), antimicrobial (Gupta & Banerjee, 1976), antifungal, antiviral (Vimala, Norhanom, & 
Yadav, 1999), anticancer (Kosuge et al., 1985), antioxidant (Gupta & Banerjee, 1976), 
vasorelaxant active, anti-inflammatory and smooth muscle relaxant effects (Othman, 
Ibrahim, Mohd, Mustafa, & Awang, 2006). 
 
2.6.8 Zingiber montanum 
 
                                     Figure 2.15: Rhizomes of Zingiber montanum 
 
 Zingiber montanum is probably native to India but is now widely cultivated in 
tropical Asia. It is also a popular home-garden plant in Southeast Asia. It is commonly 
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known as bonglai in Malaysia. The rhizomes (Figure 2.15) are used as a spice and food 
flavouring agent in culinary due to its characteristic aroma.  
 Besides that, it is a medicinal plant that popularly applied in traditional medicines 
for various common sicknesses. It acts as a carminative and stimulant for stomach, as well 
as used to treat diarrhea and colic. In Thai traditional medicine, the consumption of the 
rhizomes can help in relieving asthma as well as muscle and joint pain (Bua-in & 
Paisooksantivatana, 2009). It was also applied to paralysis in the olden days. 
 
2.6.9 Zingiber officinale 
 
                                     Figure 2.16: Rhizomes of Zingiber officinale 
 
Ginger (Zingiber ofiicinale) is the most popular species in the family of 
Zingiberaceae, which has been cultivated for thousands of years as a spice as well as for 
medicinal purposes in South East Asian countries (Park & Pizzuto, 2002). Ginger rhizome 
(Figure 2.16) is a very common condiment in culinary for preparing vegetable and meat 
dishes and as a flavouring agent in beverages, especially in countries such as India and 
China (Shukla & Singh, 2007). It is also consumed directly as fresh paste, dried powder, 
slices preserved in syrup or flavouring tea. Nowadays, ginger rhizome is widely 
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commercialized in food industries as candy, crystallized ginger chips, ginger crackers, 
ginger tea, ginger beer, ginger soother, ginger oil, pickled ginger etc. 
Ginger rhizome has been used extensively in China and India as a traditional 
medicine since ancient times (Altman & Marcussen, 2001). It has been a popular ingredient 
among Chinese, Ayurvedic and Tibb-Unani herbal medicines for treating a great range of 
disease such as colds, flu-like symptoms, nausea, headaches, toothache, constipation, 
painful menstrual period, catarrh, rheumatism, nervous disease, gingivitis, toothache, 
asthma, stroke and diabetes (Awang, 1992; Grant & Lutz, 2000; W. Wang & Z. Wang, 
2005). 
Besides that, ginger rhizome is also applied in herbal medicine practice for the 
treatment of rheumatoid arthritis and muscular discomfort in Western countries (Bordia, 
Verma, & Srivastava, 1997; Langner, Greifenberg, & Gruenwald., 1998). Based on its 
variable health-protective effects, it has been studied greatly as botanical dietary 
supplement in USA and Europe, particularly in the treatment of inflammatory diseases 
(Aggarwal & Shishodia, 2004; Park & Pizzuto, 2002; Srivastava & Mustafa, 1992).  
Ginger extracts have been scientifically proven to possess anti-inflammation 
(Mascolo, N. Jain, R. Jain, Capasso, 1989; Penna et al., 2003; Zhou, Deng, & Xie, 2006), 
anti-emesis (Sharma & Gupta, 1998), analgesic effect (Mascolo et al., 1989; Young et al., 
2005), anti-tumour (Katiyar, Aggarwal, & Mukhtar, 1996) and anti-oxidant (Masuda, 
Kikuzaki, Hisamoto, & Nakatani, 2004) properties. In addition, its major pungent 
constituent, [6]-gingerol (1-[4‟ –hydroxy-3‟ –methoxyphenyl]-5-hydroxy-3-decanone) 
(Figure 2.17) has been reported to possess interesting biochemical activities in inhibiting of 
cyclooxygenase pathway and lipoxygenase pathway (Lee & Surh, 1998). 
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     Figure 2.17: Chemical structure of [6]-gingerol (Miyoshi et al., 2003) 
  
2.6.10 Zingiber zerumbet 
 
                                     Figure 2.18: Rhizomes of Zingiber zerumbet 
 
 Zingiber zerumbet, a wild ginger in the Zingiberaceae family is commonly known 
as lempoyang in Malaysia. It has important economic properties as the plants are widely 
used in various fields, including culinary, gardening as well as traditional medical systems. 
The “pine cones” of the plant are popularly used as an ornamental in gardening, and the 
milky juice from the pine cones is used as a shampoo in Hawaii (Chien, Chen, C. Lee, F. 
Lee, & Wang, 2008).  
 In traditional medical systems, fresh rhizomes of the plant (Figure 2.18) are 
consumed as an appetizer (Ruslay et al., 2007). It is also employed to relieve stomachache, 
as a diuretic, and becomes depurative when macerated in alcohol (Songsiang, 
Pitchuanchom, Boonyarat, Hahnvajanawong, & Yenjai, 2010). Studies have shown that Z. 
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zerumbet plays a significant role in anti-allergic effects (Tewtrakul & Subhadhirasakul, 
2007), and well recognized as antiflatulent and anti-inflammatory agents. 
 The major component in the rhizome of Z. zerumbet is a crystalline sesquiterpene, 
called zerumbone (Figure 2.19), which is also readily available from a widespread of 
natural sources (Songsiang et al., 2010). Zerumbone has been studied for various biological 
activities since it possesses promising anti-cancer properties. It acts to suppress tumour 
promoters (Murakami et al., 2002) and has been slow down to inhibit the proliferation of 
human leukemia cell lines (Huang, Chien, & Wang, 2005). In addition, it is also an anti-
proliferative and anti-platelet activating factor (Jantan, Rafi, & Jalil, 2005), and possesses 
anti-HIV activities (Dai, Cardellina, McMahon, & Boyd, 1997).  
 
 
Figure 2.19: Chemical structure of zerumbone (Tanaka et al., 2001) 
 
2.7 In Vitro Nitric Oxide Assay for Assessment of Immunomodulatory Agents 
 Nitric oxide has been implicated with various diseases including cancer (refer 
section 2.2.4). Assessment of NO synthesis is of particular interest because NO level 
strongly correlates with the status of L-Arginine/NO pathway (Tsikas, 2007).  
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The NO assay is the most frequently used method for analysis of nitrite and nitrate 
concentrations based on the Griess reaction. Johann Peter Griess (1982-1888), a German 
chemist originally reported the Griess reaction as a diazotization reaction in 1879. In the 
original work, nitrite reacts with sulfanilic acid under acidic conditions, i.e. nitrous acid to 
form a diazonium ion which couples to form a readily water-soluble, red-violet coloured 
azo-dye (Tsikas, 2007).  
In this study, immunomodulatory effects of Zingiberaceae extracts on NO 
generation in macrophages cells, RAW 264.7 was assessed using in vitro NO assay. In the 
in vitro NO assay, the nitrite levels in culture supernatant as an index of NO generation is 
measured using Griess reaction (Green et al., 1982). In the Griess reaction, nitrate is to 
reduce to nitrite prior to diazotization. The colorimetric change can be quantified 
spectrophotometry and correlated with nitrite concentrations. 
 
2.8 In Vitro Assays of Angiogenesis for Assessment of Anti-metastatic Agents 
Endothelial cells are specialized epithelial cells that form the inner layer of blood 
vessels. These cells play a key role in angiogenesis which involves matrix degradation, 
migration, proliferation, and morphogenesis (Figure 2.4) eventually resulting in cancer 
metastasis. Numerous in vitro techniques have been introduced to assess the functions of 
endothelial cells (Table 2.2).  
Continuous cell proliferations with the increasing survivals supply the cells for 
generating new vessel. Effects of anti-angiogenic factors on proliferation can be determined 
through direct cell counts, thymidine or BrdU incorporation (quantification of DNA 
synthesis), or MTT assay (assessment of metabolic activity) (Goodwin, 2007). As cell 
migration is required for both tumour invasion and tumour angiogenesis, it is of particular 
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interest in the search of anti-cancer therapeutic agents (Eccles, 2004). Assays that allow 
measurement of cell migration include scratch wound assay, Transwell or Boyden chamber 
assay, and under-agarose assay. In this study, effects of Zingiberaceae extracts on 
proliferation and migration of breast cancer cells, MDA-MB-231 were assessed using MTT 
assay and scratch wound assay, respectively. 
 
Table 2.2: In vitro assays of angiogenesis (Goodwin, 2007) 
Assay Angiogenic functions assed 
Endothelial cell assays  
Zymogen assay Matric degradation 
Scratch wound assay Migration 
Transwell/Boyden chamber assay Migration 
Under-agarose assay Migration 
Cell counting Proliferation 
Thymidine incorporation Proliferation 
BrdU incorporation Proliferation 
MTT assay Proliferation 
TUNEL assay Apoptosis 
Annexin V assay Apoptosis 
On-Matrigel assay Morphogenesis 
In-collagen/Matrigel assay Morphogenesis 
Collagen sandwich assay Morphogenesis 
Matrix invasion assay All 
Microbead assay All 
  
Stem cell and organ culture assays  
Embryoid body assay All 
Aortic ring assay All 
Mouse metatarsal assay All 
 
The MTT colorimetric assay measures the mitochondria activity as a mean of 
number of viable cells. Active mitochondria in viable cells convert the yellow, soluble 
tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) into 
an insoluble, purple formazan precipitate (Denizot & Lang, 1986; Mosmann, 1983). 
Tetrazolium salts accept electrons from oxidized substrates or enzymes, such as NADH and 
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NADPH. Particularly, MTT is reduced at the ubiquinone and cytochrome b and c sites of 
the mitochondrial electron transport system and is due to succinate dehydrogenase activity. 
This reaction converts the yellow salt to purple formazan which can be dissolved in organic 
solvent, such as dimethyl sulphoxide (DMSO). The colorimetric change can be quantified 
using spectrophotometry and correlated with cell viability (S. Ahmad, A. Ahmad, 
Schneider, & White, 2006; Trevisi, Pighin, Bazzan, & Luciani, 2006).  
In the scratch wound assay, a wound is created on the monolayer confluent cells 
using a pipet tip, needle, or cell scraper. Since cell filling the cleared area may due to both 
migration and proliferation, the migration effect can be accentuated by using anti-
proliferation agents or using 0-1% serum media (Choi et al., 2009; Goodwin, 2004; 
Shanmugaraj et al., 2010). This assay can be quantified by measuring the distance of the 
wound closure in a time-dependent manner. Both MTT assay and scratch wound assay are 
well-adapted for large-scale screenings. 
 
2.9 Solvent Extraction for Specific Phytochemical Groups 
Solvent extraction is the most popular extraction method used in preparing crude 
extracts from natural products. Decisions have to be made in selecting appropriate solvents 
for extraction in order to acquire desirable active compounds. However, in most case, there 
is no preconception about chemical nature of the active compounds that are being sought. 
One approach for solving this problem is to extract the plant samples with a series of 
solvents with increasing polarity, in order to acquire different classes of chemical 
compounds for screening assays. This is based on the basic principles of „like dissolves 
like‟, where non-polar solvent will extract out non-polar substances, whereas polar solvent 
will extract out polar substances. Generally, the main groups of compound are fixed oils, 
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fats and waxes, volatile or essential oils, carotenoids, alkaloids, glycosides, aglycones, 
phenolic compounds, polysaccharides and proteins (Houghton & Raman, 1998). Table 2.3 
shows the types of phytochemicals extracted by different solvents used. 
 
 
Table 2.3: Types of phytochemicals extracted by different solvents (Houghton & Raman, 
1998) 
Polarity Solvent Chemical class extracted 
Low Light petroleum Waxes Fats Fixed oils Volatile oils 
 Hexane Waxes Fats Fixed oils Volatile oils 
 Cyclohexane Waxes Fats Fixed oils Volatile oils 
 Toluene Alkaloids Fats Fixed oils Volatile oils 
 Chloroform Alkaloids Aglycones  Volatile oils 
Medium Dichloromethane Alkaloids Aglycones  Volatile oils 
 Diethylether Alkaloids Aglycones   
 Ethylacetate Alkaloids Aglycones Glycosides  
 Acetone Alkaloids Aglycones Glycosides  
 Ethanol   Glycosides  
 Methanol Sugars Amino acids Glycosides  
High Water Sugars Amino acids Glycosides  
 Aqueous acid Sugars Amino acids  Bases 
 Aqueous alkali Sugars Amino acids  Acids 
 
2.10 Soxhlet Extractor System 
Sample preparation is a time-consuming step but is a necessity for analytical 
process, particularly when solid samples are involved. Solid samples cannot be analyzed 
directly with analytical instruments and it is therefore, required to transfer the respective 
analytes to a liquid phase (Luque de Castro & Priego-Capote, 2009). Solvents used in 
extractions are selected based on the types of phytochemicals needed to be obtained. The 
plant samples to be extracted are pre-dried to avoid the presence of water in the extracts. 
Solvent extraction of solid samples, which is commonly known as solid-liquid 
extraction, or more appropriately named as leaching or lixiviation in term of 
physicochemical, is one of the oldest techniques of solid sample preparation. Leaching 
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process is commonly done by maceration using appropriate solvents with the aids of heat or 
agitation to increase its efficiency in solubility and the rate of mass transfer. It plays an 
important role in extracting targeted compounds from insoluble high-molecular-weight 
fractions as well as removing compounds that could actually interfere with the analytical 
process (Luque de Castro & García-Ayuso, 1998). Soxhlet has been the most applied 
leaching technique. 
Soxhlet extractor was developed by von Solvent in 1879 (Soxhlet, 1879), and has 
been used as a standard leaching technique for over a century. Soxhlet extraction methods 
remain as the predominant reference for measuring the performance of other leaching 
techniques. The advantages and limitations of soxhlet extraction has been served as the 
starting points for the development of more advanced leaching techniques with a variety of 
modifications in order to minimize the shortcomings but at the same time keeping or even 
improving the former (Luque de Castro & Priego-Capote, 2009).  
Conventional soxhlet extraction was originally used to determine fat in milk 
(Soxhlet, 1879). The conventional soxhlet extractor is composed of three separate 
component, namely solvent container, sample compartment and reflux condenser. In this 
method, the solid sample is placed in a thimble at the sample compartment that is gradually 
filled with fresh solvent from the solvent container. The liquid collected in the sample 
compartment will aspirate through the siphon when it reaches the over-flow level, and drips 
into the solvent container, thus carrying extract analytes into bulk liquid. This process is 
repeated until the extraction is completed. Soxhlet extraction is said to be a continuous-
discrete technique due to its characterized operation. Since the solvent is being recycled to 
percolate the sample, the extraction system also functions in a continuous manner somehow 
(Luque de Castro & García-Ayuso, 1998).  
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Conventional soxhlet extraction (Figure 2.20) has been the best leaching technique 
used for a long time. However, improvement of the conventional extractor by fixing it with 
modern technologies allows its adaptation for the present necessities. During the past 
decades, a variety of modifications were made to the former Soxhlet extractor in order to 
reduce the leaching times with the use of auxiliary energies and automating the extraction 
procedures. Varieties of more advanced soxhlet extractor system are now available, such as 
high-pressure soxhlet extraction, automated soxhlet extraction, ultrasound-assisted soxhlet 
extraction as well as microwave-assisted soxhlet extraction.  
 
 
Figure 2.20: Conventional Soxhlet extractor system 
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CHAPTER 3 
3.0 MATERIALS AND METHODS 
3.1 Plant Materials 
 Ten local medicinal plants in the Zingiberaceae family, namely A. galanga, B. 
rotunda, C. aeruginosa, C. domestica, C. mangga, C. xanthorrhiza, K. galanga, Z. 
montanum, Z. officinale, and Z. zerumbet were selected for in vitro screening tests. Fresh 
rhizomes of the selected Zingiberaceae species were bought from Chow Kit Market, Kuala 
Lumpur, Malaysia. These plants were identified macroscopically.  
 
3.2 Preparation of Plant Extracts 
 Ten selected species of fresh Zingiberaceae rhizomes were washed with water, cut 
into small pieces and dried in an oven (Memmert) at 50˚C for three days. Dried rhizomes 
were ground into fine powder using a commercial blender (Waring). The plant samples 
were extracted using the conventional Soxhlet extractor system (Houghton & Raman, 1998).  
20 g of each sample was weighed (Kern 440-49N) and placed in a porous cellulose thimble 
(Whatman) in a sample compartment (central compartment) with a siphoning device and 
side-arm both connected to the distillation flask (lower compartment). The solvent was 
placed in the distillation flask and a reflux condenser (upper compartment) was attached 
above the sample compartment. Each plant sample was extracted using petroleum ether 
(Merck), chloroform (Merck) and methanol (Merck) sequentially at their respective boiling 
points. 
Firstly, the flask containing petroleum ether was heated at 45˚C using a heating 
mantle (Topo). The solvent evaporated when the temperature reached its boiling point. The 
vapour moved up into the central compartment through the side arm, where it was 
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subjected to condensation due to the cooling effect from the reflux condenser. Then, the 
vapour condensed, transferred to the liquid phase and dripped into the sample in the 
thimble. The solvent percolated through the sample and when the liquid exceeded the over-
flow level, the siphon aspirated the solute from the sample compartment and unloaded it 
back to the distillation flask. The process was repeated until a colourless extraction liquid 
was observed in the central compartment.  
 At the end of the extraction process, which usually lasted for a few days, the 
resultant extraction liquid in the distillation flask was subjected to evaporation using a 
rotary evaporator (Buchi). After the implementation of rotary evaporation, crude extract of 
petroleum ether were obtained. The crude extract was then kept in a specimen tube 
wrapped with aluminium foil, and left in the fume cupboard (Labconco) for further 
evaporation in order to remove all the solvent, until it became solid form. Finally, the crude 
extract was weighed and the yield was calculated according to the equation (Eq) 
                                                  Weigh of concentrated extract         
                                             Weigh of sample in the thimble (20 g)  
Eq. (1) 
The crude extract in the specimen tube was enclosed with a stopper and kept in the 
refrigerator (Whirlpool) at 4˚C.  
The thimble together with the sample was dried in the fume cupboard when the 
extraction using petroleum ether was done. When the thimble and the plant sample were 
completely dried, the same procedure was carried out using chloroform and eventually, 
methanol at their boiling temperatures, 62˚C and 65˚C, respectively. Flow chart of the plant 
extraction procedure using petroleum ether, chloroform, and methanol is shown in Figure 
3.1. 
× 100 Yield (%) = 
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Figure 3.1: Flow chart of the plant extraction procedure using petroleum ether, chloroform, 
and methanol 
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3.3 Nitric Oxide Assay 
Petroleum ether, chloroform, and methanol extracts from ten selected Zingiberaceae 
species such as A. galanga, B. rotunda, C. aeruginosa, C. domestica, C. mangga, C. 
xanthorrhiza, K. galanga, Z. montanum, Z. officinale, and Z. zerumbet were evaluated for 
their effects on the nitric oxide production in murine macrophage cells (RAW 264.7) using 
the nitric oxide assay. 
 
3.3.1 Preparation of diluents and reagents 
 Preparation of diluents and reagents for NO assay was carried out as showed in 
Appendix I.  
 
3.3.2 Cell culture for RAW 264.7 cell line 
 Murine macrophage cell line (RAW 264.7) (Figure 3.2) obtained from the 
American Type Culture Collection (ATCC, Rockville, MD, USA) was used in this 
experiment. The cell line was cultured in DMEM media with phenol red, containing high 
glucose of 4500 mg/mL, L-glutamine, HEPES, and NaHCO3, supplemented with 10% heat-
inactivated FBS, 2% penicillin/streptomycin (PAA Laboratories GmbH, Australia) and 1% 
amphotericin B (PAA Laboratories GmbH, Australia). The cell culture was maintained in a 
humidified incubator (Shel Lab, Australia) at 37ºC, with 5% carbon dioxide (CO2) and 95% 
air. The cells were grown to 90%–100% confluence. Cell culture protocol is showed in 
Appendix II.  
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Figure 3.2: Murine macrophage cells (RAW 264.7) observed under phase-contrast 
microscope with magnification 100× 
 
3.3.3 RAW 264.7 cell preparation and seeding 
Murine macrophage cells (RAW 264.7) with confluency of 90%–100% were 
detached and transferred into a 15 mL centrifuge tube. The cell suspension was centrifuged 
(Kubota) at 1000 rpm for 5 min at room temperature. The supernatant was removed and 5 
mL of fresh diluent B was added to the cell pellet which was then re-suspended gently 
using a 10 mL disposable serological pipette (Terumo, Japan).  
The cell suspension (10 µL) was taken and mixed gently with 90 µL of Trypan Blue 
solution in a microtube (Orange Scientific, Belgium). Subsequently, 10 µL of the sample 
was removed and dispensed on glass slide. The number of cells was counted using a 
haemocytometer (Marienfeld), and the percentage of cell viability was determined. The 
percentage of cell viability should be at least 95% in order to run the assay. 
The cell concentration was adjusted to 2 × 10
6 
cells/mL with diluents B. Then, 100 
µL of cell suspension was dispensed into flat bottom 96-well microplate (Nunc, Denmark). 
After plating, the plate was incubated for 2 h at 37ºC, 5% CO2 in the humidified incubator. 
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3.3.4 Sample dilution 
 Sample stock and substock were prepared before conducting serial dilution. Sample 
stock was prepared by adding 0.02 g of crude extract with 0.2 mL of 100% DMSO in a 
microtube and stored at –20ºC. Sample stock was thawed at room temperature before use. 
In this experiment, the required constant percentage of DMSO was 0.1%, and the final 
concentration for the sample needed was 100 µg/mL.  
So, for sample stock preparation,  
0.02 g sample crude extract = 20 mg  
0.02 g sample crude extract in 0.2 mL 100% DMSO = 20 mg/0.2mL 
                                                                                     = 100 mg/mL 
                                                                                     = 100 000 µg/mL 
Thus, sample stock concentration was 100 000 µg/mL. 
 Sample substock was prepared to acquire 0.2% DMSO. To prepare sample substock 
at 200 µg/mL, 0.2% DMSO, calculation were done using the formula below, 
                       M1V1 = M2V2 
(100 000 µg/mL)V1 = (200 µg/mL)(500 µL) 
                           V1 = 1µL 
Based on the calculation, 1µL from sample stock was taken out, and added to 499 µL of 
diluent B in order obtain 500 µL of sample substock with 0.2% DMSO at 200 µg/mL. 
 After preparing sample substock, serial dilution was conducted. Serial dilution was 
conducted using a sterile flat bottom 96-well microplate and multi-channel pipettor (HTL, 
Poland) in a biohazard hood (Essco Class II Biohazard Safety Cabinet). Serial dilution were 
carried out prior to the NO assay and the plate were sealed and frozen at –20°C.  
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Firstly, 80 µL of diluent A was dispensed into wells rows B to H (Figure 3.3). 
Sample substock (160 µL) was added to wells in row A, resulting in the final concentration 
here to be 200 µg/mL. Subsequently, 80 µL of dilution was transferred from wells in row A 
to row B, resulting in the final concentration in row B to be 100 µg/mL. The dilution was 
re-suspended a few times before being transferred to the following row. The steps were 
repeated until row G, and the last 80 µL of dilution after row G was discarded. Hence, final 
volume in each well was 80 µL, 0.2% DMSO. 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A             
B             
C             
D             
E             
F             
G             
H             
 
Figure 3.3: Template of serial dilution for NO assay 
 
                    Substock                   
                    Diluent A + Substock 
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After the serial dilution was conducted, the sample concentrations for the wells in 
each row were 200 µg/mL for row A, 100 µg/mL for row B, 50 µg/mL for row C, 25 
µg/mL for row D, 12.5 µg/mL for row E, 6.25 µg/mL for row F, and 3.13 µg/mL for row G.  
 
3.3.5 Treatment of RAW 264.7cells with plant extracts 
After 2 h of incubation time, unattached RAW 264.7 cells were dispersed and the 
media were discarded using a pipettor (1000 µL) (Eppendorf, Germany). Apart from 
normal cell controls, all cells were cultured with 50 µL diluent C which contained 10 
µg/mL LPS to stimulate the cells seeded in the flat bottom 96-well microplate.  
50 µL of serially diluted Zingiberaceae extracts in the serial dilution plate were then  
dispensed into each well except controls and standard. 50 µL of the serially diluted 
Zingiberaceae extracts in media containing DMSO (diluent A) subsequently added each 
well containing 50 µL of diluent C, yielded a final concentration of DMSO 0.1% per well. 
Meanwhile, the cells were treated with each Zingiberaceae extracts at 1.56 µg/mL, 3.13 
µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 µg/mL (Figure 3.4).  
The same volume of media from the serial dilution plate was added to the same 
volume of media in the cell plate. Therefore, DMSO and extract concentrations were 
halved in the wells. Controls for the template in Figure 3.4 were as follows: 
Control 1: Supplemented 5% DMEM only 
Control 2: Cells in supplemented 5% DMEM with 0.1% DMSO and 10 µg/mL LPS  
Control 3: Cells in supplemented 5% DMEM with 10 µg/mL LPS 
Control 4: Cells in supplemented 5% DMEM only 
Control 5: Cells in supplemented 5% media with 0.1% DMSO, 10 µg/mL LPS and a final 
concentration of L-NAME (a NOS inhibitor) 250 µM 
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The absorbance reading for blank control (Control 1) was required for NO 
calculation. Control 2 and Control 3 represented the negative controls, where the cells were 
stimulated by the inducer (LPS) to generate NO. Therefore, no inhibition of NO should be 
detected for the negative control, which was presented as 0% of NO inhibition. Control 
consisting of cells only (Control 4) should not show any NO generation as there was no 
inducer. The cells were therefore not stimulated to produce NO. On the other hand, cells 
treated with inducer and L-NAME (iNOS inhibitor) represented the positive control 
(Control 5). L-NAME, an iNOS inhibitor can inhibit about 70% of NO inhibition in the 
LPS-stimulated RAW 264.7 cells. The cells were incubated for 24 h at 37°C, 5% CO2, in a 
fully humidified incubator. 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Sample 1  
(100 µg/mL) 
 
 
 
Sample 1 
(1.56 µg/mL) 
Sample 2 
(100 µg/mL) 
 
 
 
Sample 2 
(1.56 µg/mL)  
Sample 3 
(100 µg/mL) 
 
 
 
Sample 3 
(1.56 µg/mL) 
Standard: NaNO2 
(100 µM) 
 
 
 
NaNO2 
(1.56 µM) 
B 
C 
D 
E 
F 
G 
H Control 1 Control 2 Control 3 Control 4 Control 5 NaNO2 
Figure 3.4: Template of a 96-well plate for NO assay showing the actual extract 
concentration (µg in 0.1% DMSO) assayed and NaNO2 standard concentrations 
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3.3.6 Measurement of nitrite concentration 
Nitrite (NO2
-
) concentrations contained in the culture supernatants as an indicator of 
NO production were determined by the Griess reaction (Chi, Cheon, & Kim, 2001). After 
24 h of incubation time, 50 µL of cell-free supernatants were collected and incubated with 
50 µL of Griess reagent (2.5% phosphoric acid, 1% sulphanilamide, and 0.1% N-(1-
naphthy)-ethylene diamine dihydrochloride) to form purple azodye (Green et al., 1982) at 
room temperature for 10 minutes (Figure 3.5). 
 Sodium nitrite (NaNO2) (Sigma, USA) was used to generate a standard curves. A 
two-fold serial dilution of NaNO2 was done, starting at 100 µM in columns A11 and A12 
(50 µL/well) (Figure 3.4). Last two wells (H11 and H12) were left empty, and only 50 µL 
of deionized water was added to each well. After that, 50 µL of Griess reagent was added to 
all wells carefully in order to avoid as much bubbles as possible. 
 
Figure 3.5: Sample plate of purple azodye formed after 50 µL of Griess reagent was added 
to 50 µL of serially diluted NaNO2 
 
 The optical density at 540 nm (OD540) was measured using the Emax precision 
microplate reader (Molecular Devices). Nitrite concentrations were determined from a least 
squares linear regression analysis of NaNO2 standard curve. Percentage of NO inhibition 
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was calculated based on the ability of the extracts in inhibiting nitrite production by 
comparing with the negative control with 0% of nitrite inhibition. 
 A standard curve was plotted using average value for each standard value versus the 
concentration of standard (Appendix III). The average absorbance value of the blank wells 
(Control 1) was subtracted from all other pairs of wells. The absorbance values for each 
pair of triplicate wells were averaged. The concentration of each unknown was determined 
by interpolation from standard curve. The percent inhibition of each samples were 
calculated according to the equation: 
                               [Control 2] – [Sample] 
                                 [Control 2]                                      
Eq. (2)                                                                                                                                          
 
3.3.7 Measurement of RAW 264.7 cell viability using the MTT assay 
Motochondrial respiration, an indicator of RAW 264.7 cell viability, was assessed 
by the mitochondria-dependent reduction of 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) to formazan (Szabó, Thiemermann, & Vane, 1993). 
The cytotoxicity effects of the extracts were evaluated using the conventional MTT assay. 
RAW 264.7 cells remaining in the flat bottom 96-well microplate following removal of 
media for NO assay were topped up with 100 µL of fresh DMEM with phenol red 
supplemented with 5% heat-inactivated FBS for each well. Then, 20 µL of 5 mg/mL MTT 
(Sigma, USA) in phosphate buffer saline (PBS) pH 7.2 was added to each well, and 
incubated at 37ºC, 5% CO2 in the humidified incubator for 4 h. 
After 4 h of incubation time (Figure 3.6), the media was carefully discarded. The 
formazan salt which formed at the bottom of each well was dissolved in 100 µL of DMSO 
× 100 Percentage of NO inhibition (%)   = 
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(Figure 3.7), and mixed in a mixer for 15 min. The optical density at 540 nm (OD540) was 
determined using the Emax precision microplate reader. The absorbance of formazan in 
control (untreated cell) was taken as 100% viability, and the percentage of cell viability was 
calculated according to the equation: 
           OD Sample 
            OD Control 2 
Eq. (3)                                                                                                                                       
 
Figure 3.6: After 4 h of RAW 264.7 cells incubated with fresh DMEM and MTT in PBS 
pH 7.2, viable cells formed brown colour formazan in the 96-well flat bottom plate 
 
 
Figure 3.7: After removal of the media, the formazan formed at the bottom of each well 
were dissolved with 100 µL of DMSO, forming purple colour solvent 
 
 
 
× 100  Percentage of cell viability (%)   = 
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3.3.8 Statistical analysis 
 Statistical analysis was performed using the Statistical Package for the Social 
Sciences Version 16.0 (SPSS 16.0). All experiments were performed at least three times 
(N=3). All quantitative data were presented as mean + standard error of mean (S.E.M) and 
analysed via analysis of variance (ANOVA). Statistically significant differences among the 
means of the groups were tested at p<0.05 using Duncan‟s multiple range test. P values less 
than 0.05 were considered statistically significant. 
 
3.4 Cell Proliferation and Viability Assay on MDA-MB-231 Cell Line 
Petroleum ether, chloroform, and methanol extracts from ten selected Zingiberaceae 
species such as A. galanga, B. rotunda, C. aeruginosa, C. domestica, C. mangga, C. 
xanthorrhiza, K. galanga, Z. montanum, Z. officinale, and Z. zerumbet were evaluated for 
their anti-proliferative effects against human breast cancer cells (MDA-MB-231) using cell 
proliferation and viability assay.  
 
3.4.1 Preparations of diluents and reagents 
Two types of diluents, namely diluent A, diluent B were prepared as in Appendix I 
(Section 1.1.2).  
 
3.4.2 Cell culture for MDA-MB-231 cell line 
 Human breast cancer cell line, MDA-MB-231 (oestrogen-receptor negative, ER–) 
(Figure 3.8), obtained from ATCC was used in this experiment. The cell line was cultured 
in DMEM with phenol red, containing high glucose of 4500 mg/mL, L-glutamine, HEPES, 
and NaHCO3, supplemented with 10% heat-inactivated FBS, 2% penicillin/streptomycin 
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and 1% amphotericin B. Cell culture were maintained in a humidified incubator at 37ºC, 
with 5% CO2 and 95% air. The cells were grown to 90–100% confluence. Cell culture 
protocol is showed in Appendix II.  
 
 
Figure 3.8: Human breast cancer cell line, MDA-MB-231 (oestrogen-receptor negative, 
ER–) observed under phase-contrast microscope with magnification 100× 
 
3.4.3 MDA-MB-231 cell preparation and seeding 
The cytotoxicity of the extracts was tested against MDA-MB-231 tumour cells. 
MDA-MB-231 cells with confluency of 90%–100% were detached using accutase 
(Innovative Cell Technologies, San Diego, CA) and transferred into a 15 mL centrifuge 
tube. The cells were centrifuged for 5 min at 1000 rpm at room temperature. The 
supernatant was removed and 1 mL of diluent B was added to the cell pellet and 
resuspended gently using a 1000 mL pipettor. 
The well-resuspended cell sample (10 µL) was taken and mixed gently with 90 µL 
of trypan blue solution in a microtube. 10 µL of the mixture was then removed and 
dispensed on glass slide. The number of cells was counted using a using a haemocytometer, 
and percentage of cell viability was determined. The percentage of cell viability should be 
at least 95% in order to run the assay. 
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Cells were seeded in flat bottom 96-well microplate (100 µL/well) at a 
concentration of 8 × 10
4 
cells/mL culture medium. After plating, the plate was incubated for 
24 h at 37ºC, 5% CO2 in the humidified incubator. 
 
3.4.4 Sample dilution 
Sample stock and substock were prepared before conducting serial dilution. Sample 
stock was prepared by adding 0.02 g of crude extract with 0.2 mL of 100% DMSO in 
microtube and stored at –20ºC. Sample stock was thawed at room temperature before used. 
In this experiment, the required constant percentage of DMSO was 0.1%, and the final 
concentration for the sample needed was 100 µg/mL.  
So, for sample stock preparation,  
0.02 g sample crude extract = 20 mg  
0.02 g sample crude extract in 0.2 mL 100% DMSO = 20 mg/0.2 mL 
                                                                                     = 100 mg/mL 
                                                                                     = 100 000 µg/mL 
Thus, sample stock concentration was 100 000 µg/mL. 
 Sample substock was prepared to acquire 0.2% DMSO. To prepare sample substock 
at 200 µg/mL, 0.2% DMSO, calculation were carried out using the formula below, 
                      M1V1 = M2V2 
(100 000 µg/mL)V1 = (200 µg/mL)(500 µL) 
                            V1 = 1 µL 
Therefore, 1 µL from sample stock was taken out, and added to 499 µL of diluent B in 
order obtain 500 µL of sample substock with 0.2% DMSO at 200 µg/mL. 
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 After preparing sample substocks, serial dilution was conducted. Serial dilution was 
conducted using a sterile flat bottom 96-well microplate and multi-channel pipettor in a 
biohazard hood. Serial dilution was done prior to the cell proliferation and viability assay. 
The plate was sealed and frozen at –20°C.  
Firstly, 150 µL of diluent A was dispensed into wells rows B to H (Figure 3.9). 
Sample substock (300 µL) was added to wells in row A, which the final concentration here 
was 200 µg/mL. Then, 150 µL of dilution was transferred from wells in row A to row B, 
resulting in the final concentration in row B to be 100 µg/mL. The mixture was 
resuspended a few times before transferred to the following row. The steps were repeated 
until row G, and the last 150 µL of dilution after row G was discarded. Hence, final volume 
in each well was 150 µL, 0.2% DMSO. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A             
B             
C             
D             
E             
F             
G             
H             
 
Figure 3.9: Template of serial dilution for cell proliferation and viability assay 
 
                    Substock       
                    Diluent A + Substock 
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After the serial dilution was conducted, the sample concentrations for the wells in 
each row were 200 µg/mL for row A, 100 µg/mL for row B, 50 µg/mL for row C, 25 
µg/mL for row D, 12.5 µg/mL for row E, 6.25 µg/mL for row F, and 3.13 µg/mL for row G.  
 
3.4.5 Treatment of MDA-MB-231 cells with plant extracts 
After 24 h of incubation time, unattached cells were dispersed and the media was 
discarded using a pipettor. All cells were cultured with 100 µL of fresh DMEM with phenol 
red, containing high glucose of 4500 mg/mL, L-glutamine, HEPES, and NaHCO3, 
supplemented with 10% heat-inactivated FBS, 2% penicillin/streptomycin and 1% 
amphotericin B.  
100 µL of serially diluted Zingiberaceae extracts in the serial dilution plate was 
dispensed into each well except controls. 100 µL of the serially diluted Zingiberaceae 
extracts in media containing DMSO (diluent A) was added to each well containing 100 µL 
of diluent B, yielded a final concentration of DMSO 0.1% per well. Meanwhile, the MDA-
MB-231 cells were treated with each Zingiberaceae extracts at 1.56 µg/mL, 3.13 µg/mL, 
6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 µg/mL (Figure 3.10).  
Control groups include blank, cells in media containing 0.1% DMSO (negative 
control), and cells in media containing 0.05–3.13 µg/mL Doxorubicin hydrochloride 
(Sigma, USA) (positive control). Doxorubicin hydrochloride, a chemotherapy drug that 
used to treat breast cancers by inhibiting cell proliferation was used as the positive control 
(Laundry de Mesquita et al., 2009). The cells were incubated for 48 h at 37°C, 5% CO2, in 
a fully humidified incubator. 
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The same volume of media from the serial dilution plate was added to the same 
volume of media in the cell plate. Therefore, DMSO and extract concentrations were 
halved in the wells.  
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Sample 1 
(100 µg/mL) 
 
 
 
Sample 1 
(1.56 µg/mL) 
Sample 2 
(100 µg/mL) 
 
 
 
Sample 2 
(1.56 µg/mL) 
Sample 3 
(100 µg/mL) 
 
 
 
Sample 3 
(1.56 µg/mL) 
Doxorubicin 
hydrochloride 
(12.5 µg/mL) 
 
 
 
Doxorubicin 
hydrochloride 
(1.20 µg/mL) 
B 
C 
D 
E 
F 
G 
H Blank Negative Control 
 
Figure 3.10: Template of a 96-well plate for Cell proliferation and viability assay showing 
the actual extract concentration (µg in 0.1% DMSO) and Doxorubicin hydrochloride (µg in 
0.1% DMSO) assayed 
 
 
3.4.6 Measurement of MDA-MB-231 cell proliferation or viability 
Growth of tumoral cells was quantified by the ability of living cells to reduce the 
yellow dye MTT to a blue formazan product (Mosmann, 1983). At the end of 48 h 
incubation, old media were removed, and treated cells were added with 100 µL of fresh 
DMEM with phenol red, containing high glucose of 4500 mg/mL, L-glutamine, HEPES, 
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and NaHCO3, supplemented with 5% FBS. After that, 20 µL of 5mg/mL MTT was added 
into each well and incubated for 4 h.  
After 4 h of incubation time, the formazan product (Figure 3.11) of MTT reduction 
was dissolved in 100 µL of DMSO. Then, the plate was mixed in a mixer for 15 min. The 
optical density at 540nm (OD540) was determined using the Emax precision microplate 
reader. For time-dependent assays, cells were incubated with Zingiberaceae extracts for 48 
h. The absorbance of formazan in control (untreated cell) was taken as 100% proliferation 
or viability, and the cytotoxicity index (CI) of cells are expressed as percentage calculated 
according to the equation: 
    OD540 of (treated cells)  
    OD540 0f (control cells) 
Eq. (4)                                                                                                                                          
 
 
Figure 3.11: Formazan formed at the bottom of the well were observed under a phase-
contrast microscope with magnification 100× 
 
 
 
× 100 CI =  1   – 
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3.4.7 Statistical analysis 
All experiments were performed at least three times (N=3). All quantitative data 
were presented as mean + standard error of mean (S.E.M) and analysed using SPSS 16.0 
and Graphpad Prism 4.02 programme.  
 Growth inhibitory effects from exposure of cells to different concentrations of crude 
Zingiberaceae extracts were presented in terms of percentage of cytotoxicity index and IC50 
values. Cytostatic concentrations (IC50) were identified as the concentration of crude 
Zingiberaceae extract required to inhibit 50% cell proliferation or viability compared with 
the control groups. The IC50 values were obtained by nonlinear regression using the 
GraphPad Prism Version 4.02 programme.  
 
3.5 Cytotoxicity Assay  
The most cytotoxic extracts (IC50 < 10 µg/mL) against MDA-MB-231 cells were 
selected for in vitro toxicity study using MTT assay in order to assess their potential 
toxicity against normal, non-tumoural human lung fibroblast cells, MRC-5. The selected 
extracts were petroleum ether extracts of A. galanga, B. rotunda, and Z. zerumbet; as well 
as chloroform extracts of A. galanga, B. rotunda, and C. domestica. 
 
3.5.1 Preparations of diluents and reagents 
Two types of diluents, namely diluent A, diluent B were prepared as in Appendix I 
(Section 1.1.3).  
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3.5.2 Cell culture for MRC-5 cell line 
 MRC-5 cell line (Figure 3.12) was cultured in MEM with phenol red, containing L-
glutamine, HEPES, NaHCO3, and sodium pyruvate supplemented with 10% heat-
inactivated FBS, 2% penicillin/streptomycin and 1% amphotericin B. Cell culture were 
maintained in a humidified incubator at 37ºC, with 5% CO2 and 95% air. The cells were 
grown to 90% to 100% confluence. Cell culture protocol is showed in Appendix II.  
 
 
Figure 3.12: Human lung fibroblast cell line (MRC-5) observed under phase-contrast 
microscope with magnification 100× 
 
3.5.3 MRC-5 cell preparation and seeding 
The cytotoxic extracts were tested against MRC-5 cell line. MRC-5 cells with 
confluency of 90%–100% were detached using accutase and transferred into a 15 mL 
centrifuge tube. The cells were centrifuged for 5 min at 1000 rpm at room temperature. The 
supernatant was removed and 1 mL of diluent B was added to the cell pellet and 
resuspended gently using a 1000 µL pipettor. 
The well-resuspended cell sample (10 µL) was taken and mixed gently with 90 µL 
of trypan blue solution in a microtube. Then, 10 µL of the sample was removed and 
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dispensed on glass slide. The number of cells was counted using a using a haemocytometer, 
and percentage of cell viability was determined. The percentage of cell viability should be 
at least 95% in order to run the assay.  
Cells were seeded in flat bottom 96-well microplate (100 µL/well) at a 
concentration of 8 × 10
4 
cells/mL culture medium. After plating, the plate was incubated for 
24 h at 37ºC, 5% CO2 in the humidified incubator. 
 
3.5.4 Sample dilution 
 Sample dilution was carried out as described in section 3.4.4. 
 
3.5.5 Treatment of MRC-5 cells with selected cytotoxic plant extracts 
Treatment of MRC-5 cells with the selected cytotoxic extracts was carried out as 
described in section 3.4.5. 
 
3.5.6 Measurement of cell viability 
Measurement of MRC-5 cell viability using MTT assay was carried out as described 
in section 3.4.6. 
 
3.5.7 Statistical analysis 
Statistical analysis of the experiment was performed as described in section 3.4.7. 
 
3.6 Scratch Wound Assay 
Petroleum ether, chloroform, and methanol extracts from ten selected Zingiberaceae 
species such as A. galanga, B. rotunda, C. aeruginosa, C. domestica, C. mangga, C. 
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xanthorrhiza, K. galanga, Z. montanum, Z. officinale, and Z. zerumbet were evaluated for 
their anti-migration effects against human breast cancer cells (MDA-MB-231) using scratch 
wound assay. 
 
3.6.1 Preparation of diluents and reagents 
Two types of diluents, namely diluent A, diluent B were prepared as in Appendix I 
(Section 1.1.4). 
 
3.6.2 Cell culture for MDA-MB-231 cell line 
Cell culture for MDA-MB-231 cell line was carried put as described in section 3.4.2. 
 
3.6.3 MDA-MB-231 cell preparation and seeding 
MDA-MB-231 cells with confluency of 90%–100% were detached using accutase 
and transferred into a 15 mL centrifuge tube. The cells were centrifuged for 5 min at 1000 
rpm at room temperature. The supernatant was removed and 5 mL of diluent B was added 
to the cell pellet and resuspended gently using a 10 mL disposable serological pipette. 
The well-resuspended cell sample (10 µL) was taken and mixed gently with 90 µL 
of Trypan Blue solution in a microtube. Then, 10 µL of the sample was removed and 
dispensed on glass slide. The number of cells was counted using a using a haemocytometer, 
and percentage of cell viability was determined. The percentage of cell viability should be 
at least 95% in order to run the assay. Cells were seeded onto six-well plate at a 
concentration of 1 × 10
6
 cells per well and grown to confluence. The plate was incubated at 
37ºC, 5% CO2 in the humidified incubator. 
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3.6.4 Sample dilution 
Sample dilution of stock and substock for use in the scratch wound assay was 
carried out as described in section 3.4.4. 
9980 µL of diluent B was dispensed into a 15 mL centrifuge tube labeled as “Tube 
1”, while 5 mL of diluent A was dispensed into another 15 mL centrifuge tube labeled as 
“Tube 2”. Extract stock (20 µL) was added to “Tube 1”, resulting in a concentration of 
sample extract to be 200 µg/mL. Subsequently, 5 mL of the well re-suspended dilution was 
transferred from Tube 1 to Tube 2, resulting in the final concentration of sample extract in 
Tube 2 to be 100 µg/mL (Figure 3.13). The dilution was mixed a few times and 3 mL of the 
dilution in Tube 2 was discarded. The volume in each tube was 5 mL, 0.2% DMSO. 
The same procedure of serial dilution was carried out for the subsequent 
concentrations such as 50 µg/mL, 25 µ/mL, 12.5 µg/mL, etc. Serial dilution was conducted 
using sterile centrifuge tubes and serological pipette in a biohazard hood. Serial dilution 
were carried out be prior to the scratch wound assay. After the serial dilution was 
conducted, the sample concentrations for each centrifuge tube were 200 µg/mL in Tube 1 
and 100 µg/mL in Tube 2. 
 
 
 
 
 
 
 
 
75 
 
 
 
 
 
 
 
 
 
 
 
                  Figure 3.13: Diagram of serial dilution for Scratch wound assay 
 
                    Substock       
                    Diluent A + Substock 
 
 
3.6.5 Treatment of MDA-MB-231 cells with plant extracts 
 Confluent cell monolayers in the 6-well plate were carefully wounded by scratching 
with a sterile 200 µL-pipette tip along the diameter of the well (Figure 3.14). The cells were 
washed twice with PBS to remove any cell debris before their subsequent incubation with 
1%-heated inactivated FBS culture medium in the absence (negative control) or presence of 
Zingiberaceae extracts.  
 
Tube 1 
5 mL Substock 
Tube 2 
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Figure 3.14: Confluent cell monolayers of MDA-MB-231 were wounded using a sterile 
200 µL-pipette tip along the diameter of the well, which was then observed under a phase-
contrast microscope with magnification 50× 
 
All cells were cultured in 2 mL of fresh DMEM with phenol red, containing high 
glucose of 4500 mg/mL, L-glutamine, HEPES, and NaHCO3, supplemented with 1%-heat 
inactivated FBS (Choi et al., 2009), 2% penicillin/streptomycin and 1% amphotericin B 
(diluent B).  
2 mL of serially diluted Zingiberaceae extracts were dispensed into each well 
except controls. 2 mL of the serially diluted Zingiberaceae extracts in media containing 
DMSO (diluent A) subsequently added to each well containing 2mL of diluent B, yielded a 
final concentration of DMSO 0.1% per well (Figure 3.15).  
The cells were incubated in Zingiberaceae extracts at their optimum concentrations 
or vehicle alone for 48 h at 37°C, 5% CO2, in a fully humidified incubator and 
photographed under a phase-contrast microscope. The culture treatments were repeated 
twice and each sample was assayed in triplicates. 
 
 
 
77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Template of a six-well plate for scratch wound assay showing the actual 
extract concentration (µg in 0.1% DMSO) assayed 
 
The same volume of media from the serial dilution plate was added to the same 
volume of media in the cell plate. Therefore, DMSO and extract concentrations were 
halved in the wells.  
 
3.6.6 Measurement of cell migration ability 
Cells were serum-starved and stimulated or non-stimulated with Zingiberaceae 
extracts for 24, and 48 h. Wound closure of the cell monolayer was observed under the 
microscope at 50× magnification, and photographs were captured immediately after 
Negative 
control 
(cells only) 
Cells treated 
with sample 1 
at 50 µg/mL 
Cells treated 
with sample 1 
at 50 µg/mL 
Cells treated 
with sample 2 
at 50 µg/mL 
Cells treated 
with sample 2 
at 50 µg/mL 
Negative 
control 
(cells only) 
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treatment (0 h), and after 24 h and 48 h later. Five fields of each of the wounds were 
captured and mean values for the selected fields per well were analyzed. 
 The relative cell migration capability has been described by Liu et al. (2005) (Peng, 
Chen, Peng, Su, & Hsieh-Li, 2006), and has been modified by Peng et al. (2007) to 
absolute migration capability (MCA) as: 
                                         MCA (mm/h)   =      G0 – Gt  
                                                                             2t 
Eq. (5)                                                                                                                                          
where G0 is the initial gap for the cell line at 0 h (mm), 
           Gt is the final gap for the cell line treated with Zingiberaceae extract at 
                 certain concentration or vehicle alone for a time period of t (h) (mm), and 
           t is the overall time period for incubation (h). 
 
3.6.7 Statistical analysis 
Statistical analysis was performed using SPSS 16.0. All experiments were 
performed at least three times (N=3). All quantitative data were presented as mean + 
standard error of mean (S.E.M) and analysed via analysis Paired-Samples t-test. P values 
less than 0.05 were considered statistically significant.  
 
3.7 Thin-layer Chromatography 
Thin-layer chromatography (TLC) qualitatively analysed components of crude 
extract. The most potential Zingiberaceae extracts based on the screening tests were 
chloroform extract of A. galanga, chloroform extract of C. domestica, and petroleum ether 
extract of Z. zerumbet. These extracts showed potent effects in inhibition of nitric 
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production in activated macrophage cells (RAW 264.7), anti-proliferation and anti-
migration activities against human breast cancer cells (MDA-MB-231). More importantly, 
these extracts possess SX values distinctly greater than 100 which indicated their promising 
properties for further studies in the development of anti-cancer drugs. Therefore, they were 
selected for qualitative analysis using TLC to determine the chemical groups contained in 
the crude extract. 
 
3.7.1 Stationary phase 
Commercially available silica gel TLC plate (20 cm × 20 cm) was cut into strips of 
2 cm × 10 cm. A straight line was drawn parallel along the width, with 1 cm distance from 
each end of the thin-layer plate using a pencil (Figure 3.16). 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: A cut of TLC plate (2 cm × 10 cm) with marked baseline and solvent front, 
which is ready to be used for qualitative analysis 
 
 
Solvent front 
Baseline 
2 cm 
10 cm 
8 cm 
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3.7.2 Development of mobile phase 
Crude Zingiberaceae extract was applied as a short (4 mm), narrow, and horizontal 
line on the baseline of the TLC plate. Each plate was developed in one of a series of the 
mobile phases, usually consisting of single solvent and covering a wide range of polarities. 
Optimization of mobile phase development was conducted according to the concept of 
PRISMA system (Appendix IV). Nine solvents chosen based on their „solvent strength‟ 
(related to its polarity) (Appendix IV, Table 3.1) for the development of mobile phase were 
hexane, diethylether, methanol, dimethylformamide, acetic acid, dichloromethane, ethyl 
acetate, toluene, and chloroform. 
A 1:1:1 combination of diethylether, dichloromethane, and ethyl acetate, including 
the addition of appropriate hexane were used as the mobile phase in the TLC test for crude 
chloroform extracts of A. galanga and C. domestica. On the other hand, a 9:1 combination 
of dichloromethane and chloroform were used as the mobile phase in the TLC test for crude 
petroleum ether extract of Z. zerumbet. 
 
3.7.3 Choice of detection systems 
Some of the components of an extract may be coloured, and thus can be visualized 
on white stationary phase in daylight. However, most of the components have little or no 
colour, and other methods are used to make them visible. Two most common methods used 
are examination under Ultraviolet (UV) light and the use of spray reagents to produce 
fluorescent or colour derivatives. The detection methods used for this experiment are 
shown in Table 3.1. 
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Thin-layer chromatography is a highly reproducible method for qualitative chemical 
analysis of the nature (chemical groups) of the substances contained in a complex mixture. 
These may already be known as the results of preliminary chemical tests. 
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Table 3.1: Selection of detection systems for thin-layer chromatography (Houghton & Raman, 
1998) 
Detection method/ 
Spray reagent 
Treatment Types of compounds 
detected 
 
Methods other than chromogenic spray: 
Daylight - Coloured substances 
 
UV light 254 nm Layer which fluoresces at 254 nm was 
examined in darkened area. 
 
Non-fluorescent layer was examined in 
darkened area. 
Compounds containing 
conjugated double bonds 
Some fluorescent 
compounds – usually 
have extended π electron 
system 
 
UV light 365 nm Non-fluorescent layer was examined in 
darkened area. 
 
Some fluorescent 
compounds 
Exposure to iodine 
vapour 
A sealed iodine chamber was used (iodine 
crystals in bottol of TLC tank). Layer was 
leave in contact with iodine vapour and then 
removed. Yellow or brown zone was noted. 
The zone will quickly disappear but can be 
revisualized by replacing the layer in the 
chamber or fixed by spraying with 0.5% w/v 
starch dextrin solution. 
 
Many types of 
compounds, particularly 
if double bonds are 
present 
Chromogenic sprays
1
: 
50% Sulphuric acid 
 
Layer sprayed with the reagent was heated at 
105°C for 10 min. Then, the layer was 
observed in daylight. 
  
Most organic compounds 
give a yellow, brown or 
black zone 
Dragendorff‟s reagent Layer sprayed with the reagent was examined 
in daylight. Layer can be over-sprayed with 5% 
aqueous iron (III) chloride, 5% aqueous 
sodium nitrite or 10% sulphuric acid to make 
zones appear darker. 
 
Alkaloids give orange 
zones on yellow 
background 
Vanillin/sulphuric 
acid reagent 
Two types of solvents, known as ethanolic 
sulphuric acid (Solvent A) and ethanolic 
vanillin (Solvent B) were prepared. Layer was 
sprayed with Solvent A followed by Solvent B. 
Then, the layer was heated at 110°C for 10 
min. 
Terpenoid gives purple 
spot 
 
Phenol gives red zone 
and other colours 
1 
Recipe for solvent preparation for the chromogenic sprays was presented in Appendix IV. 
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3.7.4 Measurement of retardation factor 
Retardation factor or Rf value is a useful parameter to measure a given substance. Rf 
value is defined as the ratio of the distance from the baseline (point of application) to the 
centre of the zone divided by the distance from the baseline to the solvent front (Figure 
3.17) (Houghton & Raman, 1998).  
 
 
 
 
 
 
 
 
 
 
Figure 3.17: Typical TLC chromatogram 
 
Rf can be calculated as  
                          Distance of the compound moved from the baseline                     x 
 
 
Eq. (6) 
 
 
Solvent front 
Baseline 
 
y 
         
x 
 
Extract 
Coloured zone 
Rf     = 
    Distance of the solvent from the baseline 
= 
× y 
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CHAPTER 4 
4.0 Results 
Ten fresh rhizomes of the selected Zingiberaceae species of A. galanga, B. rotunda, 
C. aeruginosa, C. domestica, C. mangga, C. xanthorrhiza, K. galanga, Z. montanum, Z. 
officinale, and Z. zerumbet were extracted with petroleum ether, chloroform, and methanol 
using Soxhlet extractor system. The resulting 30 Zingiberaceae extracts were then 
evaluated for NO inhibitory activity in stimulated RAW 264.7 cells, anti-proliferative and 
anti-migration activities against MDA-MB-231 cells. 
 
4.1 Effects of the Zingiberaceae Extracts on Nitric Oxide Inhibitory Activity 
A total of 30 Zingiberaceae extracts were tested for in vitro NO inhibitory activities 
in LPS (10 µg/mL) stimulated RAW 264.7 cells. The effect at various concentrations was 
observed after 24 h, and dose-response graphs for the extracts (Figure 4.1–4.10) were 
generated. The nitrite levels in culture supernatant as an index of NO generation were 
measured using Griess reaction (Green et al., 1982). 
Evaluations were done at seven different concentrations, of 1.56 µg/mL, 3.13 
µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 µg/mL for each 
Zingiberaceae extracts. Cell viability was determined using the conventional MTT assay to 
exclude the possibility that the observed effects on NO inhibition were due to their potential 
cytotoxicity. When samples exhibited marked toxicity (cell viability < 80%) at certain 
concentrations, the effects of extracts on NO inhibition for that particular concentration 
were eliminated from being compared. Evaluations were carried out in triplicate and the 
mean + standard error of mean (S.E.M.) were calculated. 
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Based on Section 3.3.5, control groups used in the experiment included „blank or 
media only‟ (Control 1), „cells with inducer‟ (Control 2 and Control 3), „cells only‟ 
(Control 4), and „cells with inducer and L-NAME‟ (Control 5). The absorbance reading for 
Control 1 (media only) was required for NO calculation (Appendix III). Cells with inducers 
(Control 2 and Control 3) represented the negative controls, where cells were stimulated by 
the inducer (LPS) to generate NO. Therefore, no inhibition of NO could be detected for the 
negative control, which was presented as 0% of NO inhibition (Figure 4.1–4.10). Control 
consisting of cells only (Control 4) did not show any NO generation. This was due to the 
absence of inducer and thus, the cells were therefore not stimulated to produce NO. On the 
other hand, positive control consisted of cells treated with inducer and L-NAME (iNOS 
inhibitor). They exhibited about 70% of NO inhibition in the LPS-stimulated RAW 264.7 
cells.  
  
(a) Alpinia galanga 
The results in this study indicated that the extracts could modulate NO production in 
LPS-activated macrophages. Figure 4.1 showed the effects of crude petroleum ether, 
chloroform, and methanol extracts of A. galanga on nitric oxide production in RAW 264.7 
cells. Crude petroleum ether extract inhibited NO production dose-dependently at 78.04% 
(1.56 µg/mL) and 93.38% (3.13 µg/mL) [Figure 4.1 (A)]. At 6.25–100 µg/mL tested, the 
extract exerted pronounced cytotoxicity with RAW 264.7 cell viability less than 40% at 
6.25 µg/mL and less than 5% at 12.5–100 µg/mL (Table 4.1). The readings from these 
concentrations were therefore eliminated from being compared. Crude chloroform extract 
on the other hand inhibited NO production dose-dependently up to 43.97% (1.56 µg/mL), 
58.95% (3.13 µg/mL), 81.12% (6.25 µg/mL) and 96.60% (12.5 µg/mL) [Figure 4.1 (B)]. At 
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higher concentrations tested, the extract exerted marked cytotoxicity with RAW 264.7 cell 
viability less than 65% at 25 µg/mL and less than 5% at 50 µg/mL and 100 µg/mL (Table 
4.1). As before, readings from the concentrations were therefore omitted from being 
compared. Crude methanol extract dose-dependently inhibited NO production at 16.55% 
(1.56 µg/mL), 21.17% (3.13 µg/mL), 23.31% (6.25 µg/mL), 27.50% (12.5 µg/mL), 36.23% 
(25 µg/mL), 46.32% (50 µg/mL) and 57.51% (100 µg/mL) [Figure 4.1 (C)]. The NO 
inhibitory effects observed were not due to the cytotoxicity effects of the extract as the cell 
viability was more than 95% at all concentrations evaluated (Table 4.1). 
 
(b) Boesenbergia rotunda 
Figure 4.2 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of B. rotunda on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 21.33% (1.56 µg/mL), 26.11% 
(3.13 µg/mL), 37.30% (6.25 µg/mL) and 71.45% (12.5 µg/mL) [Figure 4.2 (A)]. At 25–100 
µg/mL tested, the extract exerted pronounced cytotoxicity with RAW 264.7 cell viability 
about 50% at 25 µg/mL and less than 5% at 50–100 µg/mL (Table 4.1). The readings from 
these concentrations were therefore eliminated from being compared. Crude chloroform 
extract on the other hand dose-dependently inhibited NO production at 17.32% (1.56 
µg/mL), 28.85% (3.13 µg/mL), 44.13% (6.25 µg/mL) and 67.47% (12.5 µg/mL) [Figure 
4.2 (B)]. At higher concentrations tested, the extract exerted marked cytotoxicity with 
RAW 264.7 cell viability less than 50% at 25 µg/mL and less than 5% at 50 µg/mL and 100 
µg/mL (Table 4.1). As before, readings from the concentrations were therefore omitted 
from being compared. Crude methanol extract dose-dependently inhibited NO production 
up at 6.79% (1.56 µg/mL), 10.06% (3.13 µg/mL), 11.14% (6.25 µg/mL), 16.03% (12.5 
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µg/mL), 29.13% (25 µg/mL) and 54.81% (50 µg/mL) [Figure 4.2 (C)]. At 100 µg/mL, the 
extract exerted mild cytotoxicity on RAW 264.7 cells, which the cell viability with 75% 
(Table 4.1). 
 
(c) Curcuma aeruginosa 
Figure 4.3 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of C. aeruginosa on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 11.98% (1.56 µg/mL), 15.34% 
(3.13 µg/mL), 26.42% (6.25 µg/mL), 38.46% (12.5 µg/mL), 64.10% (25 µg/mL)  [Figure 
4.3 (A)]. At 50–100 µg/mL tested, the extract exerted pronounced cytotoxicity with RAW 
264.7 cell viability less than 70% at 50 µg/mL and less than 5% at 100 µg/mL (Table 4.1). 
The readings from these concentrations were therefore eliminated from being compared. 
Crude chloroform extract on the other hand dose-dependently inhibited NO production at 
17.12% (1.56 µg/mL), 20.41% (3.13 µg/mL), 15.38% (6.25 µg/mL) and at 37.81% (12.5 
µg/mL), 64.30% (25 µg/mL) and 89.68% (50 µg/mL) [Figure 4.3 (B)]. At 100 µg/mL, the 
extract exerted marked cytotoxicity with RAW 264.7 cell viability less than 15% (Table 
4.1). As before, readings from the concentrations were therefore omitted from being 
compared. Crude methanol extract dose-dependently inhibited NO production up at 10.19% 
(1.56 µg/mL), 12% (3.13 µg/mL), 15.01% (6.25 µg/mL), 20.36% (12.5 µg/mL), 24.17% 
(25 µg/mL), 33.16% (50 µg/mL) and 61.07% (100 µg/mL) [Figure 4.3 (C)]. The NO 
inhibitory effects observed were not due to the cytotoxicity effects of the extract as the cell 
viability was more than 90% at all concentrations evaluated (Table 4.1). 
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Figure 4.1: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Alpinia galanga on NO production in RAW 264.7 cells. Each bar represents the 
mean + S.E. calculated from three independent experiments. 
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Figure 4.2: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Boesenbergia rotunda on NO production in RAW 264.7 cells. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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Figure 4.3: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma aeruginosa on NO production in RAW 264.7 cells. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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(d) Curcuma domestica 
Figure 4.4 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of C. domestica on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 18.25% (1.56 µg/mL), 27.80% 
(3.13 µg/mL), 42.40% (6.25 µg/mL), 70.03% (12.5 µg/mL), 94.79% (25 µg/mL) [Figure 
4.4 (A)]. At 50–100 µg/mL tested, the extract exerted pronounced cytotoxicity with RAW 
264.7 cell viability less than 75% at 50 µg/mL and less than 5% at 100 µg/mL (Table 4.1). 
The readings from these concentrations were therefore eliminated from being compared. 
Crude chloroform extract on the other hand dose-dependently inhibited NO production at 
18.28% (1.56 µg/mL), 38.16% (3.13 µg/mL) and 89.22% (6.25 µg/mL) [Figure 4.4 (B)]. At 
higher concentrations tested, the extract exerted marked cytotoxicity with RAW 264.7 cell 
viability about 50% at 12.5 µg/mL, less than 15% at 25 µg/mL and less than 10% at 50– 
100 µg/mL (Table 4.1). As before, readings from the concentrations were therefore omitted 
from being compared. (Table 4.1). Crude methanol extract dose-dependently inhibited NO 
production up at 19.05% (1.56 µg/mL), 28.92% (3.13 µg/mL), 64.38% (6.25 µg/mL) and 
98.67% (12.5 µg/mL) [Figure 4.4 (C)]. At the higher concentrations tested, the extract 
exerted cytotoxicity with cell viability less than 60% at 25 µg/mL and less than 10% at 50–
100 µg/mL (Table 4.1). 
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Figure 4.4: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma domestica on NO production in RAW 264.7 cells. Each bar represents 
the mean + S.E. calculated from three independent experiments. 
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(e) Curcuma mangga 
Figure 4.5 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of C. mangga on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 9.42% (1.56 µg/mL), 11.85% 
(3.13 µg/mL), 16.55% (6.25 µg/mL), 20.77% (12.5 µg/mL), 32.46% (25 µg/mL) and 
64.49% (50 µg/mL) [Figure 4.5 (A)]. At 100 µg/mL, the extract exerted pronounced 
cytotoxicity with RAW 264.7 cell viability less than 30% (Table 4.1). The readings from 
the concentration were therefore eliminated from being compared. Crude chloroform 
extract on the other hand dose-dependently inhibited NO production at 3% (1.56 µg/mL), 
6.64% (3.13 µg/mL), 7.61% (6.25 µg/mL) and at 18.43% (12.5 µg/mL), 33.65% (25 µg/mL) 
and 73.04% (50 µg/mL) [Figure 4.5 (B)]. At 100 µg/mL, the extract exerted marked 
cytotoxicity with RAW 264.7 cell viability less than 60% (Table 4.1). As before, readings 
from the concentrations were therefore omitted from being compared. Crude methanol 
extract dose-dependently inhibited NO production up at 3.35% (1.56 µg/mL), 4.33% (3.13 
µg/mL), 4.65% (6.25 µg/mL), 6.31% (12.5 µg/mL), 8.13% (25 µg/mL), 10.11% (50 µg/mL) 
and 17.48% (100 µg/mL) [Figure 4.5 (C)]. The NO inhibitory effects observed were not 
due to the cytotoxicity effects of the extract as the cell viability was more than 95% at all 
concentrations evaluated (Table 4.1). 
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Figure 4.5: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma mangga on NO production in RAW 264.7 cells. Each bar represents 
the mean + S.E. calculated from three independent experiments. 
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(f) Curcuma xanthorrhiza 
Figure 4.6 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of C. xanthorrhiza on nitric oxide production in RAW 264.7 cells. Crude 
petroleum ether extract dose-dependently inhibited NO production at 8.79% (1.56 µg/mL), 
10.43% (3.13 µg/mL), 20% (6.25 µg/mL), 31.68% (12.5 µg/mL), 60.85% (25 µg/mL) and 
90.68% (50 µg/mL) [Figure 4.6 (A)]. At 100 µg/mL, the extract exerted pronounced 
cytotoxicity with RAW 264.7 cell viability less than 5% (Table 4.1). The readings from the 
concentration were therefore eliminated from being compared. Crude chloroform extract on 
the other hand dose-dependently inhibited NO production at 6.49% (1.56 µg/mL), 10.64% 
(3.13 µg/mL), 29.08% (6.25 µg/mL) and 71.07% (12.5 µg/mL) [Figure 4.6 (B)]. At higher 
concentrations tested, the extract exerted marked cytotoxicity with RAW 264.7 cell 
viability less than 60% at 25 µg/mL and less than 10% at 50–100 µg/mL (Table 4.1). As 
before, readings from the concentrations were therefore omitted from being compared. 
Crude methanol extract dose-dependently inhibited NO production up at 2.98% (1.56 
µg/mL), 4.39% (3.13 µg/mL), 7.14% (6.25 µg/mL), 13.40% (12.5 µg/mL), 36.93% (25 
µg/mL), 79.05% (50 µg/mL) and 99.19% (100 µg/mL) [Figure 4.6 (C)]. The NO inhibitory 
effects observed were not due to the cytotoxicity effects of the extract as the cell viability 
was more than 95% at all concentrations evaluated (Table 4.1). 
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Figure 4.6: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol extract 
of Curcuma xanthorrhiza on NO production in RAW 264.7 cells. Each bar represents the 
mean + S.E. calculated from three independent experiments. 
1
0
.4
3
 +
 1
.3
8
 
2
0
.0
0
 +
 4
.3
2
 
3
1
.6
8
 +
 5
.0
7
 
6
0
.8
5
 +
 4
.5
7
 
9
0
.6
8
 +
 1
.4
5
 
7
0
.9
6
 +
 3
.6
0
 
8
.7
9
 +
 2
.4
1
 
7
1
.0
7
 +
 4
.9
8
 
7
1
.6
4
 +
 3
.3
0
 
1
0
.6
4
 +
 2
.8
2
 
6
.4
9
+
 3
.0
1
 
2
9
.0
8
 +
 3
.0
1
 
7
1
.9
9
 +
 3
.0
9
 
2
.9
8
 +
 1
.0
9
 
4
.3
9
 +
 1
.0
8
 
7
.1
4
 +
 1
.6
8
 
1
3
.4
0
 +
 0
.8
1
 
9
9
.1
9
 +
 0
.4
5
 
7
9
.0
5
 +
 1
.9
3
 
3
6
.9
3
 +
 0
.7
6
 
(C) 
(B) 
(A) 
97 
 
(g) Kaempferia galanga 
Figure 4.7 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of K. galanga on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 12.36% (1.56 µg/mL), 17.63% 
(3.13 µg/mL), 22.11% (6.25 µg/mL), 34.63% (12.5 µg/mL), 55.78% (25 µg/mL), 83.53% 
(50 µg/mL) and 96.10% (100 µg/mL) [Figure 4.7 (A)]. The NO inhibitory effects observed 
were not due to the cytotoxicity effects of the extract as the demonstrated RAW 264.7cell 
viability were more than 95% at all concentrations tested (Table 4.1). Crude chloroform 
extract on the other hand dose-dependently inhibited NO production up at 14.62% (1.56 
µg/mL), 17.24% (3.13 µg/mL), 22.95% (6.25 µg/mL), 38.53% (12.5 µg/mL), 64.85% (25 
µg/mL), 93.05% (50 µg/mL) and 97.90% (100 µg/mL) [Figure 4.7 (B)]. The NO inhibitory 
effects observed were not due to the cytotoxicity effects of the extract as the demonstrated 
RAW 264.7cell viability were more than 95% at all concentrations tested (Table 4.1). 
Crude methanol extract dose-dependently inhibited NO production up at 8.73% (1.56 
µg/mL), 10.33% (3.13 µg/mL), 13.06% (6.25 µg/mL), 17.71% (12.5 µg/mL), 25.26% (25 
µg/mL), 42.27% (50 µg/mL) and 69.48% (100 µg/mL) [Figure 4.7 (C)]. The NO inhibitory 
effects observed were not due to the cytotoxicity effects of the extract as the cell viability 
was more than 95% at all concentrations evaluated (Table 4.1). 
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Figure 4.7: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Kaempferia galanga on NO production in RAW 264.7 cells. Each bar represents 
the mean + S.E. calculated from three independent experiments. 
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(h) Zingiber montanum 
Figure 4.8 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of Z. montanum on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 11.87% (1.56 µg/mL), 22.29% 
(3.13 µg/mL), 41.17% (6.25 µg/mL), 65.09% (12.5 µg/mL), 77.09% (25 µg/mL) and 
93.36% (50 µg/mL) [Figure 4.8 (A)]. At 100 µg/mL, the extract exerted pronounced 
cytotoxicity with RAW 264.7 cell viability less than 10% (Table 4.1). The readings from 
the concentration were therefore eliminated from being compared. Crude chloroform 
extract on the other hand dose-dependently inhibited NO production up at 2.46% (1.56 
µg/mL), 7.52% (3.13 µg/mL), 16.17% (6.25 µg/mL), 43.60% (12.5 µg/mL), 87.54% (25 
µg/mL), 99.41% (50 µg/mL) and 100% (100 µg/mL) [Figure 4.8 (B)]. The NO inhibitory 
effects observed were not due to the cytotoxicity effects of the extract as the demonstrated 
RAW 264.7cell viability were more than 90% at all concentrations tested (Table 4.1). 
Crude methanol extract dose-dependently inhibited NO production up at 3.19% (1.56 
µg/mL), 4.48% (3.13 µg/mL), 5.90% (6.25 µg/mL), 9.64% (12.5 µg/mL), 12.53% (25 
µg/mL), 17.40% (50 µg/mL) and 34.56% (100 µg/mL) [Figure 4.8 (C)]. The NO inhibitory 
effects observed were not due to the cytotoxicity effects of the extract as the cell viability 
was more than 95% at all concentrations evaluated (Table 4.1). 
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Figure 4.8: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Zingiber montanum on NO production in RAW 264.7 cells. Each bar represents 
the mean + S.E. calculated from three independent experiments. 
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(i) Zingiber officinale 
Figure 4.9 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of Z. officinale on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 16% (1.56 µg/mL), 21.33% 
(3.13 µg/mL), 32.41% (6.25 µg/mL), 44.78% (12.5 µg/mL), 72.95% (25 µg/mL) and 
98.27% (50 µg/mL) [Figure 4.9 (A)]. At 100 µg/mL, the extract exerted pronounced 
cytotoxicity with RAW 264.7 cell viability less than 5% (Table 4.1). The readings from the 
concentration were therefore eliminated from being compared. Crude chloroform extract on 
the other hand dose-dependently inhibited NO production up at 11.55% (1.56 µg/mL), 
16.38% (3.13 µg/mL), 23.90% (6.25 µg/mL), 45.46% (12.5 µg/mL), 83.27% (25 µg/mL) 
and 95.36% (50 µg/mL) [Figure 4.9 (B)]. At 100 µg/mL, the extract exerted pronounced 
cytotoxicity with RAW 264.7 cell viability less than 70% (Table 4.1). The readings from 
the concentration were therefore eliminated from being compared. Crude methanol extract 
dose-dependently inhibited NO production up at 7.27% (1.56 µg/mL), 7.61% (3.13 µg/mL), 
9.07% (6.25 µg/mL), 10.23% (12.5 µg/mL), 15.61% (25 µg/mL), 18.03% (50 µg/mL) and 
19.01% (100 µg/mL) [Figure 4.9 (C)]. The NO inhibitory effects observed were not due to 
the cytotoxicity effects of the extract as the cell viability was more than 95% at all 
concentrations evaluated (Table 4.1). 
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Figure 4.9: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Zingiber officinale on NO production in RAW 264.7 cells. Each bar represents 
the mean + S.E. calculated from three independent experiments. 
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(j) Zingiber zerumbet 
Figure 4.10 showed the effects of crude petroleum ether, chloroform, and methanol 
extracts of Z. zerumbet on nitric oxide production in RAW 264.7 cells. Crude petroleum 
ether extract dose-dependently inhibited NO production at 82.84% (1.56 µg/mL), 95.51% 
(3.13 µg/mL) and 97.52% (6.25 µg/mL) [Figure 4.10 (A)]. At higher concentrations tested, 
the extract exerted pronounced cytotoxicity with RAW 264.7 cell viability less than 5% 
(Table 4.1). The readings from the concentration were therefore eliminated from being 
compared. Crude chloroform extract on the other hand dose-dependently inhibited NO 
production up at 40.46% (1.56 µg/mL), 62.31% (3.13 µg/mL), 86.81% (6.25 µg/mL), 
91.41% (12.5 µg/mL), 93.38% (25 µg/mL), 94.38% (50 µg/mL) and 94.54% (100 µg/mL) 
[Figure 4.10 (B)]. The NO inhibitory effects observed were not due to the cytotoxicity 
effects of the extract as the cell viability was more than 95% at all concentrations evaluated 
(Table 4.1). The NO inhibitory effects observed were not due to the cytotoxicity effects of 
the extract as the cell viability was more than 95% at all concentrations evaluated (Table 
4.1). 
Unlike the other extracts, crude methanol extract of Z. zerumbet stimulate NO generation. 
Percentage of NO generation at each tested concentration was compared with control 
consisting of cells only (Control 4 as stated in Section 3.3.5) [Figure 4.10 (C)]. In Control 4, 
NO was not generated (0% of NO) in the absence of inducer. The cells were therefore not 
stimulated to produce NO. Percentage of NO generation was calculated using Equation (2) 
as stated in Section 3.36. Crude methanol extract dose-dependently stimulated NO 
production up at 3.36% (1.56 µg/mL), 13.31% (3.13 µg/mL), 21.74% (6.25 µg/mL), 
45.50% (12.5 µg/mL), 56.05% (25 µg/mL), 90.67% (50 µg/mL) and 162.01% (100 µg/mL) 
[Figure 4.10 (C)].  
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Figure 4.10: Effects of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Zingiber zerumbet on NO production in RAW 264.7 cells. Each bar represents 
the mean + S.E. calculated from three independent experiments. 
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4.1.1 Effects of the Zingiberaceae extracts on viability of RAW 264.7 cells 
Effects of the crude Zingiberaceae extracts on viability of RAW cells were 
examined using MTT assay. RAW 264.7 cells viability in the flat bottom 96-well 
microplate following removal of media for NO assay were immediately tested using MTT 
assay at 1.56 µg/mL, 3.13 µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 
µg/mL. The concentrations tested for MTT assay were exactly the same as the 
concentration tested for NO assay. Effects of the crude Zingiberaceae extracts on viability 
of RAW cells were presented Table 4.1. Most extracts were quite toxic to RAW 264.7 cells 
except petroleum ether extract of K. galanga; chloroform extracts of K. galanga, Z. 
montanum, and Z. zerumbet; as well as methanol extracts of A. galanga, C. aeruginosa, C. 
mangga, K. galanga, Z. montanum, and Z. officinale. 
106 
 
 
Table 4.1: Effects of the Zingiberaceae extracts on viability of RAW 264.7 cells 
Zingiberaceae sp. 
 
Solvent
1
 Percentage of viability (%) 
Control 1.56 µg/mL 3.13 µg/mL 6.25µg/mL 12.5 µg/mL 25 µg/mL 50 µg/mL 100 µg/mL 
Alpinia galanga p 100 98.69 + 0.35 94.35 + 1.88 39.57 + 4.56 3.31 + 0.80 2.34 + 0.09 2.28 + 0.17 2.60 + 0.15 
 c 100 99.47 + 0.46 99.33 + 0.46 99.16 + 0.47 95.46 + 3.46 64.16 + 6.89 3.87 + 1.06 2.42 + 0.72 
 m 100 98.56 + 0.39 99.13 + 0.24 99.06 + 0.48 98.78 + 0.62 99.32 + 0.45 99.28 + 0.29 99.62 + 0.79 
Boesenbergia rotunda p 100 97.39 + 1.61 94.47 + 2.56 94.59 + 2.18 94.07 + 1.84 51.15 + 4.11 2.53 + 0.15 3.18 + 0.1 
 c 100 92.21 + 1.03 93.66 + 2.41 93.91 + 1.33 89.49 + 2.25 48.17 + 4.38 2.65 + 0.13 3.60 + 0.1 
 m 100 96.52 + 0.78 94.30 + 1.2 94.22 + 0.32 94.77 + 2.14 92.84 + 0.32 93.86 + 1.12 75.62 + 0.55 
Curcuma aeruginosa p 100 96.55 + 1.16 94.71 + 0.26 94.81 + 0.52 96.06 + 0.46 93.78 + 0.35 67.24 + 2.49 3.03 + 0.25 
 c 100 96.61 + 1.22 95.59 + 1.31 96.85 + 1.67 96.69 + 2.40 95.89 + 1.6 84.22 + 2.02 14.57 + 4.45 
 m 100 94.62 + 2.32 94.66 + 0.52 92.53 + 2.37 92.03 + 3.2 95.16 + 1.02 97.34 + 0.24 99.53 + 0.19 
Curcuma domestica p 100 94.82 + 0.23 94.95 + 0.94 94.69 + 0.71 97.01 + 1.54 95.03 + 1.86 73.63 + 2.83 2.95 + 0.11 
 c 100 98.12 + 0.93 93.58 + 1.35 90.72 + 1.01 51.43 + 7.55 11.19 + 1.65 5.76 + 0.74 9.59 + 0.97 
 m 100 98.33 + 0.67 98.11 + 0.26 96.30 + 0.75 95.48 + 0.90 58.06 + 9.42 9.48 + 3.63 4.15 + 0.46 
Curcuma mangga p 100 97.13 + 0.99 97.04 + 1.32 95.99 + 0.73 96.86 + 0.74 96.15 + 0.46 89.12 + 1.20 27.92 + 0.58 
 c 100 99.47 + 0.93 98.04 + 1.49 98.48 + 0.15 98.93 + 0.56 98.54 + 0.15 92.43 + 0.48 56.97 + 1.59 
 m 100 98.36 + 0.23 97.97 + 0.21 97.79 + 0.09 97.35 + 0.01 98.14 + 0.03 97.31 + 0.05 98.52 + 0.55 
1 
Solvents used in extraction: p:  petroleum ether; c: chloroform,  m: methanol. 
 
The cytotoxicity effects of the extracts were evaluated using the conventional MTT assay. Cells remaining in the flat bottom 96-well microplate following removal of 
media for NO assay were topped up with 100 µL of fresh DMEM with phenol red supplemented with 5% FBS for each well. Then, 20 µL of MTT dye solution was 
added to each well, and incubated for 4 h. After that, 100 µL of DMSO was added to each well and plate was mixed for 15 min. Absorbance at 540 nm was measured 
using a microplate reader as a measure of the density of live cells. Results shown are the mean of three-independent experiments with triplicates treatments + SEM. 
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Table 4.1 (continued) 
Zingiberaceae sp. 
 
Solvent
1
 Percentage of viability (%) 
Control 1.56 µg/mL 3.13 µg/mL 6.25µg/mL 12.5 µg/mL 25 µg/mL 50 µg/mL 100 µg/mL 
Curcuma xanthorrhiza p 100 99.39 + 0.15 98.37 + 0.89 99.12 + 0.40 99.59 + 0.38 99.71 + 0.15 96.02 + 1.22 3.48 + 0.29 
 c 100 98.96 + 0.52 98.50 + 0.58 98.64 + 0.67 96.09 + 1.89 57.29 + 4.28 7.65 + 1.29 9.97 + 1.19 
 m 100 98.42 + 0.3 97.97 + 1.16 99.59 + 0.3 98.43 + 0.39 99.36 + 0.35 99.06 + 0.25 98.49 + 0.37 
Kaempferia galanga p 100 96.07 + 1.06 95.48 +1.26 96.38 + 1.24 94.53 + 0.89 95.21 + 1.31 92.97 + 1.68 89.35 + 0.37 
 c 100 97.79 + 0.80 95.32 + 1.62 97.32 + 0.73 97.40 + 0.62 97.9 + 1.08 90.65 + 2.03 81.00 + 0.23 
 m 100 98.73 + 0.21 98.62 + 0.26 98.53 + 0.79 97.72 + 1.00 97.67 + 1.37 98.08 + 0.85 97.76 + 0.41 
Zingiber montanum p 100 97.45 + 2.34 97.06 + 0.73 96.68 + 0.88 93.66 + 2.16 88.35 + 0.60 82.12 + 1.06 6.93 + 2.45 
 c 100 97.09 + 1.36 96.07 + 1.5 97.41 + 0.86 97.99 + 0.96 97.16 + 0.38 96.99 + 1.45 85.95 + 1.92 
 m 100 97.59 + 0.7 96.96 + 0.73 96.94 + 0.79 98.23 + 0.29 98.13 + 0.92 99.11 + 0.13 99.17 + 0.75 
Zingiber officinale p 100 97.11 + 0.45 97.28 + 0.42 97.97 + 0.93 97.51 + 0.82 97.04 + 2.17 87.35 + 1.94 2.31 + 0.64 
 c 100 97.65 + 0.71 96.68 + 0.55 95.79 + 0.27 95.69 + 0.37 95.77 + 0.46 86.19 + 2.56 68.63 + 2.6 
 m 100 97.81 + 0.36 97.74 + 0.43 99.19 + 0.15 99.68 + 1.00 99.01 + 0.13 98.68 + 0.58 96.32 + 1.25 
Zingiber zerumbet p 100 99.08 + 0.36 99.17 + 0.27 95.77 + 0.25 75.30 + 1.20 60.16 + 1.22 45.06 + 3.41 2.63 + 0.2 
 c 100 99.22 + 0.71 98.84 + 0.38 99.21 + 0.09 99.41 + 0.17 98.56 + 0.49 99.21 + 0.38 98.39 + 0.71 
 m 100 97.21 + 0.26 97.12 + 0.46 96.59 + 0.59 96.67 + 0.46 96.84 + 0.36 98.64 + 0.23 99.05 + 0.67 
1 
Solvents used in extraction: p: petroleum ether, c: chloroform,  m: methanol. 
 
The cytotoxicity effects of the extracts were evaluated using the conventional MTT assay. Cells remaining in the flat bottom 96-well microplate following removal of 
media for NO assay were topped up with 100 µL of fresh DMEM with phenol red supplemented with 5% FBS for each well. Then, 20 µL of MTT dye solution was 
added to each well, and incubated for 4 h. After that, 100 µL of DMSO was added to each well and plate was mixed for 15 min. Absorbance at 540 nm was measured 
using a microplate reader as a measure of the density of live cells. Results shown are the mean of three-independent experiments with triplicates treatments + SEM.
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4.1.2 Comparisons on nitric oxide inhibitory activities among Zingiberaceae extracts  
          at 1.56–100 µg/mL 
The results of screening indicated that 29 (96%) of the extracts exhibit NO 
inhibitory activity in LPS-stimulated macrophages. The only inactive extract tested was 
crude methanol extract of Z. zerumbet, which surprisingly, showed inverse effect by 
stimulating NO generation from the lowest concentration (1.56 µg/mL) to the highest 
concentration (100 µg/mL) tested in a dose-dependent manner [Figure 4.10 (C)]. The active 
extracts were compared at each concentration (Figue 4.11–4.17).  
At the lowest sample concentration tested (1.56 µg/mL) (Figure 4.11), crude 
petroleum ether extracts of A. galanga and Z. zerumbet exhibited the highest NO inhibitory 
activity (> 75% inhibition), with no significant difference. Chloroform extracts of A. 
galanga and Z. zerumbet, possessed NO inhibitory activity of > 40%, with no significance 
difference between the two. The rest of the extracts did not showed obvious inhibitory 
activity at such low concentration. RAW 264.7 cells, treated with the extracts at 1.56 
µg/mL showed cell viability > 80%. 
Based on Figure 4.12, the overall NO inhibitory activities for the extracts tested at 
3.13 µg/mL did not differ singificantly when compared with the previous concentration 
tested (1.56 µg/mL). However, there were increases of NO inhibititory activities for all of 
the extracts. Crude petroleum ether extracts of A. galanga and Z. zerumbet represented the 
most effective extracts at this concentration, with > 90% of NO inhibitory activity. On the 
other hand, NO inhibitory activities for crude chloroform extracts of A. galanga and Z. 
zerumbet increased to > 50%. Even though there were slight increased of NO inhibitory 
activities for the remaining extracts, the activities were still low (< 40%). RAW 264.7 cells 
treated with extracts at 3.13 µg/mL showed RAW 264.7 cell viability > 80%. 
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Figure 4.11: Effects of crude Zingiberaceae extracts at 1.56 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
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Figure 4.12: Effects of crude Zingiberaceae extracts at 3.13 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
 
At the subsequent sample concentration tested, 6.25 µg/mL (Figure 4.13), the NO 
inhibitory activities for chloroform extracts of A. galanga, C. domestica, Z. zerumbet; and 
petroleum ether extract of Z. zerumbet were > 75%. The activity for methanol extract of C. 
domestica was increased to > 60%, whereas the activities for the remaining extracts were > 
110 
 
50%. RAW 264.7 cells treated with petroleum ether extract of A. galanga showed cell 
viability < 80% at this concentration. This extract was therefore omitted and not presented 
in Figure 4.13. 
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Figure 4.13: Effects of crude Zingiberaceae extracts at 6.25 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
 
Many extracts exerted obvious boosts of NO inhibitory activity at the subsequent 
sample concentration tested, 12.5 µg/mL (Figure 4.14). The most effective extracts were 
chloroform extracts of A. galanga, Z. zerumbet; and methanol extract of C. domestica, 
which inhibited > 90% of NO generation in the LPS-stimulated RAW 264.7 cells. 
Petroleum ether extracts of B. rotunda, C. domestica, Z. montanum; chloroform extracts of 
B. rotunda and C. xanthorrhiza exhibited NO inhibititory activity in the range of 60–75%. 
The activities for the other presented extracts did not exceed 50%. Toxic extracts (resulting 
in cell viability < 80%) at this concentration tested included petroleum ether extracts of A. 
galanga, Z. zerumbet; and chloroform extract of C. domestica, which were not presented 
for comparison. 
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Figure 4.14: Effects of crude Zingiberaceae extracts at 12.5 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
 
At 25 µg/mL of sample concentration tested (Figure 4.15), petroleum ether extracts 
of C. domestica, Z. montanum, Z. officinale; chloroform extracts of Z. montanum, Z. 
officinale, and Z. zerumbet exerted > 70% of NO inhibition. However, petroleum ether 
extract of C. domestica; chloroform extract of Z. montanum and Z. zerumbet were 
significantly better than petroleum ether extract of Z. montanum, Z. officinale; and 
chloroform extract of Z. officinale in NO inhibition. Extracts which were able to inhibit 60–
75% of NO generation were petroleum ether extract of C. aeruginosa, C. xanthorrhiza, K. 
galanga; chloroform extracts of C. aeruginosa, and K. galanga. RAW 264.7 cells treated 
with all extracts presented here showed cell viability of > 80%. 
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Figure 4.15: Effects of crude Zingiberaceae extracts at 25 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
 
 
Based on Figure 4.16, most of the extracts were effective in NO inhibition at 50 
µg/mL. Chloroform extracts of C. aeruginosa, K. galanga, Z. montanum, Z. officinale, Z. 
zerumbet; petroleum ether extracts of C. xanthorrhiza, Z. montanum, and Z. officinale 
could inhibit almost 90% of NO production in LPS-stimulated RAW 264.7 cells. Methanol 
extract of C. xanthorrhiza and petroleum ether extract of K. galanga inhibited NO 
production in the range of 75–85%, and were significantly better than petroleum ether and 
chloroform extracts of C. mangga, which inhibited NO production at 60% and 70%, 
respectively. RAW 264.7 cells treated with 19 extracts showed cell viability > 80%.  
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Figure 4.16: Effects of crude Zingiberaceae extracts at 50 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
 
 
The highest concentration tested for each extracts were 100 µg/mL, only 11 extracts 
resulted in RAW 264.7 cell viability > 80% and were compared in Figure 4.17. This 
indicated that most of the crude Zingiberaceae extracts were toxic at higher concentrations. 
Among these extracts, methanol extracts of C. xanthorrhiza; petroleum ether extract of K. 
galanga; and chloroform extracts of K. galanga, Z. montanum, and Z. zerumbet inhibited > 
90% of NO generation. The remaining extracts possessed low NO inhibitory activity even 
at such high concentration. 
Crude petroleum ether extracts of A. galanga and Z. zerumbet elicited the highest 
percentage of NO inhibition (> 70%) at the lowest concentration (1.56 µg/mL) (Fig. 4.11.). 
However, their high activity of NO inhibition was correlated with their high toxicity to 
RAW 264.7 cells, which showed toxicity at 6.25 µg/mL and 12.5 µg/mL, respectively. On 
the other hand, crude petroleum ether extracts of K. galanga; chloroform extracts of K. 
galanga, Z. montanum, and Z. zerumbet; as well as methanol extracts of A. galanga, C. 
aeruginosa, C. mangga, K. galanga, Z. montanum, and Z. officinale did not show 
114 
 
cytotoxicity at the pharmacologically doses (< 100 µg/mL) (Fig. 4.17). Among these 
extracts, chloroform extract of Z. zerumbet were shown to possess high NO inhibition 
activity to the variable concentrations with no cytotoxicity against RAW 264.7 cells. 
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Figure 4.17: Effects of crude Zingiberaceae extracts at 100 µg/mL on NO production in 
RAW 264.7 cells. Each bar represents the mean + S.E. calculated from three independent 
experiments. Comparisons among different extracts that yielded statistically significant 
difference (p < 0.05) according to ANOVA were indicated by different letters above each 
bar. Letter „a‟ means significantly better than „b‟, „b‟ means significantly better than „c‟, etc. 
 
 The effectiveness of NO inhibition activity at each concentration for the extracts 
was classified into four groups according to its inhibitory rate (IR) as follows: strongly 
active (IR > 70%), moderately active (IR, 50–60%), weakly active (IR, 30–49%), and 
inactive (IR < 29%) (Table 4.2).  
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Table 4.2: Classifications of the effectiveness of NO inhibition activity of 29 tested crude Zingiberaceae extracts1 at 1.56 µg/mL, 3.13 
µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 µg/mL in RAW 264.7 cells 
Concentration Strongly active 
(IR > 70%) 
Moderately active 
(IR, 50 – 60%) 
Weakly active 
(IR, 30 – 49%) 
Inactive 
(IR < 29%) 
1.56 µg/mL Alpinia galanga (p)  Alpinia galanga (c) Alpinia galanga (m) 
 Zingiber zerumbet (p)  Zingiber zerumbet (c) Boesenbergia rotunda (p) 
    Boesenbergia rotunda (c) 
    Boesenbergia rotunda (m) 
    Curcuma aeruginosa (p) 
    Curcuma aeruginosa (c) 
    Curcuma aeruginosa (m) 
    Curcuma domestica (p) 
    Curcuma domestica (c) 
    Curcuma domestica (m) 
    Curcuma mangga (p) 
    Curcuma mangga (c) 
    Curcuma mangga (m) 
    Curcuma xanthorrhiza (p) 
    Curcuma xanthorrhiza (c) 
    Curcuma xanthorrhiza (m) 
    Kaempferia galanga (p) 
    Kaempferia galanga (c) 
    Kaempferia galanga (m) 
    Zingiber montanum (p) 
    Zingiber montanum (c) 
    Zingiber montanum (m) 
    Zingiber officinale (p) 
    Zingiber officinale (c) 
    Zingiber officinale (m) 
 
3.13 µg/mL Alpinia galanga (p) Alpinia galanga (c) Curcuma domestica (c) Alpinia galanga (m) 
 Zingiber zerumbet (p) Zingiber zerumbet (c)  Boesenbergia rotunda (p) 
    Boesenbergia rotunda (c) 
    Boesenbergia rotunda (m) 
    Curcuma aeruginosa (p) 
    Curcuma aeruginosa (c) 
    Curcuma aeruginosa (m) 
    Curcuma domestica (p) 
    Curcuma domestica (m) 
    Curcuma mangga (p) 
    Curcuma mangga (c) 
    Curcuma mangga (m) 
    Curcuma xanthorrhiza (p) 
    Curcuma xanthorrhiza (c) 
    Curcuma xanthorrhiza (m) 
    Kaempferia galanga (p) 
    Kaempferia galanga (c) 
    Kaempferia galanga (m) 
    Zingiber montanum (p) 
    Zingiber montanum (c) 
    Zingiber montanum (m) 
    Zingiber officinale (p) 
    Zingiber officinale (c) 
    Zingiber officinale (m) 
1 Each crude Zingiberaceae extract was tested at 1.56 µg/mL, 3.13 µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 
µg/mL in triplicates (N = 3). RAW 264.7 cells were stimulated with 10µg/ml LPS to generate NO. The effectiveness of the NO inhibition 
activity was categorized into four groups, namely strongly active, moderately active, weakly active, and inactive according to the IR 
values. In the Table, p represents petroleum ether extract, c represents chloroform extract, and m represents methanol extract. 
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Table 4.2 (continued) 
Concentration Strongly active 
(IR > 70%) 
Moderately active  
(IR, 50 – 60%) 
Weakly active  
(IR, 30 – 49%) 
Inactive 
(IR < 29%) 
6.25 µg/mL Alpinia galanga (c) Curcuma domestica (m) Boesenbergia rotunda (p) Alpinia galanga (m) 
 Curcuma domestica (c)  Boesenbergia rotunda (c) Boesenbergia rotunda (m) 
 Zingiber zerumbet (p)  Curcuma domestica (p) Curcuma aeruginosa (p) 
 Zingiber zerumbet (c)  Curcuma mangga (p) Curcuma aeruginosa (c) 
   Zingiber montanum (p) Curcuma aeruginosa (m) 
   Zingiber officinale (p) Curcuma mangga (p) 
    Curcuma mangga (c) 
    Curcuma mangga (m) 
    Curcuma xanthorrhiza (p) 
    Curcuma xanthorrhiza (c) 
    Curcuma xanthorrhiza (m) 
    Kaempferia galanga (p) 
    Kaempferia galanga (c) 
    Kaempferia galanga (m) 
    Zingiber montanum (c) 
    Zingiber montanum (m) 
    Zingiber officinale (c) 
    Zingiber officinale (m) 
 
12.5 µg/mL Alpinia galanga (c) Boesenbergia rotunda (c) Curcuma aeruginosa (p) Alpinia galanga (m) 
 Boesenbergia rotunda (p) Zingiber montanum (p) Curcuma aeruginosa (c) Boesenbergia rotunda (m) 
 Curcuma domestica (p)  Curcuma xanthorrhiza (p) Curcuma aeruginosa (m) 
 Curcuma domestica (m)  Kaempferia galanga (p) Curcuma mangga (p) 
 Curcuma xanthorrhiza (c)  Kaempferia galanga (c) Curcuma mangga (c) 
 Zingiber zerumbet (c)  Zingiber montanum (c) Curcuma mangga (m) 
   Zingiber officinale (p) Curcuma xanthorrhiza (m) 
   Zingiber officinale (c) Kaempferia galanga (m) 
    Zingiber montanum (m) 
    Zingiber officinale (m) 
 
25 µg/mL Curcuma domestica (p) Curcuma aeruginosa (p) Alpinia galanga (m) Boesenbergia rotunda (m) 
 Zingiber montanum (p) Curcuma aeruginosa (c) Curcuma mangga (p) Curcuma aeruginosa (m) 
 Zingiber montanum (c) Curcuma xanthorrhiza (p) Curcuma mangga (c) Curcuma mangga (m) 
 Zingiber officinale (p) Kaempferia galanga (p) Curcuma xanthorrhiza (m) Kaempferia galanga (m) 
 Zingiber officinale (c) Kaempferia galanga (c)  Zingiber montanum (m) 
 Zingiber zerumbet (c)   Zingiber officinale (m) 
 
50 µg/mL Curcuma aeruginosa (c) Boesenbergia rotunda (m) Alpinia galanga (m) Curcuma mangga (m) 
 Curcuma mangga (c) Curcuma mangga (p) Curcuma aeruginosa (m) Zingiber montanum (m) 
 Curcuma xanthorrhiza (p) Curcuma mangga (c) Kaempferia galanga (m) Zingiber officinale (m) 
 Curcuma xanthorrhiza (m)    
 Kaempferia galanga (p)    
 Kaempferia galanga (c)    
 Zingiber montanum (p)    
 Zingiber montanum (c)    
 Zingiber officinale (p)    
 Zingiber officinale (c)    
 Zingiber zerumbet (c)  
 
  
100 µg/mL Curcuma xanthorrhiza (m) Alpinia galanga (m) Zingiber montanum (m) Curcuma mangga (m) 
 Kaempferia galanga (p) Curcuma aeruginosa (m)  Zingiber officinale (m) 
 Kaempferia galanga (c) Kaempferia galanga (m)   
 Zingiber montanum (c)    
 Zingiber zerumbet (c)    
1 Each crude Zingiberaceae extract was tested at 1.56 µg/mL, 3.13 µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 
µg/mL in triplicates (N = 3). RAW 264.7 cells were stimulated with 10µg/ml LPS to generate NO. The effectiveness of the NO inhibition 
activity was categorized into four groups, namely strongly active, moderately active, weakly active, and inactive according to the IR 
values. In the Table, p represents petroleum ether extract, c represents chloroform extract, and m represents methanol extract. 
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Based on Table 4.2, 19 of 30 crude Zingiberaceae extracts strongly inhibited (IR > 
70%) NO generation in RAW 264.7 cells, which were the petroleum ether extracts of A. 
galanga, B. rotunda, C. domestica, C. xanthorrhiza, K. galanga, Z. montanum, Z. officinale, 
and Z. zerumbet; chloroform extracts of A. galanga, C. aeruginosa, C. domestica, C. 
xanthorrhiza, K. galanga, C. mangga, Z. montnaum, Z. officinale, and Z. zerumbet; as well 
as methanol extracts of C. domestica and C. xanthorrhiza. 
In particular, extracts with markedly high NO inhibitory activities (IR > 90%) were 
the petroleum ether extracts of A. galanga (at 3.13 µg/mL), C. domestica (at 25 µg/mL), C. 
xanthorrhiza (at 50 µg/mL), K. galanga (at 100 µg/mL), Z. montanum (at 50 µg/mL), Z. 
officinale (at 50 µg/mL), and Z. zerumbet (at 3.13 µg/mL and 6.25 µg/mL); chloroform 
extracts of A. galanga (at 12.5 µg/mL), K. galanga (at 50 µg/mL and 100 µg/mL), Z. 
montanum (at 50 µg/mL and 100 µg/mL), Z. officinale (at 50 µg/mL), and Z. zerumbet (at 
12.5 µg/mL, 25 µg/mL, 50 µg/mL and 100 µg/mL); as well as methanol extracts of C. 
domestica (at 12.5 µg/mL) and C. xanthorrhiza (at 100 µg/mL). 
In this study, petroleum ether extract of A. galanga was selected as the most 
potential extract as it possessed the strongest NO inhibitory activity at the lowest 
concentration. Overall, nineteen (63%) crude Zingiberaceae extracts possesses strong NO 
inhibition activities. Among these active extracts, 14 extracts were effective in reducing 
NO generation with IR > 90%. These results suggested that the selected Zingiberaceae 
species contain secondary metabolites with immunomodulatory properties that should be 
further investigated.  
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4.2 Effects of the Zingiberaceae Extracts on MDA-MB-231 Cell Proliferation or  
       Viability 
In the search of natural product with anti-cancer activity, the effects of 30 crude 
Zingiberaaceae extracts on proliferation of oestrogen negative human breast cancer cells 
(MDA-MB-231) were tested. Each extract was tested for cytotoxicity at 1.56 µg/mL, 3.13 
µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 µg/mL against MDA-
MB-231 cells, using the conventional MTT assay. The effect at various concentrations was 
studied after 48 h, and dose-response graphs for the extracts (Figure 4.18–4.27) were 
generated. The cells exhibited concentration-dependent growth inhibition by the crude 
Zingiberaceae extracts. 
 
(a) Alpinia galanga 
Figure 4.18 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of A. galanga on MDA-MB-231 cells. The results indicated that 
crude petroleum ether extract exerted a pronounced cytotoxic effect against MDA-MB-231 
cells, which inhibited at least 80% of cell proliferation at 3.13 µg/mL. At 6.25–100 µg/mL, 
cell growth inhibition was almost 100% [Figure 4.18 (A)]. Crude chloroform extract 
inhibited more than 95% of cell proliferation at 12.5–100 µg/mL [Figure 4.18 (B)]. Crude 
methanol extract was weakly inhibitory against MDA-MB-231 cells even though the 
cytotoxicity index growth inhibition was showed to be dose-dependently. The highest 
cytotoxicity index indicated was less than 20% at 100 µg/mL [Figure 4.18 (C)]. Only 
extracts which inhibit at least 50% of cell growth at < 30 µg/mL are considered as actively 
cytotoxic (Suffness & Pezzuto, 1990). Those which do not are not considered as cytotoxic. 
Therefore, based on this, methanol extract of A. galanga was not considered as cytotoxic. 
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(b) Boesenbergia rotunda 
Figure 4.19 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of B. rotunda on MDA-MB-231 cells. The results in indicated that 
crude petroleum ether [Figure 4.19 (A)] and chloroform [Figure 4.19 (B)] extracts inhibited 
almost 100% of cell proliferation at 25–100 µg/mL. Crude methanol extract showed a 
dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells [Figure 
4.19 (C)]. The highest inhibition was more than 65% at 100 µg/mL. However, at 
concentration 50 µg/mL or lower, the inhibition effects dropped to less than 30%. 
 
(c) Curcuma aeruginosa 
Figure 4.20 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of C. aeruginosa on MDA-MB-231 cells. Crude petroleum ether 
extract showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-
231 cells [Figure 4.20 (A)]. At 50 µg/mL and 100 µg/mL, the inhibition of cell 
proliferation was more than 90%. The inhibition at 25 µg/mL or lower was less than 30%. 
Crude chloroform extract showed a dose-dependent inhibitory effect on cell proliferation 
against MDA-MB-231 cells [Figure 4.20 (B)]. The highest cytotoxicity effect was 80% at 
100 µg/mL. The cytotoxicity effect at 50 µg/mL or lower was less than 30%. Crude 
methanol extract was weakly inhibitory against MDA-MB-231 cells even though the 
cytotoxicity index was showed to be dose-dependently [Figure 4.20 (C)]. The overall 
cytotoxicity effects were less than 15% at 1.56–100 µg/mL. Since inhibitory percentage 
was less than 50% at 30 µg/mL, all three extracts of C. aeruginosa were deemed as not 
actively cytotoxic against MDA-MB-231 cells. 
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Figure 4.18: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Alpinia galanga on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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Figure 4.19: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Boesenbergia rotunda on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated   from three independent experiments. 
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Figure 4.20: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma aeruginosa on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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(d) Curcuma demestica 
Figure 4.21 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of C. domestica on MDA-MB-231 cells. Crude petroleum ether 
extract inhibited more than 90% of cell proliferation at 25–100 µg/mL [Figure 4.20 (A)]. 
Based on Figure 4.21 (B), crude chloroform extract inhibited more than 85% of cell 
proliferation at 25 µg/mL. There was a decrease of cytotoxicity index (%) at 50 µg/mL and 
100 µg/mL. This phenomenon may be due to the heavy pigment of the crude extracts 
which lead to higher absorbance values obtained using Emax microplate reader. Crude 
methanol extract showed a dose-dependent inhibitory effect on cell proliferation against 
MDA-MB-231 cells [Figure 4.21 (C)]. It inhibited more than 80% of cell proliferation at 
25–100 µg/mL. 
(e) Curcuma mangga 
Figure 4.22 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of C. mangga on MDA-MB-231 cells. Crude petroleum ether extract 
showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells 
[Figure 4.22 (A)]. However, the inhibition of cell proliferation was less than 45% at 100 
µg/mL. Crude chloroform extract showed a dose-dependent inhibitory effect on cell 
proliferation against MDA-MB-231 cells [Figure 4.22 (B)]. At6 1.56 – 25 µg/mL, growth 
inhibition was less than 30%. However, it possessed more than 90% of the cytotoxicity to 
inhibit cell proliferation at 50–100 µg/mL. Crude methanol extract was non-cytotoxic 
against MDA-MB-231 cells [Figure 4.22 (C)]. The overall inhibitory effects were less than 
6%, which could be considered as non-toxic to the cells. Since growth inhibition by all 
three extracts of C. mangga did not even reach 50% at 20 µg/mL, these extracts were 
deemed as not toxic against MDA-MB-231 cells. 
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Figure 4.21: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma domestica on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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Figure 4.22: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma mangga on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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(f) Curcuma xanthorrhiza  
Figure 4.23 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of C. xanthorrhiza on MDA-MB-231 cells. Crude petroleum ether 
extract showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-
231 cells [Figure 4.23 (A)]. At 50 µg/mL, the cytotoxicity was more than 50%, while at 
100 µg/mL, it inhibited almost 100% of cell proliferation. Based on Figure 4.23 (B), crude 
chloroform extract showed a dose-dependent inhibitory effect on cell proliferation against 
MDA-MB-231 cells. At 25 µg/mL, the cytotoxicity was more than 70%, while at 50–100 
µg/mL, it inhibited at least 85% of cell proliferation. Crude methanol extract showed a 
dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells [Figure 
4.23 (C)]. The inhibitory effects were less than 20% at 50 µg/mL or lower, but it boosted to 
more than 75% at 100 µg/mL. Based on the percentages of inhibition at 25 µg/mL (Figure 
4.23), chloroform extract of C. xanthorrhiza was deemed as actively cytotoxic and those 
that were not were petroleum ether and methanl extracts of C. xanthorrhiza. 
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Figure 4.23: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Curcuma xanthorrhiza on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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(g) Kaempferia galanga 
Figure 4.24 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of K. galanga on MDA-MB-231 cells. Crude petroleum ether extract 
was moderately growth inhibitory against MDA-MB-231 cells as showed in the dose-
dependently graph [Figure 4.24 (A)]. At 1.56–50 µg/mL, growth inhibitory was less than 
30%. The highest cytotoxicity to inhibit cell proliferation was less than 45% at 100 µg/mL. 
At the lower concentrations tested, the cytotoxicity were less than 25%. Crude chloroform 
extract showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-
231 cells [Figure 4.24 (B)]. At 1.56–25 µg/mL, growth inhibitory was less than 50%. At 
higher concentrations, it inhibited more than 50% of cell proliferation at 50 µg/mL and 
more than 80% at 100 µg/mL. Based on Figure 4.24 (C), crude methanol extract showed a 
dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells. It only 
inhibited more than 50% of cell proliferation at 100 µg/mL. 
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Figure 4.24: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Kaempferia galanga MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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(h) Zingiber montanum 
Figure 4.25 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of Z. montanum on MDA-MB-231 cells. Crude petroleum ether 
showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells 
[Figure 4.25 (A)]. It inhibited more than 85% of cell proliferation at 50–100 µg/mL. At the 
other lower concentrations, the inhibitory effect on cell proliferation was less than 50%. 
Crude chloroform extract showed a dose-dependent inhibitory effect on cell proliferation 
against MDA-MB-231 cells [Figure 4.25 (B)]. It inhibited more than 80% of cell 
proliferation at 50–100 µg/mL. At the other lower concentrations, the inhibition on cell 
proliferation was less than 50%. Crude methanol extract was not cytotoxic against MDA-
MB-231 cells [Figure 2.25 (C)]. The overall inhibitory effects were less than 6%. Therefore, 
all extracts of Z. montanum were considered not cytotoxic against MDA-MB-231 cells. 
 
(i) Zingiber officinale 
Figure 4.26 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of Z. officinale on MDA-MB-231 cells. Crude petroleum ether 
showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells 
[Figure 4.26 (A)]. At 1.56–50 µg/mL, the inhibitory effects were less than 40%, but 
boosted to more than 75% at 100 µg/mL. Crude chloroform extract showed a dose-
dependent inhibitory effect on cell proliferation against MDA-MB-231 cells [Figure 4.26 
(B)]. The inhibitory effects were less than 40% at 1.56–25 µg/mL. However, the inhibitory 
effects were boosted to 60% and 95% at 50 µg/mL and 100 µg/mL, respectively. Crude 
methanol extract was not cytotoxic against MDA-MB-231 cells [Figure 4.26 (C)]. The 
131 
 
overall inhibitory effects were less than 8%. So all extracts of Z. officinale were considered 
as non-cytotoxic against MDA-MB-231 cells. 
 
(j) Zingiber zerumbet 
Figure 4.27 showed the cytotoxicity effects of crude petroleum ether, chloroform, 
and methanol extracts of Z. zerumbet on MDA-MB-231 cells. Crude petroleum ether 
extract showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-
231 cells [Figure 4.27 (A)]. The inhibitory effects on cell proliferation was more than 75% 
at 12.5 µg/mL and increased to more than 95% at 100 µg/mL. Crude chloroform extract 
showed a dose-dependent inhibitory effect on cell proliferation against MDA-MB-231 cells 
[Figure 4.27 (B)]. At 1.56 – 25 µg/mL, the inhibitory effects on MDA-MB-231 cells were 
less than 40%. The cytotoxicity to inhibit cell proliferation was more than 60% at 50 
µg/mL, and 85% at 100 µg/mL. Crude methanol extract was not cytotoxic against MDA-
MB-231 cells [Figure 4.27 (C)]. The overall inhibitory effects were less than 8%. 
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Figure 4.25: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Zingiber montanum on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
 
1
6
.5
7
 +
 3
.7
3
 
2
6
.8
3
 +
 8
.7
3
 
4
2
.7
0
 +
 9
.3
9
 
9
1
.0
3
 +
 4
.6
7
 
9
8
.5
0
 +
 0
.3
5
 
1
0
.3
0
 +
 4
.3
2
 
8
.0
7
 +
 4
.9
8
 
2
2
.0
3
 +
 0
.2
7
 
7
8
.3
3
 +
 1
.2
0
 
4
5
.8
3
 +
 5
.2
4
 
8
0
.3
7
 +
 0
.5
8
 
2
5
.4
3
 +
 1
.8
3
 
1
9
.3
0
 +
 2
.1
5
 
1
7
.3
3
 +
 2
.6
3
 
1
.9
7
 +
 1
.5
7
 
0
.2
0
 +
 0
.1
0
 
0
.2
7
 +
 0
.0
7
 
1
.3
7
 +
 0
.9
7
 
3
.0
7
 +
 2
.1
2
 
5
.7
3
 +
 2
.4
4
 
0
.8
0
 +
 0
.3
5
 
(C) 
(B) 
(A) 
133 
 
 
C
on
tr
ol
g/
m
L

1.
56
 
g/
m
L

3.
13
 
g/
m
L

6.
25
 
g/
m
L

12
.5
 
g/
m
L

25
 
g/
m
L

50
 
g/
m
L

10
0 
0
25
50
75
100
C
y
to
to
x
ic
it
y
 I
n
d
e
x
 (
%
)
 
 
 
C
on
tr
ol
g/
m
L

1.
56
 
g/
m
L

3.
13
 
g/
m
L

6.
25
 
g/
m
L

12
.5
 
g/
m
L

25
 
g/
m
L

50
 
g/
m
L

10
0 
0
25
50
75
100
C
y
to
to
x
ic
it
y
 I
n
d
e
x
 (
%
)
 
           
           
C
on
tr
ol
g/
m
L

1.
56
 
g/
m
L

3.
13
 
g/
m
L

6.
25
 
g/
m
L

12
.5
 
g/
m
L

25
 
g/
m
L

50
 
g/
m
L

10
0 
0
25
50
75
100
C
y
to
to
x
ic
it
y
 I
n
d
e
x
 (
%
)
 
       
 
Figure 4.26: Growth inhibition by (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Zingiber officinale on MDA-MB-231 cells using the MTT assay. Each bar 
represents the mean + S.E. calculated from three independent experiments. 
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Figure 4.27: Cytotoxicity of crude (A) petroleum ether, (B) chloroform, and (C) methanol 
extracts of Zingiber zerumbet on MDA-MB-231 cells. Each bar represents the mean + S.E. 
calculated from three independent experiments. 
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(k) Doxorubicin hydrochloride 
Doxorubicin hydrochloride was used as the positive control at 0.05–3.13 µg/mL. 
Based on Figure 4.28 which presented the cytotoxicity effects of doxorubicin hydrochloride 
on MDA-MB-231 cells, it inhibited more than 50% of the cell proliferation at 1.56 µg/mL. 
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Figure 4.28: Growth inhibition by doxorubicin hydrochloride on MDA-MB-231 cells 
using the MTT assay. Each bar represents the mean + S.E. calculated from three 
independent experiments. 
 
 
4.2.1 Comparisons of the Zingiberaceae extracts on inhibitory effects of cell 
           proliferation or viability of MDA-MB-231 cells 
Cytostatic concentration (IC50) is defined as the concentration of an inhibitor where the 
response is reduced by half. In the screening program to the discovery and development of 
potential anticancer natural compounds, the criteria of the American National Cancer 
Institute was adopted, that a crude extract with IC50 lower than 30 µg/mL was considered to 
be promising for further purification (Suffness & Pezzuto, 1990). Complete dose-response 
curves were generated and IC50 values were calculated for the Zingiberaceae extracts 
(Table 4.3) against MDA-MB-231 cells line.  
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Based on the IC50 values indicated in Table 4.3 for the 30 extracts tested, 12 
extracts showed IC50 lower than 30 µg/mL, nine showed IC50 lower than 20 µg/mL, and 
four extracts showed IC50 lower than 10 µg/mL. These extracts with IC50 lower than 30 
µg/mL were petroleum ether extracts of A. galanga, B. rotunda, C. domestica, Z. 
montanum, and Z. zerumbet; chloroform extracts of A. galanga, B. rotunda, C. domestica, 
C. xanthorrhiza, K. galanga, and Z. montanum; as well as methanol extract of C. domestica. 
The strongest cytotoxicity activity was detected for the petroleum ether extract of A. 
galanga, which presenting the lowest IC50 value, 2.82 µg/mL. 
 The results demonstrated that no appreciable loss in cell growth was observed in 
cells incubated with increased concentrations of methanol extracts of A. galanga, C. 
aeruginosa, and C. mangga, Z. montanum, Z. officinale and Z. zerumbet; as well as 
petroleum ether extracts of C. mangga and K. galanga. These extracts possessed IC50 
values which were more than 100 µg/mL. 
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Table 4.3: In vitro cytotoxicity of Zingiberaceae extracts on MDA-MB-231 cells measured 
by the MTT assay 
Zingiberaceae species Solvent
1
 IC50 (µg/mL) 
MDA-MB-231 cell line 
   
Alpinia galanga p 2.87 
 c 6.19 
 m >100 
Boesenbergia rotunda p 9.21 
 c 10.25 
 m 55.06 
Curcuma  aeruginosa p 30.13 
 c 55.68 
 m >100 
Curcuma domestica p 14.34 
 c 10.10 
 m 15.51 
Curcuma mangga p >100 
 c 30.10 
 m >100 
Curcuma xanthorrhiza p 42.78 
 c 17.34 
 m 58.78 
Kaempferia galanga p >100 
 c 29.63 
 m 48.76 
Zingiber montanum p 26.16 
 c 25.38 
 m >100 
Zingiber officinale p 55.93 
 c 30.06 
 m >100 
Zingiber zerumbet p 7.46 
 c 31.48 
 m >100 
Doxorubicin hydrochloride - 1.27 
1 
Solvents used in extraction: p: petroleum ether, c: chloroform, m: methanol 
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4.3 Cytotoxicity of the Zingiberaceae Extracts on MRC-5 Cells 
In the search of new anti-cancer drug, it is desired to find not only the most active, 
but also the least toxic substances against normal cells. It is very important that such 
selection could be done at the preliminary stage of in vitro studies, which is at the very 
beginning of drug developmental process (Popiolkiewicz, Polkowski, Skierski, & Mazurek, 
2005). Therefore, toxicity of six most active Zingiberaceae extracts which exhibited 
significant inhibitory effect on the proliferation of MDA-MB-231 cells (IC50 value < 10 
µg/mL) (Table 4.3) were further investigated on human normal cells, MRC-5. These 
extracts were petroleum ether and chloroform extracts of A. galanga, petroleum ether and 
chloroform extracts of B. rotunda, chloroform extract of C. domestica, and petroleum ether 
extract of Z. zerumbet (Table 4.3). Toxicity of the extracts was measured using 
conventional MTT assay at 1.56 µg/mL, 3.13 µg/mL, 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 
50 µg/mL and 100 µg/mL for 48 h. 
 
(a) Petroleum ether extract of Alpinia galanga 
Figure 4.29 showed the cytotoxicity effects of crude petroleum ether extract of A. 
galanga against MRC-5 cells. The results indicated that the extract exerted a pronounced 
cytotoxic effect against MRC-5 cells, which exerted at least 80% of killing effects at 3.13 
µg/mL. At higher concentrations tested, the killing effects were 100%.  
 
(b) Chloroform extract of Alpinia galanga 
Figure 4.30 showed the cytotoxicity effects of crude chloroform extract of A. 
galanga against MRC-5 cells. The results indicated that the extract exerted cytotoxic 
effects against MRC-5 cells in a dose-dependent manner. The cytotoxicity index of the 
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extract was less than 25% at 1.56–6.25 µg/mL, but boost to almost 50% at 12.5 µg/mL. At 
25–100 µg/mL, the cytototoxicity indexes against MRC-5 cells were almost 100%. 
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Figure 4.29: Cytotoxic effects of crude petroleum ether extract of Alpinia galanga on 
MRC-5 cells using the MTT assay. Each bar represents the mean + S.E. calculated from 
three independent experiments. 
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Figure 4.30: Cytotoxic effects of crude chloroform extract of Alpinia galanga on MRC-5 
cells using the MTT assay. Each bar represents the mean + S.E. calculated from three 
independent experiments. 
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(c) Petroleum ether extract of Boesenbergia rotunda 
Figure 4.31 showed the cytotoxicity effects of crude petroleum ether extract of B. 
rotunda against MRC-5 cells. The results indicated that the extract exerted cytotoxic effects 
against MRC-5 cells in a dose-dependent manner. The cytotoxicity index of the extract was 
very low at 1.56–6.25 µg/mL (cytotoxicity index < 6%), but boost to almost 50% at 12.5 
µg/mL. At 25–100 µg/mL, the cytototoxicity indexes against MRC-5 cells were almost 
100%. 
 
 
C
on
tr
ol
g/
m
L

1.
56
 
g/
m
L

3.
13
 
g/
m
L

6.
25
 
g/
m
L

12
.5
 
g/
m
L

25
 
g/
m
L

50
 
g/
m
L

10
0 
0
25
50
75
100
C
y
to
to
x
ic
it
y
  
In
d
e
x
 (
%
)
 
Figure 4.31: Cytotoxic effects of crude petroleum ether extract of Boesenbergia rotunda 
on MRC-5 cells using the MTT assay. Each bar represents the mean + S.E. calculated from 
three independent experiments. 
 
(d) Chloroform extract of Boesenbergia rotunda 
Figure 4.32 showed the cytotoxicity effects of crude chloroform extract of B. 
rotunda against MRC-5 cells. The results indicated that the extract exerted cytotoxic effects 
against MRC-5 cells in a dose-dependent manner. The cytotoxicity index of the extract was 
very low at 1.56–6.25 µg/mL (cytotoxicity index < 6%), increased to about 30% at 12.5 
µg/mL, and boosted to almost 100% at 25–100 µg/mL. 
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Figure 4.32: Cytotoxic effects of crude chloroform extract of Boesenbergia rotunda on 
MRC-5 cells using the MTT assay. Each bar represents the mean + S.E. calculated from 
three independent experiments. 
 
(e) Chloroform extract of Curcuma domestica 
Figure 4.33 showed the cytotoxicity effects of crude chloroform extract of C. 
domestica against MRC-5 cells. The results indicated that the extract exerted cytotoxic 
effects against MRC-5 cells in a dose-dependent manner. The cytotoxicity index of the 
extract was very low at 1.56–6.25 µg/mL (cytotoxicity index < 10%), increased to about 
50% at 12.5 µg/mL, and boosted to more than 90% at 25–100 µg/mL. 
 
(f) Petroleum ether extract of Zingiber zerumbet 
Figure 4.34 showed the cytotoxicity effects of crude petroleum ether extract of Z. 
zerumbet against MRC-5 cells. The results indicated that the extract exerted cytotoxic 
effects against MRC-5 cells in a dose-dependent manner. The cytotoxicity index of the 
extract was very low at 1.56–6.25 µg/mL (cytotoxicity index < 15%), increased to more 
than 50% at 12.5 µg/mL, and boosted to more than 80% at 25–100 µg/mL. 
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Figure 4.33: Cytotoxic effects of crude chloroform extract of Curcuma domestica on 
MRC-5 cells using the MTT assay. Each bar represents the mean + S.E. calculated from 
three independent experiments. 
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Figure 4.34: Cytotoxic effects of crude petroleum ether extract of Zingiber zerumbet on 
MRC-5 cells using the MTT assay. Each bar represents the mean + S.E. calculated from 
three independent experiments. 
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4.3.1 Comparisons of the Zingiberaceae extracts on viability of MRC-5 cells 
Assessment of potential toxicity of the most active Zingiberaceae extracts with IC50 
values < 10 µg/mL in the previous screening test (Cell proliferation and viability assay) 
were selected for cytotoxicity studies against human normal cells, MRC-5 using 
conventional MTT assay for 48 h. In the selection of the least toxic extracts among the 
most active ones, a special parameter, known as Selectivity Index (SX) was applied. 
Selectivity Index is a selectivity indicator of tested substances towards tumour cells 
(Popiolkiewicz et al., 2005). In this experiment, the SX represents the ratio of IC50 obtained 
in toxicity testing using MRC-5 cells to IC50 of the same extract in cytotoxicity test using 
MDA-MB-231 cells, and then multiplied by 100 (SX = IC50(MRC-5)/IC50(MDA-MB-231) × 100). 
The SX value above 100 indicates that the cytotoxic effect of tested substance is 
greater towards cancer cells. The SX value of 100 or below would suggest that the tested 
concentration of the substance for achieving therapeutic effect is similar to or lower than 
the concentration causing toxic effects to normal cells. Therefore, the most promising 
substances for development of anti-cancer drug would have SX values distinctly higher 
than 100 (Popiolkiewicz et al., 2005). Table 4.4 demonstrated the SX values for the six 
selected Zingiberaceae extracts tested, which were the crude petroleum ether and 
chloroform extracts of A. galanga, petroleum ether and chloroform extracts of B. rotunda, 
chloroform extract of C. domestica, and petroleum ether extract of Z. zerumbet. 
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Table 4.4: In vitro cytotoxicity of Zingiberaceae extracts on MRC-5 and MDA-MB-231 
cells and their selectivity index 
Zingiberaceae species Solvent
1
 Cell line, IC50 (µg/mL) Selectivity Index 
(SX) MRC-5 MDA-MB-
231 
Alpinia galanga p 2.86 2.87 100 
 c 11.87 6.19 192 
Boesenbergia rotunda p 12.78 9.21 139 
 c 13.22 10.25 129 
Curcuma domestica  c 12.32 10.10 122 
Zingiber zerumbet  p 12.09 7.46 162 
1 
Solvents used in extraction: p: petroleum ether, c: chloroform, m: methanol 
 
 
Based on the result in Table 4.4, only crude petroleum ether extract of A. galanga 
possessed SX value equal to 100. This indicated that the cytotoxicity of this extract to kill 
cancerous cells (MDA-MB-231 cells) and non-cancerous cell (MRC-5) were similar, and 
thus it was inappropriate for further studies even though it was the most active extract 
tested in the NO assay, cell proliferation and viability assay (MTT assay), and scratch 
wound assay. The other extracts possess SX values distinctly higher than 100, which 
indicated that their cytotoxicity is more prone to kill cancerous cells (MDA-MB-231) than 
normal cells (MRC-5), and thus hold potential for further studies in the development of 
anti-cancer drug. 
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4.4 Effects of the Zingiberaceae Extracts on the Migration of MDA-MB-231 Cells 
Cell migration is an important factor to probe the metastatic potential of cancer cells. 
The effects of 30 crude Zingiberaceae extracts on migration of hormone-independent 
human breast cancer cells (MDA-MB-231) were tested using the scratch wound assay. In 
the assay, cells were seeded into six-well plate and cultured to confluence. The confluent 
monolayer cells were then carefully wounded along the diameter of the well using a sterile 
200 µL-pipette tip and cell debris was removed by washing with PBS. The wounded cell 
monolayer was incubated in the absence (negative control) or presence of Zingiberaceae 
extract in 1%-serum media for 48 h at 37ºC, with 5% CO2. 
This study was conducted at the categorized concentrations of the Zingiberaceae 
extracts based on the IC50 value showed in Table 4.3. Inhibitory effects of the 
Zingiberaceae extracts on the proliferation of MDA-MB-231 cells were classified into four 
groups (Table 4.5). Anti-migration activity of Zingiberaceae extracts in Group 1, Group 2, 
Group 3 and Group 4 were conducted at 12.5 µg/mL, 25 µg/mL, 50 µg/mL, and 100 µg/mL, 
respectively.  
Cell migration into the wound area was imaged through phase-contrast microscope 
(magnification, 50×) and photographed at 0 h, 24 h and 48 h [Figure 4.35 (A)–4.65 (A)]. 
Gap distance for the wound closure was measured at 0 h, 24 h 48 h and the significance 
difference of the gap distances between control and treated cells were compared at 24 h and 
48 h [Figures 4.35 (B)–4.65 (B)]. Extracts resulting in the smallest wound closure (or 
largest gap measured at post-treatment) are those deemed most effective in inhibiting cell 
migration. The MDA-MB-231 cells treated with Zingiberaceae extracts spread slower 
along the wound edges than cells with vehicle alone.  
146 
 
Table 4.5: Classifications of the effectsof anti-proliferative activity or viability of 30 tested crude Zingiberaceae extracts1 
against MDA-MB-231 cells into four groups. 
Group 1 Group 2 
 
Group 3 
 
Group 4 
Alpinia galanga (p) Boesenbergia rotunda (m) Curcuma aeruginosa (c) Alpinia galanga (m) 
Alpinia galanga (c) Curcuma aeruginosa (p) Curcuma xanthorrhiza (m) Curcuma aeruginosa (m) 
Boesenbergia rotunda (p) Curcuma mangga (c)  Curcuma mangga (p) 
Boesenbergia rotunda (c) Curcuma xanthorrhiza (p)  Curcuma mangga (m) 
Curcuma domestica (p) Kaempferia galanga (c)  Kaempferia galanga (p) 
Curcuma domestica (c) Kaempferia galanga (m)  Zingiber montanum (m) 
Curcuma domestica (m) Zingiber montanum (p)  Zingiber officinale (m) 
Curcuma xanthorrhiza (c) Zingiber montanum (c)  Zingiber zerumbet (m) 
Zingiber zerumbet (p) Zingiber officinale (p)   
 Zingiber officinale (c)   
 Zingiber zerumbet (c)   
1 Each crude Zingiberaceae extract was tested at 1.56 µg/mL, 3.13 µg/mL, 6.25 µ/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, 
and 100 µg/mL in triplicates (N = 3). The extracts were tested against MDA-MB-231 cells using conventional MTT assay. 
The effects of anti-proliferative activity were categorized into Gorup 1, Group 2, Group 3 and Group 4 based on their IC50 
values. In the Table, p represents petroleum ether extract, c represents chloroform extract, and m represents methanol 
extract. 
 
(a) Alpinia galanga 
Effects of crude petroleum ether extract of A. galanga (tested at 12.5 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.35. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.380 mm) and 
became highly colonised at 48 h (gap distance, 0.146 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.35 (A)], with gap distances 0.728 mm and 0.741 mm at 
24 h and 48 h, respectively [Figure 4.35 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.35 (B)]. This showed that petroleum ether extract of A. 
galanga exhibited significant inhibitory effect on migration of MDA-MB-231 cells. There 
was no cell migration activity observed. Moreover, longer incubation (48 h) with the 
extract led to greater inhibition of MDA-MB-231 cell migration. 
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(B) 
Figure 4.35: Effects of crude petroleum ether extract of Alpinia galanga at 12.5 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Alpinia galanga at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude chloroform extract of A. galanga (tested at 12.5 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.36. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.380 mm) and 
became highly colonised at 48 h (gap distance, 0.146 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.36 (A)], with gap distances 0.740 mm and 0.775 mm at 
24 h and 48 h, respectively [Figure 4.36 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.35 (B)]. This showed that chloroform extract of A. 
galanga exhibited significant inhibitory effect on migration of MDA-MB-231 cells. There 
was no cell migration activity observed. Moreover, longer incubation (48 h) with the 
extract led to greater inhibition of MDA-MB-231 cell migration. 
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Figure 4.36: Effects of crude chloroform extract of Alpinia galanga at 12.5 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Alpinia galanga at 12.5 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
 
Effects of crude methanol extract of A. galanga (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.37. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.332 mm) and 
became highly colonised at 48 h (gap distance, 0.116 mm). MDA-MB-231 cells treated 
with the extracts spread along the wound edges at 24 h (gap distance, 0.348 mm) and 
become highly colonised at 48 h (gap distance, 0.159 mm). Statistical analysis using 
paired-sample t-test (p < 0.05) did not indicate significance differences between the gap 
distances of control and treated cells (at 24 h and 48 h ) [Figure 4.37 (B)]. This showed that 
methanol extract of A. galanga did not exhibit anti-migration activity against MDA-MB-
231 cells. 
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Figure 4.37: Effects of crude methanol extract of Alpinia galanga at 100 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Alpinia galanga at 100 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
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(b) Boesenbergia rotunda 
Effects of crude petroleum ether extract of B. rotunda (tested at 12.5 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.38. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.432 mm) and 
became highly colonised at 48 h (gap distance, 0.192 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.38 (A)], with gap distances 0.528 mm and 0.492 mm at 
24 h and 48 h, respectively [Figure 4.38 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.38 (B)]. This showed that petroleum ether extract of B. 
rotunda exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.38: Effects of crude petroleum ether extract of Boesenbergia rotunda at 12.5 
µg/mL on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle 
alone (Control) and petroleum ether extract of Boesenbergia rotunda at 12.5 µg/mL were 
(A) photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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cells (at 24 h and 48 h) [Figure 4.39 (B)]. This showed that chloroform extract of B. 
rotunda exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
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delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.39: Effects of crude chloroform extract of Boesenbergia rotunda at 12.5 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Boesenbergia rotunda at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude methanol extract of B. rotunda (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.40. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.351 mm) and 
became highly colonised at 48 h (gap distance, 0.132 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.40 (A)], with gap distances 0.387 mm and 0.234 mm at 
24 h and 48 h, respectively [Figure 4.40 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells at 48 h [Figure 4.40 (B)]. This showed that methanol extract of B. rotunda exhibited 
significant inhibitory effect on migration of MDA-MB-231 cells at 48 h. It delayed the cell 
migration of MDA-MB-231 cells compared to that of the control cells at 48 h. 
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Figure 4.40: Effects of crude methanol extract of Boesenbergia rotunda at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Boesenbergia rotunda at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude petroleum ether extract of C. aeruginosa (tested at 25 µg/mL) on 
the migration of MDA-MB-231 cells are shown in Figure 4.41. The untreated MDA-MB-
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mm at 24 h and 48 h, respectively [Figure 4.41 (B)]. Statistical analysis using paired-
sample t-test (p < 0.05) indicate significance differences between the gap distances of 
control and treated cells (at 24 h and 48 h ) [Figure 4.41 (B)]. This showed that petroleum 
ether extract of C. aeruginosa exhibited significant inhibitory effect on migration of MDA-
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MB-231 cells. It delayed the cell migration of MDA-MB-231 cells compared to that of the 
control cells in a time-dependent manner. 
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Figure 4.41: Effects of crude petroleum ether extract of Curcuma aeruginosa at 25 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Curcuma aeruginosa at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude chloroform extract of C. aeruginosa (tested at 50 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.42. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.405 mm) and 
became highly colonised at 48 h (gap distance, 0.208 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.42 (A)], with gap distances 0.668 mm and 0.629 mm at 
24 h and 48 h, respectively [Figure 4.42 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.42 (B)]. This showed that chloroform extract of C. 
aeruginosa exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.42: Effects of crude chloroform extract of Curcuma aeruginosa at 50 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Curcuma aeruginosa at 50 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
Effects of crude methanol extract of C. aeruginosa (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.43. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.332 mm) and 
became highly colonised at 48 h (gap distance, 0.116 mm). MDA-MB-231 cells treated 
with the extracts spread along the wound edges at 24 h (gap distance, 0.327 mm) and 
become highly colonised at 48 h (gap distance, 0.041 mm). Statistical analysis using 
paired-sample t-test (p < 0.05) did not indicate significance differences between the gap 
distances of control and treated cells (at 24 h and 48 h ) [Figure 4.37 (B)]. This showed that 
methanol extract of C. aeruginosa did not exhibit anti-migration activity against MDA-
MB-231 cells. 
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Figure 4.43: Effects of crude methanol extract of Curcuma aeruginosa at 100 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Curcuma aeruginosa at 100 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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(d) Curcuma domestica 
Effects of crude petroleum ether extract of C. domestica (tested at 12.5 µg/mL) on 
the migration of MDA-MB-231 cells are shown in Figure 4.44. The untreated MDA-MB-
231 cells (negative control) spread along the wound edges at 24 h (gap distance, 0.428 mm) 
and became highly colonised at 48 h (gap distance, 0.164 mm). In contrast, for MDA-MB-
231 cells treated with the extracts spread along the wound edges were seen to be slower 
than that of the untreated cells [Figure 4.44 (A)], with gap distances 0.455 mm and 0.266 
mm at 24 h and 48 h, respectively [Figure 4.44. (B)]. Statistical analysis using paired-
sample t-test (p < 0.05) indicate significance differences between the gap distances of 
control and treated cells at 48 h [Figure 4.44 (B)]. This showed that petroleum ether extract 
of C. domestica exhibited significant inhibitory effect on migration of MDA-MB-231 cells 
at 48 h. It delayed the cell migration of MDA-MB-231 cells compared to that of the control 
cells at 48 h. 
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Figure 4.44: Effects of crude petroleum ether extract of Curcuma domestica at 12.5 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Curcuma domestica at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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cells (negative control) spread along the wound edges at 24 h (gap distance, 0.428 mm) and 
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24 h and 48 h, respectively [Figure 4.45 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h) [Figure 4.45 (B)]. This showed that chloroform extract of C. 
domestica exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
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delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.45: Effects of crude chloroform extract of Curcuma domestica at 12.5 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Curcuma domestica at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude methanol extract of C. domestica (tested at 12.5 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.46. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.374 mm) and 
became highly colonised at 48 h (gap distance, 0.172 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.46 (A)], with gap distances 0.533 mm and 0.416 mm at 
24 h and 48 h, respectively [Figure 4.46 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.46 (B)]. This showed that methanol extract of C. 
domestica exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.46: Effects of crude methanol extract of Curcuma domestica at 12.5 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Curcuma domestica at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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cells (at 24 h and 48 h ) [Figure 4.47 (B)]. This showed that petroleum ether extract of C. 
mangga exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
0
.3
7
4
 +
 0
.0
2
3
 
0
.5
3
3
 +
 0
.0
4
2
 
0
.1
7
2
 +
 0
.0
4
7
 
0
.4
1
6
 +
 0
.0
4
6
 
165 
 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.47: Effects of crude petroleum ether extract of Curcuma mangga at 100 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Curcuma mangga at 100 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude chloroform extract of C. mangga (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.48. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.362 mm) and 
became highly colonised at 48 h (gap distance, 0.142 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.48 (A)], with gap distances 0.568 mm and 0.530 mm at 
24 h and 48 h, respectively [Figure 4.48 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.48 (B)]. This showed that chloroform extract of C. 
mangga exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.48: Effects of crude chloroform extract of Curcuma mangga at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Curcuma mangga at 25 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
 
Effects of crude methanol extract of C. mangga (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.49. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.350 mm) and 
became highly colonised at 48 h (gap distance, 0.120 mm). MDA-MB-231 cells treated 
with the extracts spread along the wound edges at 24 h (gap distance, 0.380 mm) and 
become highly colonised at 48 h (gap distance, 0.183 mm). Statistical analysis using 
paired-sample t-test (p < 0.05) did not indicate significance differences between the gap 
distances of control and treated cells (at 24 h and 48 h) [Figure 4.49 (B)]. This showed that 
methanol extract of C. mangga did not exhibit anti-migration activity against MDA-MB-
231 cells. 
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Figure 4.49: Effects of crude methanol extract of Curcuma mangga at 100 µg/mL on 
migration in MDA-MB-23 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Curcuma mangga at 100 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
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Effects of crude petroleum ether extract of C. xanthorrhiza (tested at 25 µg/mL) on 
the migration of MDA-MB-231 cells are shown in Figure 4.50. The untreated MDA-MB-
231 cells (negative control) spread along the wound edges at 24 h (gap distance, 0.287 mm) 
and became highly colonised at 48 h (gap distance, 0.074 mm). MDA-MB-231 cells treated 
with the extracts spread along the wound edges at 24 h (gap distance, 0.296 mm) and 
become highly colonised at 48 h (gap distance, 0.103 mm). Statistical analysis using 
paired-sample t-test (p < 0.05) did not indicate significance differences between the gap 
distances of control and treated cells at 48 h [Figure 4.50 (B)]. This showed that petroleum 
ether extract of C. xanthorrhiza did not exhibit anti-migration activity against MDA-MB-
231 cells. 
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Figure 4.50: Effects of crude petroleum ether extract of Curcuma xanthorrhiza at 25 
µg/mL on migration in MDA-MB-23 cells. After wounding, the cells treated with vehicle 
alone (Control) and petroleum ether extract of Curcuma xanthorrhiza at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
Effects of crude chloroform extract of C. xanthorrhiza (tested at 12.5 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.51. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.377 mm) and 
became highly colonised at 48 h (gap distance, 0.172 mm). MDA-MB-231 cells treated 
with the extracts spread along the wound edges at 24 h (gap distance, 0.498 mm) and 
become highly colonised at 48 h (gap distance, 0.318 mm). Statistical analysis using 
paired-sample t-test (p < 0.05) did not indicate significance differences between the gap 
distances of control and treated cells at both 24 h and 48 h [Figure 4.51 (B)]. This showed 
that chloroform extract of C. xanthorrhiza did not exhibit anti-migration activity against 
MDA-MB-231 cells. 
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Figure 4.51: Effects of crude chloroform extract of Curcuma xanthorrhiza at 12.5 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Curcuma xanthorrhiza at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude methanol extract of C. xanthorrhiza (tested at 50 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.52. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.371 mm) and 
became highly colonised at 48 h (gap distance, 0.148 mm). MDA-MB-231 cells treated 
with the extracts spread along the wound edges at 24 h (gap distance, 0.399 mm) and 
become highly colonised at 48 h (gap distance, 0.195 mm). Statistical analysis using 
paired-sample t-test (p < 0.05) did not indicate significance differences between the gap 
distances of control and treated cells at 48 h [Figure 4.52 (B)]. This showed that methanol 
extract of C. xanthorrhiza did not exhibit anti-migration activity against MDA-MB-231 
cells. 
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Figure 4.52: Effects of crude methanol extract of Curcuma xanthorrhiza at 50 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Curcuma xanthorrhiza at 50 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
Effects of crude petroleum ether extract of K. galanga (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.53. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.341 mm) and 
became highly colonised at 48 h (gap distance, 0.104 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.53 (A)], with gap distances 0.508 mm and 0.458 mm at 
24 h and 48 h, respectively [Figure 4.53 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.53 (B)]. This showed that petroleum ether extract of K. 
galanga exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
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delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.53: Effects of crude petroleum ether extract of Kaempferia galanga at 100 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Kaempferia galanga at 100 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude chloroform extract of K. galanga (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.54. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.362 mm) and 
became highly colonised at 48 h (gap distance, 0.142 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.54 (A)], with gap distances 0.418 mm and 0.280 mm at 
24 h and 48 h, respectively [Figure 4.54 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.54 (B)]. This showed that chloroform extract of K. 
galanga exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.54: Effects of crude chloroform extract of Kaempferia galanga at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Kaempferia galanga at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
 
Effects of crude methanol extract of K. galanga (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.55. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.287 mm) and 
became highly colonised at 48 h (gap distance, 0.074 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.55 (A)], with gap distances 0.312 mm and 0.132 mm at 
24 h and 48 h, respectively [Figure 4.55 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.55 (B)]. This showed that methanol extract of K. galanga 
exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It delayed the 
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cell migration of MDA-MB-231 cells compared to that of the control cells in a time-
dependent manner. 
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Figure 4.55: Effects of crude methanol extract of Kaempferia galanga at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Kaempferia galanga at 25 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
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Effects of crude petroleum ether extract of Z. montanum (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.56. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.417 mm) and 
became highly colonised at 48 h (gap distance, 0.203 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.56 (A)], with gap distances 0.572 mm and 0.435 mm at 
24 h and 48 h, respectively [Figure 4.56 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.56 (B)]. This showed that petroleum ether extract of Z. 
montanum exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.56: Effects of crude petroleum ether extract of Zingiber montanum at 25 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Zingiber montanum at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
Effects of crude chloroform extract of Z. montanum (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.57. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.417 mm) and 
became highly colonised at 48 h (gap distance, 0.203 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.57 (A)], with gap distances 0.524 mm and 0.366 mm at 
24 h and 48 h, respectively [Figure 4.57 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.57 (B)]. This showed that chloroform extract of Z. 
montanum exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
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delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.57: Effects of crude chloroform extract of Zingiber montanum at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Zingiber montanum at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude methanol extract of Z. montanum (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.58. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.341 mm) and 
became highly colonised at 48 h (gap distance, 0.104 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.58 (A)], with gap distances 0.404 mm and 0.271 mm at 
24 h and 48 h, respectively [Figure 4.58 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.58 (B)]. This showed that methanol extract of Z. 
montanum exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.58: Effects of crude methanol extract of Zingiber montanum at 100 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Zingiber montanum at 100 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
Effects of crude petroleum ether extract of Z. officinale (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.59. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.351 mm) and 
became highly colonised at 48 h (gap distance, 0.132 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.59 (A)], with gap distances 0.550 mm and 0.457 mm at 
24 h and 48 h, respectively [Figure 4.59 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells (at 24 h and 48 h ) [Figure 4.59 (B)]. This showed that petroleum ether extract of Z. 
officinale exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It 
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delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in a 
time-dependent manner. 
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Figure 4.59: Effects of crude petroleum ether extract of Zingiber officinale at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Zingiber officinale at 25 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
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Effects of crude chloroform extract of Z. officinale (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.60. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.314 mm) and 
became highly colonised at 48 h (gap distance, 0.104 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.60 (A)], with gap distances 0.365 mm and 0.281 mm at 
24 h and 48 h, respectively [Figure 4.60 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells at 48 h [Figure 4.60 (B)]. This showed that chloroform extract of Z. officinale 
exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It delayed the 
cell migration of MDA-MB-231 cells compared to that of the control cells in a time-
dependent manner. 
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Figure 4.60: Effects of crude chloroform extract of Zingiber officinale at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Zingiber officinale at 25 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
 
Effects of crude methanol extract of Z. officinale (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.61. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.401 mm) and 
became highly colonised at 48 h (gap distance, 0.147 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.61 (A)], with gap distances 0.421 mm and 0.250 mm at 
24 h and 48 h, respectively [Figure 4.61 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells at 48 h [Figure 4.61 (B)]. This showed that methanol extract of Z. officinale exhibited 
significant inhibitory effect on migration of MDA-MB-231 cells. It delayed the cell 
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migration of MDA-MB-231 cells compared to that of the control cells in a time-dependent 
manner. 
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Figure 4.61: Effects of crude methanol extract of Zingiber officinale at 100 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Zingiber officinale at 100 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
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Effects of crude petroleum ether extract of Z. zerumbet (tested at 12.5 µg/mL) on 
the migration of MDA-MB-231 cells are shown in Figure 4.62. The untreated MDA-MB-
231 cells (negative control) spread along the wound edges at 24 h (gap distance, 0.454 mm) 
and became highly colonised at 48 h (gap distance, 0.217 mm). In contrast, for MDA-MB-
231 cells treated with the extracts spread along the wound edges were seen to be slower 
than that of the untreated cells [Figure 4.62 (A)], with gap distances 0.580 mm and 0.550 
mm at 24 h and 48 h, respectively [Figure 4.62 (B)]. Statistical analysis using paired-
sample t-test (p < 0.05) indicate significance differences between the gap distances of 
control and treated cells at 48 h [Figure 4.62 (B)]. This showed that petroleum ether extract 
of Z. zerumbet exhibited significant inhibitory effect on migration of MDA-MB-231 cells. 
It delayed the cell migration of MDA-MB-231 cells compared to that of the control cells in 
a time-dependent manner. 
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Figure 4.62: Effects of crude petroleum ether extract of Zingiber zerumbet at 12.5 µg/mL 
on migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and petroleum ether extract of Zingiber zerumbet at 12.5 µg/mL were (A) 
photographed under a phase-contrast microscope (magnification, 50×) and (B) the 
migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample was 
assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) according to 
paired-sample t-test was indicated as * above each bar. 
 
Effects of crude chloroform extract of Z. zerumbet (tested at 25 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.63. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.314 mm) and 
became highly colonised at 48 h (gap distance, 0.104 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.63 (A)], with gap distances 0.470 mm and 0.412 mm at 
24 h and 48 h, respectively [Figure 4.63 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells at 48 h [Figure 4.63 (B)]. This showed that chloroform extract of Z. zerumbet 
exhibited significant inhibitory effect on migration of MDA-MB-231 cells. It delayed the 
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cell migration of MDA-MB-231 cells compared to that of the control cells in a time-
dependent manner. 
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Figure 4.63: Effects of crude chloroform extract of Zingiber zerumbet at 25 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and chloroform extract of Zingiber zerumbet at 25 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
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Effects of crude methanol extract of Z. zerumbet (tested at 100 µg/mL) on the 
migration of MDA-MB-231 cells are shown in Figure 4.64. The untreated MDA-MB-231 
cells (negative control) spread along the wound edges at 24 h (gap distance, 0.401 mm) and 
became highly colonised at 48 h (gap distance, 0.147 mm). In contrast, for MDA-MB-231 
cells treated with the extracts spread along the wound edges were seen to be slower than 
that of the untreated cells [Figure 4.64 (A)], with gap distances 0.453 mm and 0.297 mm at 
24 h and 48 h, respectively [Figure 4.64 (B)]. Statistical analysis using paired-sample t-test 
(p < 0.05) indicate significance differences between the gap distances of control and treated 
cells at 48 h [Figure 4.64 (B)]. This showed that methanol extract of Z. zerumbet exhibited 
significant inhibitory effect on migration of MDA-MB-231 cells. It delayed the cell 
migration of MDA-MB-231 cells compared to that of the control cells in a time-dependent 
manner. 
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Figure 4.64: Effects of crude methanol extract of Zingiber zerumbet at 100 µg/mL on 
migration in MDA-MB-231 cells. After wounding, the cells treated with vehicle alone 
(Control) and methanol extract of Zingiber zerumbet at 100 µg/mL were (A) photographed 
under a phase-contrast microscope (magnification, 50×) and (B) the migrating distances 
were measured and plotted at 0 h, 24 h, and 48 h. The sample was assayed in triplicates (N 
= 3), and statistically significant difference (p < 0.05) according to paired-sample t-test was 
indicated as * above each bar. 
 
[6]-Gingerol (1,[4‟-hydroxy-3‟-methyoxyphenyl-5-hydroxy]-3-decanone) is one of 
the major pungent elements of ginger (Z. officinale), has been found to exhibit anti-
metastatic activity of MDA-MB-231 human breast cancer cells (Lee, Seo, Kang, & Kim, 
2008). Therefore, it was used as the positive control in this assay. The results in Figure 4.65 
demonstrated that 12.5 µg/mL of [6]-Gingerol exhibited significant inhibitory effect on 
migration of MDA-MB-231 cells at 48 h [Figure 4.65 (B)]. It delayed the cell migration of 
MDA-MB-231 cells compared to that of the control cells in a time-dependent manner 
[Figure 4.65 (A)]. 
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Figure 4.65: Effects of [6]-Gingerol at 12.5 µg/mL on migration in MDA-MB-231 cells. 
After wounding, the cells treated with vehicle alone (Control) and [6]-Gingerol at 100 
µg/mL were (A) photographed under a phase-contrast microscope (magnification, 50×) and 
(B) the migrating distances were measured and plotted at 0 h, 24 h, and 48 h. The sample 
was assayed in triplicates (N = 3), and statistically significant difference (p < 0.05) 
according to paired-sample t-test was indicated as * above each bar. 
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4.4.1 Comparisons of the Zingiberaceae extracts on inhibitory effects of cell       
           migration activity of MDA-MB-231 cells 
Absolute migration capability (MCA) was used as the parameter for evaluating 
migration capability of breast cancer cell line (MDA-MB-231) after treated with crude 
Zingiberaceae extracts in vitro. MCA value for untreated cells (negative control) was 6.03 × 
10
-3
 mm/h at 48 h of incubation time, which represented the migration capability of MDA-
MB-231 cells in normal conditions. Untreated cells were able to invade the scratched area 
that is fully re-colonised at 48 h later. 
In the Scratch wound assay, the largest gaps observed after treated with the extracts 
reveal the most effective agent in anti-migration. The MDA-MB-231 cells treated with 
Zingiberaceae extracts spreading along the wound edges would have become slower than 
that of cells with vehicle alone. In comparison with the MCA values (Table 4.6), all of the 
tested Zingiberaceae extracts except crude methanol extract of C. aeruginosa (tested at 100 
µg/mL) did inhibit or slow down the migration activity of MDA-MB-231 cells. However, 
the overall results revealed that Zingiberaceae plants are good candidate for anti-migration 
activities.  
Based on the results in Table 4.6, petroleum ether and chloroform extracts of A. 
galanga (tested at 12.5 µg/mL) inhibited migration of MDA-MB-231 cells effectively, with 
MCA values –5.73 × 10
-3
 mm/h and –8.02 × 10-3 mm/h at 48 h of incubation time, 
respectively. The smaller the value of MCA manifests the lower migration capability. 
Negative MCA values represented no migration activity could be observed. Besides these 
extracts, several extracts showed effective anti-migration activities as well, which were 
chloroform extract of C. domestica (tested at 12.5 µg/mL), and petroleum ether extract of Z. 
194 
 
zerumbet (tested at 12.5 µg/mL), with MCA values 1.35 × 10
-4 
mm/h and 1.63 × 10
-3 
mm/h 
at 48 h of incubation time.  
 It was interesting that most of methanol extracts of Zingiberaceae which did not 
inhibit cell proliferations of MDA-MB-231 at 100 µg/mL, did slow down the cell migration 
at 48 h time point. These extracts are methanol extracts of A. galanga (MCA, 5.78 × 10
-3
 
mm/h), C. mangga (MCA, 5.72 × 10
-3 mm/h), Z. montanum MCA, 4.43 × 10
-3
 mm/h), Z. 
officinale (MCA, 4.81 × 10
-3
 mm/h) , and Z. zerumbet (MCA, 4.45 × 10
-3
 mm/h). The only 
inactive extract in anti-migration activity was methanol extract of C. aeruginosa at 100 
µg/mL. The MCA values for the cells treated with it was 8.13 × 10
-3
 mm/h at 24 h and 7.04 
× 10
-3
 mm/h at 48 h, which were obviously greater than the MCA values of untreated cells 
(MCA, 7.35 × 10
-3
 mm/h at 24 h; MCA 6.03 × 10
-3
 mm/h at 48 h). 
 In the comparisons of MCA values between 24 h and 48 h of incubation time, 
several extracts showed anti-migration activity only at 48 h of incubation time. These 
extracts were methanol extract of A. galanga (tested at 100 µg/mL), petroleum ether extract 
of C. xanthorrhiza (tested at 25 µg/mL), and methanol extract of K. galanga (tested at 25 
µg/mL).  MCA values for methanol extract of A. galanga at 24 h incubation time was 7.63 
× 10
-3
 mm/h, but decreased to 5.78 × 10
-3
 mm/h at 48 h later. MCA values for petroleum 
ether extract of C. xanthorrhiza at 24 h incubation time was 7.65 × 10
-3
 mm/h, but 
decreased to 5.83 × 10
-3
 mm/h at 48 h later. MCA values for methanol extract of K. galanga 
at 24 h incubation time was 7.60 × 10
-3
 mm/h, but decreased to 5.68 × 10
-3
 mm/h at 48 h 
later. Based on the scenarios, Scratch wound assay is much better to be performed at 48 h 
time point rather than just 24 h, which could better elaborate the anti-migration acitivities 
of each crude Zingiberaceae extracts. 
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Table 4.6: Absolute migration capability of Zingiberaceae extracts determined by Scratch 
wound assay using MDA-MB-231 cells 
Zingiberaceae 
species 
Solvent
1
 Concentration 
(µg/mL) 
Absolute migration capability, MCA 
(mm/h) 
MDA-MB-231 cell line, incubation 
status 
   24 h  48 h 
 
Control 
 
- 
 
0 
 
7.35 × 10
-3
 
 
6.03 × 10
-3
 
Alpinia galanga p 12.5 –8.75 × 10-4 –5.73 × 10-4 
 c 12.5 –8.75 × 10-4 –8.02 × 10-4 
 m 100 7.63 × 10
-3
 5.78 × 10
-3
 
Boesenbergia 
rotunda 
p 12.5 5.21 × 10
-3
 2.98 × 10
-3
 
 c 12.5 4.29 × 10
-3
 2.53 × 10
-3
 
 m 25 5.90 × 10
-3
 4.54 × 10
-3
 
Curcuma aeruginosa p 25 3.21 × 10
-3
 1.93 × 10
-3
 
 c 50 1.31 × 10
-3
 1.06 × 10
-3
 
 m 100 8.13 × 10
-3
 7.04 × 10
-3
 
Curcuma domestica p 12.5 4.96 × 10
-3
 4.45 × 10
-3
 
 c 12.5 5.63 × 10
-4
 1.35 × 10
-4
 
 m 12.5 3.27 × 10
-3
 2.85 × 10
-3
 
Curcuma mangga p 100  1.38 × 10
-3
 1.17 × 10
-3
 
 c 25 1.90 × 10
-3
 1.34 × 10
-3
 
 m 100 7.33 × 10
-3
 5.72 × 10
-3
 
Curcuma 
xanthorrhiza 
p 25 7.65 × 10
-3
 5.83 × 10
-3
 
 c 12.5 4.94 × 10
-3
 4.34 × 10
-3
 
 m 50 6.58 × 10
-3
 5.42 × 10
-3
 
Kaempferia galanga p 100 4.38 × 10
-3
 2.71 × 10
-3
 
 c 25 4.73 × 10
-3
 3.80 × 10
-3
 
 m 25 7.60 × 10
-3
 5.68 × 10
-3
 
Zingiber montanum p 25 3.65 × 10
-3
 3.25 × 10
-3
 
 c 25 4.50 × 10
-3
 3.90 × 10
-3
 
 m 100 6.08 × 10
-3
 4.43 × 10
-3
 
Zingiber officinale p 25 3.44 × 10
-3
 2.69 × 10
-3
 
 c 25 5.96 × 10
-3
 3.85 × 10
-3
 
 m 100 6.06 × 10
-3
 4.81 × 10
-3
 
Zingiber zerumbet p 12.5 2.63 × 10
-3
 1.63 × 10
-3
 
 c 25 3.88 × 10
-3
 2.54 × 10
-3
 
 m 100 5.65 × 10
-3
 4.45 × 10
-3
 
[6]-Gingerol - 
 
12.5 5.38 × 10
-3
 4.32 × 10
-3
 
1 
Solvents used in extraction: p: petroleum ether, c: chloroform, m: methanol; (-) not tested. 
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4.5 Qualitative Analysis Using Thin-layer Chromatography 
Three most potential Zingiberaceae tested based on the screening tests were crude 
chloroform extract of A. galanga, crude chloroform extract of C. domestica, and crude 
petroleum ether extract of Z. zerumbet. Petroleum ether extract of Z. zerumbet showed the 
strongest NO inhibitory activity in activated macrophages, RAW 264.7, whereas 
chloroform extracts of A. galanga and C. domestica showed the potent effects in anti-
proliferation and anti-migration activities against human breast cancer cells, MDA-MB-231.  
More importantly, these extracts possess SX values distinctly greater than 100 (Table 4.4), 
which indicated their promising properties for further studies in the development of anti-
cancer drugs. 
The extracts were subjected for qualitative analysis using TLC to determine a large 
extent of nature substances or chemical groups present in the crude extracts. Types of 
compounds detected from the TLC tests for crude chloroform extract of A. galanga, crude 
chloroform extract of C. domestica, and crude petroleum ether extract of Z. zerumbet were 
presented in Table 4.7, Table 4.8 and Table 4.9, respectively. These are known as the 
results of preliminary chemical tests.  
Based on Table 4.7, 15 compounds were detected in the crude chloroform extract of 
A. galanga. Nine (60%) of the compounds containing conjugated double bonds, or double 
bond. Twelve compounds were detected in thee crude chloroform extract of C. domestica 
(Table 4.8). It was interesting to observed that C6 (Rf = 0.66) showed positive results for all 
of the detection methods applied. Eleven (92%) of the compounds containing conjugated 
double bonds and eight (67%) were organic compounds. For crude petroleum ether extract 
of Z. zerumbet, 15 compounds were detected (Table 4.9). Seven (47%) of the compounds 
were from the group of secondary compound, terpenoids.
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Table 4.7: Qualitative analysis of crude chloroform extract of Alpinia galanga using thin-layer chromatography 
Labeled 
compound
1
 
Rf
2
 Daylight UV light 
at 254 nm 
UV light 
at 365 nm 
Iodine 
vapour 
50% H2SO4 Dragendorff’s 
reagent 
Vanillin/H2SO4 
reagent 
Types of compounds detected 
A1 0.05 - - - brown - - - Compounds with double bonds 
A2 0.15 - red green brown - - purple Compounds containing conjugated double 
bonds; fluorescent compounds; and 
terpenoids 
A3 0.18 - - - brown - - - Compounds with double bonds 
A4 0.26 - red - brown - - - Compounds with conjugated double 
bonds; and compounds with double bonds 
A5 0.35 - red - - - - - Compounds containing conjugated double 
bonds 
A6 0.56 - - yellow - - - - Fluorescent compounds  
A7 0.63 - - - - black - purple Organic compounds; and terpenoids  
A8 0.65 - red green brown - - - Compounds containing conjugated double 
bonds; fluorescent compounds; and 
compounds with double bonds. 
A9 0.71 - red - - - - - Compounds containing conjugated double 
bonds 
A10 0.75 - - - - - - yellow Phenols  
A11 0.79 - red - brown yellow - - Compounds containing conjugated double 
bonds; compounds with double bonds; 
and organic compounds 
A12 0.83 - red - brown black - - Compounds containing conjugated double 
bonds; compounds with double bonds; 
and organic compounds 
A13 0.85 red - blue brown - - - Coloured substances; fluorescent 
compounds; and compounds with double 
bonds 
A14 0.89 yellow red - - - - - Coloured substances; compounds with 
conjugated double bonds 
A15 0.96 - blue - brown - - - Compounds with conjugated double 
bonds; and compounds with double bond 
1
Resoluted compounds of crude chloroform extract of Alpinia galanga observed as bands on the stationary phase using several detection methods/spray reagents. 
2
Rf: Retardation factor calculated by Eq. (6). 
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Table 4.8: Qualitative analysis of crude chloroform extract of Curcuma domestica using thin-layer chromatography 
Labeled 
compound
1
 
Rf
2
 Daylight UV light 
at 254 nm 
UV light 
at 365 nm 
Iodine 
vapour 
50% H2SO4 Dragendorff’s 
reagent 
Vanillin/H2SO4 
reagent 
Types of compounds detected 
C1 0.09 - red - - brown orange - Compounds containing conjugated double 
bonds; organic compounds; and alkaloids 
C2 0.15 - red - - brown - - Compounds containing conjugated double 
bonds; and organic compounds 
C3 0.25 - red - - brown - - Compounds containing conjugated double 
bonds; and organic compounds 
C4 0.33 - red - - brown - yellow Compounds containing conjugated double 
bonds; organic compounds; and phenols 
C5 0.49 - red - - black - purple Compounds containing conjugated double 
bonds; organic compounds; and 
terpenoids 
C6 0.66 yellow yellow yellow brown black orange red Coloured substances; compounds 
containing conjugated double bonds; 
fluorescent compounds; compounds with 
double bonds; organic compounds; 
alkaloids; and phenols 
C7 0.74 - red - - brown - - Compounds containing conjugated double 
bonds; and organic compounds 
C8 0.80 - red - - brown - - Compounds containing conjugated double 
bonds; and organic compounds 
C9 0.84 - red - - - - purple Compounds containing conjugated double 
bonds; and terpenoids 
C10 0.88 - red - - - - - Compounds containing conjugated double 
bonds 
C11 0.90 -  blue - - - - Fluorescent compounds 
C12 0.95 - red - brown - - red Compounds containing conjugated double 
bonds; compounds with double bonds; 
and phenols 
1
Resoluted compounds of crude chloroform extract of Curcuma domestica observed as bands on the stationary phase using several detection methods/spray reagents. 
2
Rf: Retardation factor calculated by Eq. (6). 
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Table 4.9: Qualitative analysis of crude petroleum ether extract of Zingiber zerumbet using thin-layer chromatography 
Labeled 
compound
1
 
Rf
2
 Daylight UV light 
at 254 nm 
UV light 
at 365 nm 
Iodine 
vapour 
50% H2SO4 Dragendorff’s 
reagent 
Vanillin/H2SO4 
reagent 
Types of compounds detected 
Z1 0.08 - red yellow - - - - Compounds containing conjugated double 
bonds; and fluorescent compounds 
Z2 0.13 - - - brown brown - purple Compounds with double bonds; oorganic 
compounds; and terpenoids 
Z3 0.16 yellow - - - - - purple Coloured substances; and terpenoids 
Z4 0.20 - red yellow - - - - Compounds containing conjugated double 
bonds; and fluorescent compounds 
Z5 0.23 - - blue - - - - Fluorescent compounds 
Z6 0.38 - - - brown - - purple Compounds with double bonds; and 
terpenoids 
Z7 0.59 - - - - brown - purple Organic compounds; and terpenoids 
Z8 0.61 - - - brown brown - purple Compounds with double bonds; organic 
compounds; and terpenoids 
Z9 0.63 - red - - - - - Compounds containing conjugated double 
bonds 
Z10 0.64 yellow - - brown - - - Coloured substances; and compounds 
with double bonds 
Z11 0.68 - red - - - - purple Compounds containing conjugated double 
bonds; and terpenoids 
Z12 0.71 - red - - - - - Compounds containing conjugated double 
bonds 
Z13 0.75 - - yellow brown - - - Fluorescent compounds; and compounds 
with double bond 
Z14 0.90 - - blue brown - - purple Fluorescent compounds; compound with 
double bonds; and terpenoids 
Z15 0.98 - - yellow - - - - Fluorescent compounds 
1
Resoluted compounds of crude petroleum ether extract of Zingiber zerumbet observed as bands on the stationary phase using several detection methods/spray reagents. 
2
Rf: Retardation factor calculated by Eq. (6).
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CHAPTER 5 
5.0 Discussion 
5.1 Extraction of the Selected Zingiberaceae Species 
Solvent extraction is the most popular method of extract preparation from natural 
products. The solvents have the potential in extracting different classes of chemical 
compounds based on their polarity properties. Since there was no preconception about the 
chemical nature of the active compounds that were being sought, Soxhlet extraction was 
carried out in order to extract the Zingiberaceae rhizomes of A. galanga, B. rotunda, C. 
aeruginosa, C. domestica, C. mangga, C. xanthorrhiza, K. galanga, Z. montanum, Z. 
officinale, and Z. zerumbet exhaustively with a range of solvent of increasing polarity, 
namely petroleum ether, chloroform and methanol.  
Petroleum ether is a solvent with low polarity, commonly used in extracting 
chemical classes of compounds, such as waxes, fats, fixed oils or volatile oils. Chloroform 
is commonly used to extract chemical classes of alkaloids, aglycones and volatile oils. 
Higher polarity solvent, such as methanol is specifically used to extract sugar, amino acids 
and glycosides (Houghton & Raman, 1998). Three crude extracts were generated from each 
Zingiberaceae species, and a total of 30 extracts from ten selected Zingiberaceae species 
were obtained for the screening programmes. 
Conventional soxhlet extraction is a very simple methodology that is easily 
applicable and requires only little training. It was used in preparing crude extracts of ten 
selected Zingiberaceae rhizomes in this research. The petroleum ether, chloroform and 
methanol solvents in the distillation flask were heated at their boiling temperature at 45°C, 
62°C and 65°C, respectively. The vapour formed passed through the side-arm and up into 
the sample compartment, where the vapour liquefied due to the cooling effect from the 
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reflux condenser. The liquid dripped into the thimble and the extracts collected in the 
sample compartment unloaded back to the distillation flask once it reached the top of the 
siphon. The process was repeated and the extracts collected in the distillation flask, 
gradually became more and more concentrated. The extraction for each sample with a 
particular solvent took an average of three days to complete. A relatively small volume of 
fresh solvent was needed since the solvent was being recycled, but the volume used should 
effectively proportional to the time for which the process was allowed to continue 
(Houghton & Raman, 1998). 
Conventional Soxhlet extraction has several advantages that resulting in it being one 
of the most efficient leaching techniques to date (Luque de Castro & Priego-Capote, 2009). 
One of most outstanding advantages is that the sample is repeatedly being exposed to the 
recyclable fresh portion of the extracting solvent which facilitates the displacement of the 
transfer equilibrium (Luque de Castro & García-Ayuso, 1998; Luque de Castro & Priego-
Capote, 2009). Based on its continuous-discrete characteristic of operation, it is useful for 
achieving exhaustive extraction of plant material with a particular solvent, where 100% 
yield of particular component is desired. It is also an efficient way of performing 
exhaustive extraction when using a series of solvents with increasing polarity, such as 
petroleum ether, hexane, chloroform, methanol, and water (Houghton & Raman, 1998).  
Besides that, a relatively high temperature is maintained in this Soxhlet extractor 
system where heat is applied directly to the distillation flask and reaches the extraction 
cavity to some extent (Luque de Castro & García-Ayuso, 1998; Luque de Castro & Priego-
Capote, 2009). In addition, extract collected in the bulk liquid form can be subjected 
directly to rotary evaporation without filtration after the leaching step. Moreover, it can 
extract more samples mass compared to the latest alternatives, such as microwave-assisted 
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extraction and supercritical fluid extraction (Luque de Castro & Priego-Capote, 2009). A 
relatively small volume of fresh solvent is required as the solvent is being recycled 
throughout the operation. Since the basic apparatus of Soxhlet extractor is inexpensive, the 
sample throughput can be increased by simultaneous extraction in parallel (Luque de Castro 
& García-Ayuso, 1998). 
Although conventional Soxhlet extraction is a simple technique, several 
precautionary steps were carried out in order to obtain optimize yield. Separate items of 
glassware for the Soxhlet extractor were cleaned and dried before operating the extraction 
in order to discard any unnecessary volatile substances which would probably pollute the 
purity of the solvent. Besides that, it was necessary to dry the thimble with plant sample 
properly in between the changes of solvent to prevent carry-over of traces of the previous 
solvent into the next one. Large scale operation is not suitable to be carried out if using 
solvents with high boiling points, such as methanol and water, since the whole apparatus 
below the reflux condenser need to be at this high temperature for effective movement of 
the solvent vapour (Houghton & Raman, 1998). This may further increase the risk of 
thermal decomposition. Thus, small scale conventional Soxhlet extraction was carried out 
in this research as it was more efficient even though it was comparably more time-
consuming than the large scale operation.  
 
5.2 Effects of the Zingiberaceae Extracts on Nitric Oxide Inhibitory Activity 
Enhancement of macrophage responses without stimulating inflammatory activity 
could be beneficial not only in normal tissue homeostasis, such as clearing dead cells or cell 
debris, but also in aiding in recovery from certain inflammatory diseases (Savill & Fadok, 
2000). Petroleum ether, chloroform, and methanol extracts from ten selected Zingiberaceae 
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species such as A. galanga, B. rotunda, C. aeruginosa, C. domestica, C. mangga, C. 
xanthorrhiza, K. galanga, Z. montanum, Z. officinale, and Z. zerumbet were evaluated for 
their in vitro NO inhibitory activities in LPS-stimulated murine macrophage cells, RAW 
2647.  
The data presented in this study indicated that 29 out of 30 tested crude 
Zingiberaceae extracts (except methanol extract of Z. zerumbet) were shown to have 
exerted negative a significant immunomodulatory effects on various LPS-mediated immune 
responses. Among them, is crude petroleum ether extract of Z. zerumbet which exerted the 
strongest NO inhibitory activity (IR > 75% at 1.56 µg/mL) in LPS-activated RAW 264.7 
cells. 
These extracts showed significant inhibition of NO production in LPS-stimulated 
macrophage cells. This phenomenon is quite similar to the exposure of macrophages to 
apoptotic cells. Based on the previous reports, the presence of apoptosis cells induce 
phagocytosis but suppress inflammatory responses (Fadok et al., 1998; Voll et al., 1997), in 
order to reduce the tissues damage due to inappropriate inflammation or autoimmune 
responses during the clearance of the apoptotic cells (Savill & Fadok, 2000). 
Nitric oxide is a cytotoxic and inflammatory molecule which can interact with 
oxygen and superoxide to form RNS can result in DNA damages, mutations and eventually 
leading to carcinogenesis (Ippoushi et al., 2003). Excessive NO production by cells is 
known to be regulated by a number of cytokines. Cytokine, such as interferon-γ (IFN-γ) can 
exert direct NO-stimulatory function on it own (Liew et al., 1991; Sakurai et al., 1996; 
Stuehr & Marletta, 1987; Werner-Felmayer et al., 1990), while other cytokines usually 
provide an additional signal for the activation of NO by IFN-γ (Kmoníčková et al., 2007). 
The levels of NO and cytokines are interdependent, as high level of NO inhibits the 
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secretion of IFN-γ, while low NO concentrations stimulates its secretion (Niedbala, Wei, 
Piedrafita, Xu, & Liew, 1999). 
iNOS plays crucial roles in the sustainable production of NO in macrophage cells 
(Min et al., 2009). High amount of NO generation due to up-regulation of iNOS is 
associated with enhanced secretion of cytokines, such as TNF-α, IL-10 and IL-1. Nuclear 
factor (NF)-κB is known to be the major transcription factor to regulate iNOS gene 
expression (Konkimalla et al., 2010). In un-stimulated cells, NF-κB subunits (p65 and/or 
p50) form a complex with inhibitory factor IκB-α which remained inactive in the cytosol. 
Upon stimulation of pro-inflammatory signals such as LPS, IκB-α is phosphorylated by 
IκB-β kinase (IKK) and become inactive through ubiquitin-mediated degradation. Then, the 
released NF-κB subunits are translocated into the nucleus and acts as transcription factor in 
the LPS-induced iNOS expression in macrophage cells (Guha & Mackman, 2001).  
Two prominent pathways of iNOS inhibitory activity include suppression of iNOS 
gene expression, and direct inhibition of iNOS enzyme activity (Kim et al., 1998). Several 
phytochemicals with NO inhibitory activity have been shown to suppress the induction and 
translocation of NF-κB from the cytoplasm to nucleus (Ko et al., 2005). Since iNOS-
induced NO generation is implicated with the conversion of L-arginine to L-citruline, 
several L-arginine analogs have been reported to be iNOS inhibitors, i.e. N
G
-nitro-L-arginine 
methyl ester (L-NAME), N-iminoethyl-L-ornithine (L-NIO), and N
G
-nitro-L-arginine (L-
NNA) (Kim et al., 1998). In this study, L-NAME was used as the positive control, which 
inhibit NO generation in activated murine macrophages as a results of iNOS inhibition. The 
inhibitory effects of NO in LPS-stimulated RAW 264.7 cells were believed to accompany 
blockage of certain cytokine secretions, particularly TNF-α, as well as the suppression of 
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NF-κB and iNOS activities. However, the NO-related signaling pathway should further 
investigated in order to get a better view of the mechanisms.  
Regulations of NO production and/or iNOS activity are therefore, important 
avenues for cancer therapy and prevention. It is clear that the in vitro screening on NO 
inhibition activity by the selected crude Zingiberaceae extracts may effectively modulate 
the function of activated-macrophage by inhibiting NO production. NO acts as a marker of 
cytokine-stimulatory effects of agents and behave the bidirectional character of NO and 
cytokines interdependency (Kmoníčková et al., 2007). Nonetheless, NO inhibitory effects 
on the functional activation of macrophages, by inflammatory stimuli, have demonstrated 
that the selected Zingiberaceae species as promising anti-inflammatory medicinal plant, 
which are capable of treating macrophage-mediated acute or chronic diseases, such as 
septic shock and rheumatoid arthritis. 
Reports on NO inhibition in LPS-activated macrophage cells have been reported on 
Hibiscus cannabinus. H. cannabinus or commonly known as Kenaf from the Malvaceae 
family has been long used as folk medicine in India and Africa for the treatment of blood 
and throat disorders, bilious condition, fever and puerperium. Studies showed that ethanol 
extract of H. cannabinus fresh leaves dose-dependently inhibited NO generation and 
strongly suppress PGE2 production and COX-II expression in LPS-activated macrophages, 
RAW 264.7 (Lee et al., 2007). The suppression effects of H. cannabinus on pro-
inflammatory mediators (NO and PGE2) in LPS-activated macrophage cells resembled the 
effects of Zingiberaceae extracts in this study.  
Various local vegetables in Malaysia (locally called „ulam‟) such as Melicope 
ptelefolia, Partulaca oleracea, and Persicaria tenella have been reported to exhibit potent 
NO inhibitory activities on LPS-activated macrophage cells, RAW 264.7. Crude methanol 
205 
 
extracts of the leaves from M. ptelefolia, P. oleracea, and P. tenella exerted NO inhibitory 
activities in a concentrations-dependent manner (Abas, Lajis, Israf, Khozirah, & Kalsom, 
2006). The suppression effects of these traditional vegetables on NO production in 
activated RAW 264.7 cells resembled the effects of Zingiberaceae extracts in this study.  
Free radicals liberated from macrophage cells are important in inflammatory 
processes because they are implicated in the activation of NF-κB, which induces the 
transcription of inflammatory cytokines and COX-2. Antioxidants have been shown to be 
able to block the activation of NF-κB effectively through the stabilization of NF-κB/IκB-α 
complex (Abas et al., 2006). Zingiberaceae species, H. cannabinus, M. ptelefolia, P. 
oleracea, and P. tenella contain constituents that can inhibit NO production in activated 
macrophages. All of these plants also exhibited radical-scavenging activities (Abas et al., 
2006; Gosslau & Chen, 2004; Lee at al., 2007; Manson, 2003; Surh & Ferguson, 2003; 
Wei et al., 2005). This study further suggests that local herbs might have beneficial 
chemopreventive effects in addition to providing potential new sources of natural 
antioxidants and NO production inhibitors.  
Nitric oxide assay is regarded as an efficient, economical, and relatively reliable 
method in primary screening for intrinsic immunostimulatory activity of compounds 
through the point of view in cytokine secretion in human cell system. The presented study 
demonstrated that various crude extracts of local Zingiberaceae species exhibited NO 
inhibition activities on LPS-stimulated NO generation in RAW 264.7 cells. Overproduction 
of NO are carcinogenic and therefore, reduction of excessive NO generation using 
phytochemicals are a promising avenue for cancer prevention. The undisputable advantage 
of this screening platform is its sensitivity, general feasibility, low cost, and possibility of 
large scale performance.  
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5.3 Effects of the Zingiberaceae Extracts on MDA-MB-231 Cell Proliferation or  
       Viability 
 Breast cancer is the second leading cause of cancer mortality affecting women in 
both developed and developing countries (Jemal et al., 2007). Current treatments for the 
pathology include excision surgery, chemotherapy, radiotherapy, as well as frequently 
supported by adjuvant chemo- or hormone-therapies (Lin et al., 2009; Tsai et al., 2007). 
Majority of the cases that result in metastasis still relied on conventional therapeutic agents, 
however, the problem of drug resistance in breast cancer has been the major obstacle in 
chemotherapeutic treatment (Tannin-Spritz, Grossman, Dovrat, Gottlied, & Bergman, 
2007). High incidence of mortality is also associated with poor prognosis for the metastatic 
disease, especially in hormone-independent cancer (Bange, Zwick, & Ullrich, 2001; Cuzick, 
Warwick, Pinney, Warren, & Duffy, 2004; Houssami, Cuzick, & Dixon, 2006; Roy, Baliga, 
& Katoyar, 2005). Based on this scenario, a highly metastatic oestroegen-independent 
human breast cancer cells, MDA-MB-231 was opted for this study. Uncontrollable 
proliferations are critical stage in both carcinogenesis and metastasis.   
In carcinogenesis, there are several stages in the formation of cancer cells, which 
involves initiation, promotion, and progression stages. Uncontrollable cell proliferations 
occurred in the promotion stage that cancer cells proliferate massively and transformed into 
malignant cells. Then, malignant cells proliferate and transformed into malignant tumours, 
entering the progression stage. Once the formation of malignant tumours, metastasis occurs. 
Metastasis can be defined as the capability of malignant tumours to detach from the 
primary tumour mass, entering the blood stream or lymphatic channels, followed by 
localization and growth (cell proliferations) of secondary tumour at the new sites. Thus, 
inhibition of cancer cell proliferations is vital prior to the inhibition of metastasis.  
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 Thirty crude Zingiberaceae extracts were tested against oestrogen-independent 
human breast cancer cells, MDA-MB-231 for 48 h using conventional MTT assay. A 
significant dose-dependent anti-proliferative effect (IC50 < 30 µg/mL) has been exhibited 
by 12 (40%) of the extracts, whereas eight (27%) other extracts were inactive (IC50 > 100 
µg/mL) in inhibiting the proliferation or viability of MDA-MB-231 cells. Moreover, 6 
(20%) of the extracts possess IC50 values lower or equal to 10 µg/mL. These extracts were 
petroleum ether and chloroform extracts of A. galanga, petroleum ether and chloroform 
extracts of B. rotunda, chloroform extract of C. domestica, and petroleum ether extract of Z. 
zerumbet. Based on Table 4.3, most of the active ones were petroleum ether and chloroform 
extracts, while methanol extracts were mostly showed no appreciation loss of the cell 
growth.  The only methanol extract with IC50 < 30 µg/mL was methanol extract of C. 
domestica. These Zingiberaceae extracts possess chemopreventive properties as 
demonstrated by their ability to inhibit proliferations of MDA-MB-231 cells. 
Petroleum ether and chloroform extracts of A. galanga exhibited the strongest 
growth inhibition against MDA-MB-231 breast cancer cells, with IC50 values, 2.87 µg/mL 
and 6.19 µg/mL, respectively. Previous phytochemical studies on A. galanga rhizome 
revealed various biological activities among which are antifungal, antibacterial, 
antimycobacterial, antiviral, anticancer, antitrypanosomal (Chappuis et al., 2007). The 
cytotoxicity of A. galanga against highly metastatic breast cancer cells, MDA-MB-231 is 
reported for the first time in this study.  
Rhizomes of B. rotunda was used for treatments such as aphtlous ulcer, dry mouth, 
stomach discomfort, leucorrhea, dysentery, applied in lotions for rheumatism and muscular 
pains (Burkill, 1935). The biological properties of B. rotunda includes antimutagenic, 
antitumor, antibacterial, antifungal, analgesic, antipyretic, antispasmodic, anti-
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inflammatory and insecticidal activities (Cheenpracha et al., 2005). In this study, petroleum 
ether and chloroform extracts of B. rotunda showed strong anti-proliferative activities (IC50 
< 10 µg/mL) on MDA-MB0231 cells. The cytotoxicity of B. rotunda against highly 
metastatic breast cancer cells, MDA-MB-231 is also reported for the first time in this study.  
 Previous phytochemical studies of C. domestica extracts from the rhizome revealed 
the presence of turmerin (a water-soluble peptide), essential oils (e.g. turmerones, 
atlantones and zingiberene), and curcuminoids (e.g. curcumin). Curcumin has been reported 
as the most active constituents with numerous biological activities such as antioxidant, anti-
inflammatory and cancer chemotherapeutic properties. Curcumin has been shown to exhibit 
growth inhibitory effects in vitro in cancer cell lines derived from human prostate, large 
intestine, bone, leukaemia, and breast. It also been reported to induced apoptotic cell death 
by cell cycle arrest in the S and G2/M phases in the MCF-7 human breast tumour cell line 
(Sharma et al., 2005). In the present study, petroleum ether, chloroform and methanol 
extracts of C. domestica showed pronounce inhibitory effects (IC50 < 20 µg/mL) on MDA-
MB-231 breast cancer cells. These results are in good agreement with those previously 
reported studies concerning the anticancer activities in vitro against breast cell lines derived 
from malignant tumours (Aggarwal, Kumar, & Bharti, 2003; Sharma et al., 2005). 
 Zerumbone was identified as the main component in the volatile oils extracted from 
the rhizome of Z. zerumbet (Kitayama et al., 1999). Zerumbone had been reported to 
possess various biological properties such as anti-inflammation, anti-carcinogenesis, anti-
proliferative, and anti-HIV activities (Dai et al., 1997). In this study, petroleum ether 
extract of Z. zerumbet exerted pronounce anti-proliferative effects (IC50, 7.46 µg/mL) 
against MDA-MB-231 breast cancer cells. The anti-proliferative effects on MDA-MB-231 
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cells could be due to the presence of zerumbone, the major compound in the volatile oils 
extracted using petroleum ether solvent. 
 All of these data suggested that extracts from the selected Zingiberaceae species, 
especially A. galanga, B. rotunda, C. domestica, and Z. zerumbet deserved further 
investigations in order to determine secondary metabolites with cytotoxic properties. The 
selected extracts obtained from these species were subjected for in vitro toxicity study on 
human lung fibroblast cells, MRC-5 (Section 5.4) in order to determine their promising 
values to be recommended for future studies such as isolation, in vivo, preclinical and 
clinical investigations. 
 
5.4 Cytotoxicity of the Zingiberaceae Extracts on MRC-5 Cells 
Cytotoxicity tests against cancer cell lines are the most common screening methods 
employed in the search for new anticancer drugs. Cytotoxicity assays currently applied in 
the developmental stages of anticancer drug are able to reveal compounds with the highest 
cytotoxic activity, but are not predictive of their potential toxicity (Popiolkiewicz et al., 
2005). Based on the scenarios, appropriate selection of the preliminary screening tests are 
substantially in order to obtain the desired active substance for preclinical and clinical 
studies.  
In the drug discovery process, toxicity studies are usually conducted on animals 
before clinical trials. The disadvantages of performing toxicity study right before clinical 
examination are time-consuming, expensive and require a large number of animals for the 
experiment (Popiolkiewicz et al., 2005). In addition, there is always high possibility that 
the active substance is highly toxic in vivo. Thus, it is better to select the least toxic 
compounds among the active ones using in vitro toxicity assay at the primary screening 
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stage. Besides that, cell lines can be obtained easily obtained from ATCC, which is another 
advantage of performing in vitro toxicity studies. 
In the present study, conventional MTT assay was utilized as the in vitro toxicity 
assay using human lung fibroblast cell line (MRC-5). Assessment of the extracts‟ cytotoxic 
activity against cancer cell line must be conducted prior to the toxicity test. Based on the 
results obtained from cell proliferation and viability assay (a cytotoxicity assay) using 
MDA-MB-231 cells, six most active extracts with IC50 10 µg/mL or less were selected for 
toxicity testing. This was especially important that the cytotoxic activity of the tested 
extracts between MDA-MB-231 human breast cancer cells and normal, non-tumourigenic 
MRC-5 human lung fibroblast cells were compared.  
 A special parameter, known as selectivity index (SX) was applied in order to assess 
the selectivity of tested compounds towards tumour cells (Popiolkiewicz et al., 2005). In 
this context, SX is defined as IC50 value obtained for MDA-MB-231 cells expressed as a 
percent of that of IC50 value from the test using MRC-5 cells. It acts as an objective 
indicator which enables evaluation of selectivity of the tested extracts between cancerous 
and non-cancerous cell lines. The SX value above 100 indicates that the cytotoxic effect of 
tested substance is greater towards cancer cells. The SX value of 100 or below would 
suggest that the tested concentration of the substance for achieving therapeutic effect is 
similar to or lower than the concentration causing toxic effects to normal cells. Therefore, 
the most promising substances for development of anti-cancer drug would have SX values 
distinctly higher than 100 (Popiolkiewicz et al., 2005). Thus, extract with SX value more 
than 100 were no doubt to hold a great promise for further studies.  
Conventional MTT assay is a simple, robust and relatively inexpensive test. It is a 
very efficient and applicable method for selection of the most appropriate substance for 
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further studies. The testing of the extracts in seven concentrations and incubating cells with 
tested extracts were carried out for 48 h rather than 24 h because prolonged incubation time 
(48 h) was recommended to provide comparable experimental conditions to the standard 
cytotoxicity test (Monks et al., 1991). This was especially important as to compare tested 
extracts between human breast cancer cells, MDA-MB-231 and normal, non-tumorigenic 
human lung fibroblast cells, MRC-5, because cytotoxicity test on the latter was conducted 
for 48 h. 
 Assessment of the toxicity revealed that the most active extract against proliferation 
and viability of human breast cancer cells, MDA-MB-231 cells – crude petroleum ether 
extract of Alpinia galanga was equally cytotoxic against normal human lung fibroblast cells, 
MRC-5 (SX = 100), and that such extract can be excluded for further testing. Five other 
tested Zingiberaceae extracts with SX values distinctly higher than 100, have raised their 
possibility to serve as a new, active, but less toxic group of potential anticancer agents. This 
approach will facilitate appropriate estimation of the effective dose for toxicity tests on 
animals in the subsequent stage of drug development process. Obviously, this method can 
definitely reduce the number of animals required for in vivo testing and reducing the costs. 
 
5.5 Effects of the Zingiberaceae Extracts on Migration of MDA-MB-231 Cells 
Breast cancer accounts for approximately 20% mortality in the world, and 76% of 
all breast tumours have been categorized as invasive breast cancers. Breast tumours are 
capable of metastasis to local lymph nodes as well as to organs such as bone, lung and liver 
(Shanmugaraj et al., 2010). Metastasis is a complex and multi-steps process which involves 
cell adhesion, invasion and motility (Chu et al., 2007; Lee et al., 2008). Therefore, 
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interruption at one or more of these points is an important approach for anti-metastatic 
therapy.  
In the present study, anti-migration activities of 30 crude Zingiebraceae extracts 
were examined on MDA-MB-231 cells, a highly metastatic human breast carcinoma cells 
using scratch wound assay. Cells were seeded into six-well plate and cultured to confluence. 
A wound was scratch along the diameter of each well using 200 µL-pipette tip. The 
wounded cell monolayer was incubated with and without (negative control) Zingiberaceae 
extract in 1%-serum media for 48 h at 37ºC, with 5% CO2. The assay was used because the 
ability of tumour cells to migrate is closely associated to their metastatic potentiality.  
In vitro methods for cell migration study usually use system with 2D surfaces. In 
vitro 2D cell migration assays are prominently utilized because it is easy to be handled for 
screening tests that usually involve a large number of samples, which leads to the high 
statistical reliability of the results obtained (Entschladen et al., 2005). However, 2D model 
is inadequate since cell migration in organism or in vivo is a 3D system, which is more 
complicated. Nevertheless, 2D assays as applied in the present study are already very useful 
and appropriate for fundamental understanding of cell migration processes.  
Scratch wound assay involves both cell migration and proliferation (Hayot et al., 
2006; Peng et al., 2006), which means that anti-migration activity observed may 
accompanied by anti-proliferative activity. In this assay, 1% FBS DMEM was used as to 
reduce the possibilities to the minimum that the observed wound closure was due to cell 
proliferation. All of the Zingiberaceae extracts tested except methanol extract of Curcuma 
aeruginosa significantly inhibited migration of MDA-MB-231 human breast cancer cells. 
Several Zingiberaceae extracts exhibited anti-migration activities despite being in 
inhibiting proliferation of MDA-MB-231 cells. These extracts were methanol extracts of A. 
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galanga, C. mangga, Z. montanum, Z. officinale, and Z. zerumbet; as well as petroleum 
ether extract of C. mangga, and K. galanga. 
The pathological migration of tumour cells is a crucial event in tumour progression 
for tumour spreading, invasiveness and metastasis (Entschladen et al., 2004; Feldner & 
Brandt, 2002). Invasion of tumour cells occurs initially by interacting with extracellular 
matrix (ECM), through the process of cell matrix adhesion. When the tumour transform to 
malignant tumour and detach from the primary tumour mass, they attack the surrounding 
basement membranes (BMs) in order to adhere to its meshwork of connective tissues, eg., 
Type IV collagen, laminin, and fibronectin (Pignatelli & Stamp, 1995). 
The BM is the largest barrier between malignant cells and the bloodstream. The 
connectives tissues associated with vascular BMs must be degraded before the malignant 
tumours can penetrate it into the blood circulating system (Stetler-Stevenson, Aznavoorian, 
& Liotta, 1993; Yu, Hewitt, Kleiner, & Stetler-Stevenson, 1996). Once the malignant cell 
traversed the BMs to enter the bloodstream, dispersion of malignant tumours starts to occur 
extensively within the body (Liotta et al., 1980). Obviously, invasion of malignant tumours 
through BM is a critical step for the occurrence of metastasis (Chen & Thompson, 2003).  
Cell motility is another crucial characteristic of cancer cells in which migration of 
the cells from primary sites to secondary organ occurs. Sequence of events occur in cell 
migration process include membrane protrusion (lamellipodia or filopodia), adhesion to 
ECM, cell body translocation, and tail retraction. Hundreds of proteins inside and outside 
the cell are controlling these processes which imply actin dynamics. Therefore, proteins 
involves in cell motility are important targets for the development of anti-cancer drugs 
(Fenteany & Zhu, 2003; Giganti & Friederich, 2003; Rao & Li, 2004).  The results revealed 
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that crude Zingiberaceae extracts (except methanol extract of Curcuma aeruginosa) could 
reduce the migration of MDA-MB-231 cells. 
The mechanism by which Zingiberaceae inhibits cell migration is not yet clear. 
However, it has been well documented that breast cancer cells secrete matrix 
metalloproteinases (MMPs), which promote cancer progression by boosting cancer cell 
growth, invasion, and migration (Kohn & Liotta, 1995; Lee et al., 2008). MMPs are a 
family of zinc-dependent enzymes which consists of propeptide, catalytic, hinge and 
COOH-terminal domains. In order to function, MMPs require catalytic removal of the 
propeptide domain (Kohn & Liotta, 1995). 
Involvement of multigene family of zinc-dependent endopeptidases of MMPs, 
particularly MMP-2 and MMP-9 in the aspect of cell-migration have been studied 
prominently. MMP-2 and MMP-9 are unique because of the inclusion of three fibronectin 
Type II repeats within their catalytic domain (Kohn & Liotta, 1995). MMP-2 and MMP-9 
play a crucial rule in proteolytic degradation of ECM for regulating cancer cell migration 
process (Chena, Hsieh, Chiou, & Chub, 2005). In addition, overexpression of MMP-2 and 
MMP-9 stimulates angiogenesis, which speeds up cancer metastasis. Thus, new drug 
development by targeting this pathway is also an important approach to control cancer 
metastasis.  
Anti-migration and anti-proliferation activities against MDA-MB-231 breast cancer 
cells have also been observed in other plants such as Plumbago zeylanica from the Family 
of Plumbaginaceae. P. zeylanica is a common household plant remedy for diarrhea in India. 
(Shanmugaraj et al., 2010). The major constituents in P. zeylanica include naphthoquinones, 
steroids, sugars, napththalenones, alkanes, triterpenes and amino acids (Veluri & Diwan, 
1999). The study showed that P. zeylanica methanolic extract (PME) and its pure 
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compound, 3β-hydroxylup-20(29)-ene-27,28-dioic acid (PZP) were observed to effectively 
inhibit cell migration and proliferation of MDA-MB-231 breast cancer cells by regulating 
the expression of MMPs by inhibiting MMP-2 and MMP-9 secretion (Shanmugaraj et al., 
2010). In this light, investigation on the mechanism of active Zingiberaceae extracts against 
the migration of MDA-MB-231 cells can be conducted by targeting the expression of 
MMP-2 and MMP-9 using gelatin zymogen and immunoblot analysis.  
Some studies on anti-migration activity against MDA-MB-231 breast cancer cells 
using natural products have been reported. One of them is Citrullus colocynthis L. from the 
Family of Curcubitaceae. C. colocynthis is commonly known as Sherry or Handal, is used 
in folk people in rural areas as purgative, anti-rheumatic and used as the remedy for skin 
infections. Based on the studies, cucurbitacin glucosides isolated from C. colocynthis 
showed anti-migration and anti-proliferative activities against MDA-MB-231 breast cancer 
cells (Tannin-Spitz et al., 2007). Besides that, Sanguinarine, a benzophenanthridine 
alkaloid derived from the root of Sanguinaria canadenisis was reported to inhibit 
metastasis and invasion of MDA-MB-231 breast cancer cells (Choi et al., 2009). Anti-
migration effects of P. zeylanica, C. colocynthis and S. canadenisis resemble the anti-
migration effects of Zingiberaceae extracts in this study using scratch wound assay. This 
again reveals the potentiality of local herbs for anti-cancer researches especially for 
combating highly metastatic breast cancer. 
Cell migration is a multifactorial process, providing multiple targets for new drug 
development in order to control the metastasis activity (Sabe, 2003). To date, the present 
study is the first to demonstrate that varieties of local Zingiberaceae species can 
significantly inhibit metastatic process of MDA-MB-231 human breast cancer cells. Cancer 
metastasis is a complex process and therefore multi-assay strategies are needed to obtain 
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maximum benefit from the screening of anti-migration drugs in order to identify the 
potential compounds. 
 
5.6 Qualitative Analysis Using Thin-layer Chromatography 
Thin-layer chromatography is a useful form of chromatography which is widely 
used to identify chemical groups present in a crude extract. In this experiment, the crude 
extract was applied as a narrow, horizontal line on the TLC plate rather than a circular spot 
in order to enable the eyes to more easily distinguish substances that run very close together 
on the chromatogram. Although some components of the extracts may be coloured and can 
be observed at daylight, most of them have little or no colour and thus, use of UV lights 
and chromogenic or fluorogenic spray reagents were applied to make them visible.  
The constituents of natural products are either fluorescent (i.e. emit visible light 
when expose to UV light) or absorb UV light (i.e. observed as a dark area when exposed to 
UV light). Layer fluorescing at 254 nm and 365 nm (Houghton & Raman, 1998) were used 
in this experiment. Besides exposure to UV lights and iodine vapour, a few spray reagents 
(i.e. sulphuric acid reagent, Dragendorff‟s reagent, and vanillin/sulphuric acid reagent) 
were applied to make the colourless substance appeared to be coloured. Since the 
constituents present in the crude extracts were unknown, the used of reagents containing 
sulphuric acid is recommended (Houghton & Raman, 1998) as it oxidizes many compounds 
to give coloured derivatives on heating. 
Three crude Zingiberaceae extracts subjected for TLC tests were petroleum ether 
extract of Z. zerumbet, chloroform extracts of A. galanga and C. domestica. Crude 
petroleum ether extract of Z. zerumbet was found to be the most promising extract in 
modulating activated macrophages, RAW 264.7 by suppressing NO generation. Based on 
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the previous studies, volatile oils of the rhizomes contain zerumbone, humulene, and 
camphene (Nhareetsomchit & Nurshukriyah, 2003). The major component of the rhizomes 
is zerumbone (2,6,10-cycloundecatrien-1-one, 2,6,9,9-tetramethyl-, (E,E,E)-), which is a 
monocyclic sesquiterpene containing cross-conjugated dienone system (Kitayama et al., 
1999; Kitayama et al., 2002). Qualitative analysis of this extract using TLC indicated that 
47% of the compounds detected were terpenoids.  
In the correlation of the current TLC results and the previous studies, the resoluted 
compound of crude petroleum ether extract of Z. zerumbet, (Z11, Rf = 0.68) (Table 4.9) 
contains conjugated double bonds and belongs to terpenoids group, which apparently 
compatible with the characteristic of zerumbone. Sesquiterpene zerumbone has been 
studied for various biological activities including anti-carcinogenesis (Takada, Murakami, 
& Aggarwal, 2005) and anti-inflammation (Elliott & Brimacombe, 1987; Murakami et al., 
2003). Crude petroleum ether extract of Z. zerumbet exerted prominent effects in NO 
inhibitory activity in activated macrophages RAW 364.7 cells, anti-proliferative (IC50 = 
7.46) and anti-migration (MCA = 1.63 × 10
-3
 mm/h tested at 12.5 µg/mL for 48 h) activities 
against oestrogen-independent human breast cancer cells, MDA-MB-231. Most of the 
biological activities may probably due to the presence of major component, zerumbone 
(Takada et al., 2005). 
On the other hand, crude chloroform extract of A. galanga was selected as one of 
the potent extract for further studies because of its prominent effects in anti-proliferative 
(IC50 = 6.19 µg/mL) and anti-migration (MCA = –8.02 × 10
-4
 mm/h tested at 12.5 µg/mL 
for 48 h) activities against MDA-MB-231 cells. Results of the TLC test (Table 4.7) showed 
that two compounds (A2, Rf = 0.15 and A7, Rf = 0.63) belonging to the terpenoids group 
and one compound (A10, Rf = 0.75) belonging to the phenol group were detected. Most of 
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the compounds detected contain conjugated double bonds and/or double bonds.  Some 
works on isolating compounds form the rhizome of A. galanga have been carried out and 
published. The main compounds found in the rhizome are phenylpropanoids, and most 
abundantly of which are 1‟S-1‟-acetoxychavicol acetate (Chappuis et al., 2007), 1‟S-1‟-
acetoxyeugenol acetate (Laguna, 2003), and p-coumaryl diacetate (Desjeux, 2001) etc. 
Most of the biological activities such as antifungal, antibacterial, antimycobacterial, 
antiviral, anticancer, antitrypanosomal etc are due to the presence of phenylpropanoids 
(Kaur et al., 2010).  
Crude chloroform extract of C. domestica was found to be the second best extract in 
anti-migration activity (MCA = 1.35 × 10
-4
 mm/h tested at 12.5 µg/mL for 48 h) against 
MDA-MB-231 cells. Even though it does not rank as the best extract for any of the 
screening tests, it exerted potent effects in all of the screening tests carried out in this study. 
Based on the TLC test results (Table 4.8), the compounds detected were mainly organic 
compounds with conjugated double bonds. One of the resoluted compounds (C6, Rf = 0.66) 
detected interestingly showed positive results for all of the detection systems used in the 
TLC.  
The rhizome of C. domestica consists of turmerin (a water-soluble peptide), 
essential oils (e.g. turmerones, atlantones and zingiberene) and curcuminoids including 
curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] (Sharma et al., 
2005). Curcuminoids are phenolic compounds derived from turmerics, and curcumin 
commonly called diferuloylmethane is a hydrophobic polyphenol, which is generally 
regarded as the most active constituents of the rhizome of C. domestica (Anand et al., 
2008). Curcumin has been widely studied over the past three decades. It possesses 
antioxidant, anti-inflammatory, cancer chemopreventive and potentially chemotherapeutic 
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properties (Anand et al., 2008; Sharma et al., 2005). The effects of crude chloroform 
extract of C. domestica in NO inhibition, anti-proliferative, and anti-migration activities in 
this study are strongly thought to be due to presence of the active constituents. 
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CHAPTER 6 
6.0 Conclusion  
Scientific knowledge in immunomodulatory and anti-metastatic aspects of 30 crude 
Zingiberaceae extracts obtained from ten local Zingiberaceae species have been studied 
using in vitro screening tests. In the immunomodulatory aspect, NO assay was applied as to 
evaluate their potentials as an immunomodulator in suppressing NO generation in activated 
macrophage cells, RAW 264.7. In the anti-metastatic aspect, their anti-proliferative and 
anti-migration potentials against highly metastatic hormone-independent human breast 
cancer cells, MDA-MB-231 were evaluated using conventional MTT assays and Scratch 
wound assay.  
 Based on the results obtained in NO assay, 29 of the Zingiberaceae extracts showed 
NO inhibitory activity of various intensities at 1.56–100 µg/mL. Among these extracts, 19 
exerted strong NO inhibitory activity (IR > 70%) at various concentrations. Potential 
candidates were crude petroleum ether extract of A. galanga and Z. zerumbet, both exerting 
more than 75% of NO inhibitory activities at a low concentration. Overproduction of NO 
causes DNA mutation, protein modification, and thereby cellular damages which result in 
carcinogenesis. Besides that, carcinogenesis related to chronic inflammation caused by 
bacterial or viral infection in certain organs might be due to excessive and prolonged 
oxidative insults of macrophages. Based on this scenario, the tested Zingiberaceae extracts 
were good candidate as an immunomodulator which can effectively modulate macrophage 
functions by suppressing the overproduction of NO. 
In the anti-metastatic aspects, substance which possesses anti-proliferative activity 
is important to inhibit cancer metastasis. The screening test on anti-proliferative potentials 
by the Zingiberaceae extracts showed that 12 of them (IC50 < 30 µg/mL) could be 
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considered for further purifications based on the criteria adopted from the American 
National Cancer institute. Six of them (IC50 < 10 µg/mL) exhibited pronounce anti-
proliferative effects against MDA-MB-231 cells. These six most potential extracts were 
crude petroleum ether and chloroform extracts of A. galanga, crude petroleum ether and 
chloroform extracts of B. rotunda, crude chloroform extract of C. domestica, and crude 
petroleum ether extract of Z. zerumbet. The strongest cytotoxicity activity was detected for 
the petroleum ether extract of A. galanga. 
In the process of searching anti-cancer drug from natural products, assessment of 
their potential toxicity is vital in order to select the least toxic extracts among the active 
ones. In vitro toxicity test with the application of selectivity index (SX) enabled the 
selection of the most desirable extracts for further optimization. Five other extracts were 
showed to be more prone to kill cancerous cells than non-cancerous cells (SX > 100), and 
are therefore potential for further testing. 
Then, anti-migration effects of the Zingiberaceae extracts against MDA-MB-231 
cells were evaluated. The most effective extracts screened were crude petroleum ether and 
chloroform extracts of A. galanga, crude chloroform extract of C. domestica, and crude 
petroleum ether extract of Z. zerumbet. Crude chloroform extracts of A. galanga and C. 
domestica; as well as petroleum ether extract of Z. zerumbet which effectively inhibited or 
slowed down the migration of MDA-MB-231 cells, were previously showed to be the 
promising candidates in NO inhibition and anti-proliferative activities as well. 
As a conclusion, this was the first report demonstrating that varieties of local 
Zingiberaceae species were potent inhibitor of NO generation in activated macrophages, 
and also act as potent agents in anti-proliferative and anti-migration of highly metastatic 
human breast cancer cells, MDA-MB-231. It is needless to say that extended researches on 
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isolation and identification of the active compound, as well as the evaluation of their 
chemopreventive potential in vivo are necessary in order further affirm their biological 
activities. 
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APPENDIX I: PREPARATION OF DILUENTS AND REAGENTS 
 
1.0 Preparation of Diluents and Reagents 
 Preparation of diluents and readgents for NO assay, Cell Proliferation and Viability 
assay, Cytotoxicity assay and Scratch Wound assay are shown in Section 1.1.1 – 1.1.4.  
 
1.1.1 Diluents and Reagents for Nitric Oxide Assay 
 (a) Trypan Blue 
Trypan Blue is the stain most commonly used in distinguishing viable and 
nonviable cells. Viable cell excludes the dye, while nonviable cell absorbs the dye and 
appear blue under the haemocytometer. Trypan Blue solution (0.4%) needed for cell count 
was prepared by adding 0.2 g of Trypan Blue (Sigma, USA) powder to 50 mL of distilled 
water (dH2O). It was kept at room temperature. 
(b) Lipopolysaccharide  
Lipopolysaccharide (LPS) was used as the inducer of NO generation in RAW 264.7 
cell. LPS from Escherichia coli strain Serotype 055:B5 (Sigma, USA) was reconstituted 
with basic Dulbecco‟s Modified Eagle‟s Medium (DMEM) with phenol red (Sigma, USA), 
containing high glucose of 4500 mg/mL, L-glutamine, HEPES (Bio Basic, Canada) and 
sodium bicarbonate (NaHCO3) (AnalaR, England) at 12.5 mg/mL. It was frozen at –80°C 
in aliquots of 20 µL. 
(c) Diluents 
Three types of diluents, namely diluent A, diluent B and diluent C were prepared. 
The diluents were tissue culture media with or without dimethyl sulfoxide (DMSO) (Sigma, 
USA). Diluent A was prepared by adding DMEM without phenol red (Kimberly, USA), 
with HEPES and L-glutamine with 5% heat-inactivated fetal bovine serum (FBS) (PAA 
Laboratories GmbH, Australia), and 0.2% DMSO. Diluent B was prepared by adding 
DMEM without phenol red, with HEPES and L-glutamine with 5% heat-inactivated FBS. 
Diluent C was prepared by mixing 4980 µL of diluent B with 20 µL of LPS which gave the 
final concentration of LPS, 10 µg/mL. Diluent A and diluent B were stored at 4°C in the 
refrigerator, whereas diluent C was prepared fresh immediately before used. 
(d) N-nitro-L-arginine methyl ester hydrochloric 
N-nitro-L-arginine methyl ester hydrochloric (L-NAME) is an NOS inhibitor. In 
order to obtain L-NAME of final concentration, 250 µM in 0.2% DMSO, 1 mg of L-NAME 
(Sigma, USA) was mixed with 7.4 mL of diluent A. The prepared reagent was kept in a 15 
mL centrifuge tube (Orange Scientific, Belgium) wrapped with aluminum foil as it was 
light sensitive. It was kept at 4°C in the refrigerator. 
(e) Griess reagent 
Griess reagent (100 mL) was prepared by mixing 2.5% phosphoric acid (H2PO4) 
(Sigma, USA) (3 mL of 85% H2PO4 was dissolved in 97 mL deionized water), 1% 
sulphanilamide (Sigma, USA) (0.1 g of sulphanilamide was dissolved to 10 mL of 2.5% 
H2PO4), and 0.1% naphthy ethylene diamine dihydrochloride (Sigma, USA) (0.01 g of 
naphthyl ethylene diamine dihydrochloride was dissolved in 10 mL of 2.5% H2PO4). Griess 
reagent was prepared fresh immediately before use.  
 
1.1.2 Diluents and Reagents for Cell Proliferation and Viability Assay  
Two types of diluents, namely diluent A, diluent B were prepared. The diluents 
were tissue culture media with or without DMSO. Diluent A was prepared by adding 
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DMEM with phenol red, containing high glucose of 4500 mg/mL, L-glutamine, HEPES, 
and sodium bicarbonate, supplemented with 10% heat-inactivated FBS, 2% penicillin-
streptomycin, 1% amphotericin B, and 0.2% DMSO. Diluent B was prepared by adding 
DMEM with phenol red, containing high glucose of 4500 mg/mL, L-glutamine, HEPES, 
and sodium bicarbonate, supplemented with 10% heat-inactivated FBS with 2% penicillin-
streptomycin and 1% amphotericin B. Diluent A and diluent B were stored at 4°C. 
 
1.1.3 Diluents and Reagents for Cytotoxicity Assay 
Two types of diluents, namely diluent A, diluent B were prepared. The diluents are 
tissue culture media with or without DMSO. Diluent A was prepared by adding Minimum 
Essential Medium Eagle (MEM) with phenol red (Sigma, USA), containing L-glutamine, 
HEPES, sodium bicarbonate, and sodium pyruvate supplemented with 10% heat-
inactivated FBS, 2% penicillin-streptomycin, 1% amphotericin B, and 0.2% DMSO. 
Diluent B was prepared by adding MEM with phenol red, containing L-glutamine, HEPES, 
sodium bicarbonate, and sodium pyruvate supplemented with 10% heat-inactivated FBS 
with 2% penicillin-streptomycinand 1% amphotericin B. Diluent A and diluent B were 
stored at 4°C. 
 
1.1.4 Diluents and Reagents for Scratch Wound Assay 
Two types of diluents, namely diluent A, diluent B were prepared. The diluents 
were tissue culture media with or without DMSO. Diluent A was prepared by adding 
DMEM with phenol red, containing high glucose of 4500 mg/mL, L-glutamine, HEPES, 
and sodium bicarbonate, supplemented with 1% heat-inactivated FBS, 2% 
penicillin/streptomycin, 1% amphotericin B, and 0.2% DMSO. Diluent B was prepared by 
adding DMEM with phenol red, containing high glucose of 4500 mg/mL, L-glutamine, 
HEPES, and NaHCO3, supplemented with 1% heat-inactivated FBS, 2% penicillin-
streptomycin and 1% amphotericin B. Diluent A and diluent B were stored at 4°C. 
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APPENDIX II: CELL CULTURE PROTOCOL 
1.0 Preparation and Sterilization  
1.1 Preparation and Sterilization of Apparatus and Liquids 
All stocks of chemicals and glassware used in cell culture works were labeled and 
reserved for that purpose alone. All apparatus, liquids and reagents must be sterilized in 
order to come in contact with cultures. Methods of sterilization include dry heat, moist heat 
or autoclaving, irradiation, chemical, and filtration. The choice of sterilization methods 
depend mainly on the stability of the items at high temperature. Sterilization methods that 
were applied during the research was on-going were stated in Table 1.1. 
 
Table 2.1: Methods of sterilization and the limitations (Freshney, 2005) 
Methods Conditions Materials Limitations 
Dry heat 180°C, 2 h Heat stable: metals and 
glass. 
Some carrying may 
occur, e.g., of 
indicating tape and 
cotton plugs. 
 
Moist heat 121°C, 20 min Heat-stable liquids: 
water, salt solutions, 
autoclaveable media. 
Moderately heat-stable 
plastics: silicones, 
polycarbonate, nylon, 
polypropylene. 
 
Steam penetration 
requires steam-
permeable 
packaging. Large 
fluid loads need time 
to heat up. 
Irradiation: 
Short wave UV 
254 nM, 50–100, 
30 min  
Flat surfaces, circulating 
air. 
Will not reach 
shadow areas. Spore 
resistant. 
 
Filtration 0.1- to 0.2µm 
porosity 
All aqueous solutions; 
particularly suitable for 
heat-labile reagents and 
media. 
Not suitable for some 
solvents, e.g., 
DMSO. Slow with 
viscous solutions. 
 
 
1.1.1 Apparatus 
Non-sterile apparatus such as glassware and recyclable plastic were rinsed with tap 
water and soaked in cell culture 7X detergent (Culture Lab, Australia) overnight. After 
soaking for one day, the apparatus were brushed with bottle brush to scrub out the residues. 
Then, they were rinsed thoroughly with four changes of tap water followed by three 
changes of dH2O. After rinsing thoroughly, the apparatus were dried in drying oven 
(Memmert) at 45–50°C. After drying, bottles were loosely capped with screw caps 
(loosened one complete turn); the mouth of open mouthed glassware such as beakers were 
wrapped with aluminum foil; whereas recyclables plastic such as syringe without needle, 
centrifuge tubes and microtubes were packed in plastic bag for autoclaving. The apparatus 
were sterilized using the appropriate methods as stated in Table 1.2. 
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Both glass and plastic pipettes were used in cell culture work. Plastic pipettes 
(Orange Scientific, Belgium) were bought sterile and could be only used once. Glass 
pipettes were reusable, therefore must be washed carefully in order to remove all retained 
residues. Glass pipettes were rinsed immediately with tap water and soaked in cell culture 
7X detergent overnight after usage. Then, they were rinsed in tap water a few times 
followed by three changes of dH2O. After that, the pipettes were transferred to drying oven 
and dried with tips uppermost. Dried pipettes were sorted by size and stored dust free for 
sterilization. The pipettes were placed in appropriate pipette canisters according to their 
size and dry heat at 180°C for 2 h. 
 
Table 2.2: Sterilization of equipment and apparatus (Freshney, 2005) 
Item Sterilization 
Ampoules for freezer, glass Dry heat
1
 
Ampoules for freezer, plastic Autoclave
2
, but usually bought sterile 
Apparatus containing glass and silicone tubing Autoclave 
Disposable tips for micropipettes Autoclave in autoclavable dispensers 
Filter, reusable Autoclave 
Glassware Dry heat 
Glass bottles with screw caps Autoclave with cap slack 
Instruments Dry heat 
Magnetic stirrer bars Autoclave 
Pasteur pipettes, glass Dry heat 
Pipettes, glass Dry heat 
Screw caps Autoclave 
Silicone tubing Autoclave 
Stoppers, rubber and silicone Autoclave 
1
Dry heat, 180°C for 2 h 
2
Autoclave, 121°C for 20 min 
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Figure 2.1: Sterilizing Oven. Dry heat sterilization of pipettes is carried out at 180°C for 2 
hours. 
 
 
 
Figure 2.2: Pipette canisters were placed with spaces between to allow circulation of hot 
air in the sterilizing oven. 
 
1.1.2 Liquids 
Sterile liquids could be obtained through moist heat sterilization and filtration 
depend the characteristics. Heat-stable liquids such as water or dH2O, salt solutions or PBS, 
and some specially formulated media can be sterilized using moist heat sterilization or 
autoclaving. On the other hand, heat-labile liquids such as cell culture media can be 
sterilized by micropore filtration, which may be by positive pressure, through different 
ranges of filter sizes, or by negative pressure using a vacuum flask with filter attached. The 
sterilization methods for various reagents and media were showed in Table 1.3. On the 
whole, most reagents were sterilized through filtration if they are heat labile, and by 
autoclaving if they were heat-stable. 
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Figure 2.3: Autoclave. Heat-stable liquids such as distilled water and phosphate buffer 
saline used for cell culture works are sterilized by autoclaving. 
 
 
 
Figure 2.4: Reusable filter. Polypropylene, in line, Luer fitting or known as swinnex. 
 
Figure 2.5: Disposable Sterilizing Filter. Sartorius 25-mm sterile syringe filter with 
0.2µM pore size. 
 
 
 
 
 
249 
 
Table 2.3: Sterilization of liquids and the storage conditions (Freshney, 2005) 
Solution Sterilization Storage 
Agar Autoclave
1
 or boil Room temperature 
Amino acids Filter
2
 4°C 
Antibiotics Filter – 20°C  
Bacto-peptone Autoclave Room temperature 
Bovine serum albumin Filter (used stacked filters) 4°C 
Carboxymethyl cellulose Steam, 30 min 4°C 
Collagenase Filter – 20°C 
DMSO Self-sterilizing, dispense into 
aliquots in sterile centrifuge 
tubes 
Room temperature; 
keep dark, avoid 
contact with rubber 
or plastics (except 
polypropylene) 
EDTA Autoclave Room temperature 
Glucose, 20% Autoclave Room temperature 
Glucose, 1–2%  Filter (low concentrations; 
caramelizes if autoclaved) 
Room temperature 
Glutamine Filter – 20°C 
Glycerol Autoclave Room temperature 
Growth factors Filter (low protein binding) – 20°C 
HEPES Autoclave Room temperature 
HCL, 1 M Filter Room temperature 
Lactalbumin hydrolysate Autoclave Room temperature 
Methocel Autoclave 4°C 
MTT Filter 4°C 
NaHCO3 Filter Room temperature 
NaOH, 1 M Filter Room temperature 
Phenol red Autoclave Room temperature 
Salt solutions  
(without glucose) 
Autoclave  Room temperature 
Serum Filter; use stacked filters – 20°C 
Sodium pyruvate, 100 mM Filter – 20°C 
Transferrin Filter – 20°C 
Tryptose Autoclave Room temperature 
Trypsin Filter – 20°C 
Vitamines Filter – 20°C 
Water Autoclave Room temperature 
1
Autoclave, 121°C for 20 min 
2
Filter, 0.2-µm pore size 
 
1.2 Preparation and Sterilization of Media 
1.2.1 Basic DMEM medium 
One bottle of DMEM powder with phenol red, high glucose of 4500 mg/mL, L-
glutamine, without sodium bicarbonate (10.4 g/L) (Sigma, USA) was used to make 1L of 
basic media. DMEM powder must be stored between 4–6°C. Sterile distilled water (1L) 
was added to a sterile Graduated Erlenmeyer flask with capacity and head space, IL. The 
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flask was placed on a magnetic stirrer (Thermolyne) which was set to 200 rpm, and a 
magnetic stirrer bar was added to the medium and started stirring.  
One bottle of DMEM powder was opened and the contents were added slowly to 
the flask while mixing. Next, 2 g of sodium bicarbonate (NaHCO3) (AnalaR, England) and 
0.5206 g of HEPES (Bio Basic, Canada) were added to the medium while mixing as well. 
The powder form was stirred until completely dissolved. The pH of the medium was 
adjusted with hydrochloric acid (HCl) solution to pH 7.4 using the pH Meter (Thermo). 
When all of the constituents were completely dissolved, the magnetic stirrer bar was 
removed and the flask was brought to the biohazard hood (Escco Class II Biohazard Safety 
Cabinet) immediately for sterilization. The medium was filtered through autoclaved 
swinnex (Figure 1.4) into a sterile laboratory bottle. Sterile medium in the bottle was stored 
at 4°C in the refrigerator (Whirlpool). 
 
 
Figure 2.6: Escco Class II Biohazard Cabinet. A Class II biohazard cabinet is used to 
provide aseptic conditions for cell culture works in the laboratory. 
 
1.2.2 Supplemented DMEM 10% medium 
Basic DMEM, heat-inactivated FBS (Sigma, USA), Penicillin/Streptomycin (Sigma, 
USA) and Amphotericin B (Sigma, USA) were thawed in the water bath at 37°C. In the 
biohazard hood, 90 mL of basic DMEM was pipetted into a sterile beaker. Then, 10 mL of 
heat-inactivated FBS, 2 mL of Penicillin/Streptomycin and 1 mL of Amphotericin B were 
added to the solution. The solution was mixed s few times using 20 mL disposable syringe 
without needle (Terumo, Japan), and the solution was filtered through a 0.2-µm disposable 
syringe driven filter (Sartorius, Germany) (Figure 5) into a sterile laboratory bottle. The 
supplemented DMEM 10% medium was kept at 4°C in the refrigerator and thawed in the 
water bath at 37°C before used. 
 
1.2.3 Supplemented DMEM 20% medium 
Supplemented DMEM 10% medium and heat-inactivated FBS were thawed in 
water bath at 37°C. In the biohazard hood, 50 mL of supplemented 10% DMEM was 
transferred into a sterile beaker and 5ml of FBS was added to the solution. The solution 
was mixed a few times using a 20 mL disposable syringe without needle. Then, the solution 
was filtered through 0.2-µm disposable syringe driven filter into a laboratory bottle. The 
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supplemented DMEM 20% medium was kept at 4°C in the refrigerator and thawed in the 
water bath at 37°C before used. 
 
1.2.4 Freezing DMEM medium 
Basic DMEM and heat-inactivated FBS were thawed in a water bath at 37°C. In the 
biohazard hood, 8ml of basic DMEM, 10 mL of heat-inactivated FBS, and 2 mL of DMSO 
were transferred into a sterile beaker and mixed well using syringe without needle. After 
that, the solution was filtered through 0.2-µm disposable syringe driven filter into a sterile 
laboratory bottle. The medium was kept at 4°C in a refrigerator and thawed in room 
temperature before used. 
 
1.2.5 Phosphate buffer saline (PBS) pH 7.2 
Distilled water (1L) was added to a sterile Graduated Erlenmeyer flask with 
capacity and head space, IL. The flask was placed on a magnetic stirrer which was set to 
200 rpm, and a magnetic stirrer bar was added to the medium and started stirring. Then, 
1.52 g of sodium hydrogen phosphate (Na2HPO4) (AnalaR, England), 0.58 g of potassium 
dihydrogen phosphate (KH2PO4) (Merck, Germany), and 8.5 g of sodium chloride (NaCl) 
(Sigma, USA) were weighed and added to the solution while stirring. After that, pH of the 
medium was adjusted with sodium hydroxide (NaOH) solution to pH 7.2 using the pH 
Meter. When all of the constituents were completely dissolved, the magnetic stirrer bar was 
removed from the flask and filtered through Whatman filter paper into the laboratory bottle. 
Bottle with filtered PBS pH 7.2, with cap loosened was sterilized immediately by 
autoclaving at 121°C for 20 min. When the bottle was cooled down after sterilization, the 
cap was tightened and stored at room temperature. 
 
1.3 Quality Control, Sterility Testing, and Storage of Media 
1.3.1 Quality control 
A medium used for culture work needed to be tested before used. Sterile medium 
that was purchased readily made was possibly relied on the quality control carried by the 
supplier, except for any special requirements needed for the medium. However, the culture 
media used were prepared from powder and sterilized in the laboratory. Therefore, quality 
control involving both sterility check and culture testing were required to confirm the 
sterility.  
 
1.3.2 Sterility testing 
All of the culture media prepared were subjected for sterility check before used. 
Freshly prepared supplemented DMEM (10 mL) and freezing media (10 mL) were pipetted 
to a tissue culture flask (Fisher Scientific, Nunc) and incubated at 37°C, 5% CO2 and 95% 
air in the humidified incubator for at least three days. If any of the samples become cloudy, 
or any sign of contamination is detected, the whole batch the source prepared should be 
discarded. Preparation and sterilization steps would be done prior to get a completely sterile 
media for cell culture work.  
Moist heat sterilization or autoclaving is a highly effective method for heat stable 
solution such as H2O and PBS pH 7.2. Sterility check for autoclaved solutions were much 
less essential, provided that improper monitoring of the temperature and time spent for 
autoclaving was carried out. 
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1.3.3 Storage 
Briefly, media made up without glutamine should last for 6–9 months at 4°C. Media 
with glutamine, serum, or antibiotics could be stored for 2–3 weeks only. Thus, media with 
labile constituents should be prepared freshly and used within 3 weeks of preparation at 
4°C or stored at –20°C. Bottles of medium should be avoided to expose for a few hours 
under the fluorescent light. A dark freezer is recommended for a long-term storage.  
 
 
Figure 2.7: Refrigerator. Refrigerator with door open showing bottles of cell culture media 
stored at 4°C. 
 
2.0 Cell Culture 
2.1 Reviving cells 
Cells were kept in the liquid nitrogen (LN2) tank (MVE, USA) and stored at –196°C. 
Supplemented 20% medium was thawed in water bath at 37°C. In the biohazard hood, 1 
mL of supplemented DMEM 20% medium was pipetted into a 15 mL of centrifuge tube 
(Orange Scientific, Belgium). After that, cryovial (Simport, Canada) from the respective 
canisters was retrieved from the LN2 tank, and the cryovial was placed in a plastic beaker 
filled with ice. The code of the cells and the date of cryopreservation were recorded in the 
cell culture record book.  
The cryovial was swirled in the water bath at 37°C. When the cells in the cryovial 
were melted, the cryovial was brought to the biohazard hood immediately. The cells were 
transferred into the 15 mL centrifuge tube containing 1ml of supplemented DMEM 20% 
medium, followed by centrifuged (Kubota) at 1000 rpm for 5 min. After centrifugation, the 
supernatant was discarded, and 1 mL of supplemented DMEM 20% medium was added to 
the cell pellet which was then mixed well using a pipettor (1000 µL) (Eppendorf, Germany). 
Supplemented DMEM 20% (9 mL) was pipetted into a tissue culture flask. Then, 
the cells in the 15 mL centrifuge tube were transferred into the tissue culture flask using the 
pipettor. Finally, the cells were observed under microscope and maintained in the 
humidified incubator at 37ºC, with 5% CO2 and 95% air. Growth of cell culture was 
observed every two days and the old media was replaced with fresh supplemented DMEM 
20% media. When the cells were fully confluent, the cells were subcultivated. 
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Figure 2.8: Example of Cell Morphology in Culture. Subconfluent human breast cancer 
cell line, MDA-MB-231 (oestrogen-receptor negative, ER–) was observed under phase-
contrast microscope with magnification 100×. 
 
 
Figure 2.9: Example of Cell Morphology in Culture. Confluent human breast cancer cell 
line, MDA-MB-231 (oestrogen-receptor negative, ER–) was observed under phase-contrast 
microscope with magnification 100×. 
 
2.2 Subculture of cells 
 Supplemented DMEM 10% medium was thawed in the water bath at 37°C. 
Accutase (1 mL) (Innovative Cell Technologies, San Diego, CA), the cell detachment 
solution was thawed at room temperature. In the biohazard hood, old media in the tissue 
culture flask was discarded and the cells were washed with 10 mL of sterile PBS, pH 7.2. 
Then, 3 mL of PBS was pipetted into the tissue culture flask and subsequently added with 1 
mL of accutase. After that, the tissue culture flask was incubated in the humidified 
incubator at 37ºC, with 5% CO2 and 95% air for 5–10 min.  
 After 5 min incubation time, the tissue culture flask was tapped gently in order to 
make sure all of the cells were detached. The detached cells were transferred into a 15 mL 
centrifuge tube, and centrifuged at 1000 rpm for 5 min. While waiting centrifugation to 
complete, 9ml of supplemented DMEM 10% media was pipetted into each of three new 
tissue culture flasks. After centrifugation, the supernatant was discarded and the cell pellet 
was mixed with 3ml of supplemented DMEM 10% media using a pipettor (1000 µL). Then, 
the cells suspension (1 mL) was distributed into each flask and maintained in the 
humidified incubator at 37ºC, with 5% CO2 and 95% air. 
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Figure 2.10: CO2 incubator. CO2 incubator (Shel Lab) with door open showing cell 
culture flasks and multi-well plates. 
 
2.3 Cryopreservation of cells 
The cells were maintained in fresh supplemented 10% DMEM media for 24–48 h 
before cryopreservation was done. Freezing medium was thawed at room temperature. In 
the biohazard hood, old media in the tissue culture flask was discarded and the cells were 
washed with 10 mL of sterile PBS, pH 7.2. Then, 3 mL of PBS was pipetted into the tissue 
culture flask and subsequently added with 1 mL of accutase. After that, the tissue culture 
flask was incubated in the humidified incubator at 37ºC, with 5% CO2 and 95% air for 5–10 
min. 
After 5 min incubation time, the tissue culture flask was tapped gently in order to 
make sure all of the cells were detached. The detached cells were transferred into the 15 
mL centrifuge tube, and centrifuge at 1000 rpm for 5 min. After centrifugation, 
supernantant was discarded and the cell pellet was mixed well with 3 mL of freezing media 
in the centrifuge tube using a pipettor (1000µL). Next, 1 mL of cell suspension was 
distributed into three cryovials each. The cryovials were labeled and placed in a styrofoam 
cup and suspended in LN2 vapour (–120°C) in the dewar for 4 h. Eventually, the cryovials 
were placed into cryocane and the cane was kept in the dewar canister. The canister was 
plunged into LN2 (–196°C). 
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Figure 2.11: Liquid Nitrogen Freezer (MVE). Narrow-necked freezer with storage on 
canes in canisters at –196°C. 
 
 
Figure 2.12: Interior of Liquid Nitrogen Freezer. Six canisters were positioned under 
shoulder of the freezer. 
 
 
Figure 2.13: Canes in Canister. Cryovials are clipped onto aluminum cane, placed in the 
canister, and stored in the liquid nitrogen tank at –196°C. 
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APPENDIX III: SODIUM NITRITE STANDARD CURVE 
 
1.0 Generation of Sodium Nitrite Standard Curve 
Ptotocol for generation of Sodium Nitrite (NaNO2) Standard Curve had been 
discussed in Chapter 3 (sections 3.3.5 and 3.3.6). A two-fold serial dilution of NaNO2 was 
performed, starting at 100 µM to 1.56 µM (Chapter 3, Figure 3.4). The optical density at 
540 nm (OD540) obtained using the Emax precision microplate reader (Molecular Devices) 
was presented in Table 2.1. 
 
Table 3.1: Absorbance readings at 540 nm for a two-fold serial dilution of sodium nitrite 
coducted using a flat-bottom 96-well plate 
 Absorbance (n = 3) 
A 0.539 0.521 0.534 
B 0.276 0.227 0.262 
C 0.140 0.146 0.145 
D 0.086 0.092 0.087 
E 0.069 0.066 0.064 
F 0.048 0.054 0.050 
G 0.041 0.043 0.043 
H  0.036 0.036 0.035 
 
Three absorbance readings for each row (A–H) in Table 2.1 were averaged and transform 
to be more presentable as in Table 2.2. 
 
Table 3.2: Transformed data for plotting Sodium Nitrite Standard Curve 
 Concentration 
(µM) 
Average of Absorbance 
(ABS) 
ABS – Blank 
(Blank, H = 0.036) 
A 100 0.531 0.495 
B 50 0.255 0.219 
C 25 0.144 0.108 
D 12.5 0.088 0.052 
E 6.25 0.066 0.03 
F 3.13 0.051 0.015 
G 1.56 0.042 0.006 
H 0 0 0 
 
Absorbance (ABS – Blank) versus NaNO2 concentration was plotted in a linear least square 
regression format (Figure 2.1) using Microsoft Exel 2010. 
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Nitrite concentration (µM) 
y = absorbance 
x = nitrite concentration 
y = mx + c 
m = coefficient 
c = constant = 0 
R
2
 must be 0.95 and above 
 
Figure 3.1: Sodium Nitrite Standard Curve. Nitrite concentrations were determined from 
a least squares linear regression analysis of NaNO2 standard curve. 
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APPENDIX IV: THIN-LAYER CHROMATOGRAPHY PROTOCOL 
 
1.0 Optimization Method for Development of Mobile Phase 
The PRISMA system introduced by Nyiredy in 1985 (Houghton & Raman, 1998) 
was applied in the optimization of mobile phase development for TLC in this study. There 
are nine groups of solvents which are classified based on their „solvent strength‟ (related to 
its polarity) as listed in Table 3.1.  
The selected crude extract was run in one example of each group of the solvents. 
Three solvents giving the best resolution of the components of the crude extract were 
identified. A PRISMA construction (Figure 3.1) was drawn from these three solvents. 
Height of each vertical side corresponds to calculated solvent strength for each solvent. 
The solvent strengths of the two highest sides are then reduced by proportionate 
adding of hexane to bring them both to the same solvent strength as the lowest of the three. 
A 1:1:1 combination of the three adjusted solvents was then used as the mobile phase for 
TLC testing of the extract. If the zones run too high, hexane was added until satisfactory 
retardation factor (or Rf value) was obtained. 
 
Table 4.1: Solvent groups for PRISMA TLC optimization (Houghton & Raman, 1998) 
Group Solvents Solvent strength 
1 Hexane 0 
2 n-Butylether 2.1 
 i-Propylether 2.4 
 Methyl-t-butylether 2.7 
 Diethylether 2.8 
3 n Butanol 3.9 
 i-Propanol 3.9 
 n-Propanol 4.0 
 Ethanol 4.3 
 Methanol 5.1 
4 Tetrahydrofuran 4.0 
 Pyridine 5.3 
 Methoxyethanol 5.5 
 Dimethylformamide 6.4 
5 Acetic acid 6.0 
 Formamide 9.6 
6 Dichloromethane 3.1 
 Dichloroethane 3.5 
7 Ethyl acetate 4.4 
 Butanone 4.7 
 Dioxan 4.8 
 Acetone 5.1 
 Acetonitrile 5.8 
8 Toluene 2.4 
 Benzene 2.7 
 Nitrobenzene 4.4 
9 Chloroform 4.1 
 Nitromethane 6.0 
 Water 10.2 
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Figure 4.1: PRISMA construction from three mobile phases giving best separation. 
Height of each vertical side corresponds to calculated solvent strength for each solvent. 
 
Solvent B 
Solvent C 
Solvent A 
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2.0 Preparation of Chromogenic Sprays 
2.1 50% Sulphuric Acid 
Spray reagent, 50% sulphuric acid (H2SO4) was prepared manually in the laboratory 
by mixing 50 mL sulphuric acid with 50 mL dH2O. 
 
2.2 Dragendorff’s Reagent 
Dragendorff‟s reagent is available commercially or can be prepared manually in the 
laboratory. Firstly, 1.7 g basic bismuth nitrate was dissolved in 100 mL mixture of water-
acetic acid (dH2O-HOAc) (80:20). Next, 40 g potassium iodide (KI) was dissolved in 100 
mL dH2O. Then, a 1:1 mixture of the two solutions was made. This was the stock solution. 
Finally, 5 mL of each of the solutions were mixed and added to 20 g acetic acid in 70 mL 
dH2O for the spraying solution. 
 
2.3 Vanillin/Sulphhuric Acid Reagent 
Vanillin/sulphuric acid reagent can be prepared manually in the laboratory. Two 
types of spraying solutions were prepared. Solution A was prepared by mixing 5 mL 
sulphuric acid with 95 mL ethanol. Solution B was prepared by adding 1 g vanillin in 100 
mL ethanol. TLC plate was sprayed with Solution A and followed by Solution B, and 
subjected to be heated at 110°C. 
 
 
